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Oxygen carrying capacity has a positive association with endurance performance. As 
such, techniques such as altitude training can increase red cell mass (Hbmass) and have been shown 
to improve sea level performance. In addition to haematological changes (i.e. Hbmass), hypoxia 
can have a metabolic influence (e.g. increased oxidative and anaerobic enzyme concentration) 
resulting in changes to metabolites, which reflect systems level adaption to low oxygen carrying 
capacity environments. The use of metabolomics; therefore, represents an ideal analytical method 
to examine the physiological adaptations to hypoxia as this technique provides the ability to 
simultaneously analyse large number of metabolites present in human biological samples. The 
purpose of this thesis was to examine the acute (14 d) and chronic (42 d) influence of low oxygen 
carrying capacity on performance (Chapter Four), haematology (Chapters Three, Four and Five) 
and the metabolic profile (Chapter Three and Five).  
 Chapter Three was conducted as an observational study to examine metabolic changes 
associated with moderate altitude exposure (~3000 m; 196.4 ± 25.6 h) during a 14 d Live High 
Train Low altitude camp in 10 endurance runners (six males, four females; 29 ± 7 y). Resting 
whole blood samples were collected before altitude (baseline), 3 d and 14 d of altitude camp and 
analysed using mass spectrometry. From this data, acute metabolic profiles to altitude exposure 
were developed, which demonstrated significant separation between measured time points. 
Specifically, through mass spectrometry 36 metabolites were identified from metabolite classes 
relating to amino acids, glycolysis, and purine metabolism and indicate a shift in substrate 
utilisation (i.e. greater carbohydrate use) during acute hypoxic exposure. From canonical variate 
analysis, trajectories of the 36 identified metabolites were identified, with two different 
trajectories observed during the acute moderate hypoxic exposure. Importantly, principal 
components analysis highlighted greater variance in measured metabolites between-person when 
compared to within-person. This finding is consistent with previous literature and indicates 
individual variability during the adaptive response to altitude exposure.  
During Chapter Four and Five, Australian Red Cross blood donation (~470 mL) was used 
to reduce the oxygen carrying capacity of 13 male participants, who were then monitored over a 
42 d period. Measures of haemoglobin concentration and haematocrit % were obtained before 
blood removal (Baseline) and at seven time points (24 h, 7 d, 14 d, 21 d, 28 d, 35 d and 42 d) 
following blood removal. Additionally, exercise tests were conducted to assess fitness (V̇O2max) 
and performance (4-minute self-paced cycling time trial [4MMP]) (Chapter Four and Five) and 4 
mL blood samples were obtained for metabolomic analysis (Chapter Five).  
 
vi 
The purpose of Chapter Four was to examine the impact of reduced oxygen carrying 
capacity on V̇O2max and both the performance and pacing during a 4MMP. During this study, only 
participants that were trained cyclists (n = 7) were used for the analyses. Blood removal resulted 
in a maximal decrease of 5.4 % in V̇O2max (24 h), while the average power output during the 
4MMP decreased significantly at 24 h (7 ± 6%), 7 d (6 ± 8%) and 21 d (4 ± 6%) when compared 
with baseline values. Furthermore, the aerobic contribution during the 4MMP was significantly 
reduced, when compared with baseline, by 5 ± 4%, 4 ± 5% and 4 ± 10% at 24 h, 7 d and 21 d, 
respectively. The rate of decline in power output upon commencement of the 4MMP was 
significantly attenuated and was 76 ± 20%, 72 ± 24% and 75 ± 35% lower than baseline at 24 h, 
21 d and 42 d, respectively. These changes were unrelated to differences in haemoglobin 
concentration. Findings from this study indicated that reducing oxygen carrying capacity can 
influence pacing and the performance of middle-distance endurance events. Specifically, it 
appears that changes in pacing and performance during middle-distance endurance events are 
related to the ability to contribute power from aerobic metabolism, as an increase in anaerobic 
contribution was not observed.  
The focus of Chapter Five was to investigate, in addition to measures obtained in Chapter 
Four, the acute and chronic changes to the metabolic profile of individuals after blood donation. 
Untargeted metabolomic analyses was used on 4 mL whole blood samples obtained from 13 
participants at baseline and at multiple time points over 42 d following the removal of some 470 
mL of whole blood. Similar to findings in Chapter Four, whole blood removal resulted in a 
maximal decrease in V̇O2max (-6%) and 4MMP (-7%), with both occurring at 7 d. However, with 
the inclusion of the additional six “untrained” participants, significant reductions in oxygen 
delivery (V̇O2) only persisted for 24 h compared to 21 d in the subset of trained males (Chapter 
Four). The accelerated return is likely associated with participant fitness (i.e. V̇O2max: 53.0 ± 10.9 
mL·kg-1·min-1; (Chapter Five) vs. V̇O2max: 60.7 ± 5.5 mL·kg-1·min-1 (Chapter Four)) with the 
addition of lesser trained males seemingly diminishing the influence of oxygen delivery in the 
later time points. The metabolomics analysis revealed multi-factorial changes with 40 metabolites 
deemed significant post blood removal. Through hierarchical cluster analysis, consistent with 
acute findings during Chapter Three, purine metabolites were significantly elevated immediately 
following blood removal (acute) and remained elevated throughout the 42 d monitoring period. 
This finding indicates a chronic adaptive response, which may occur to enhance oxygen delivery 
to the periphery.  
 Overall, the series of studies have shown separation in plasma metabolites during acute 
moderate altitude exposure, which is likely linked to substrate utilisation and purine metabolism. 
Furthermore, decreasing oxygen carrying capacity does not appear to influence the anaerobic 
contribution to high-intensity middle-distance endurance exercise even with observed reductions 




Three and Five) has identified purine metabolism as an important marker of adaptation to hypoxia. 
Further research should focus on purine metabolism as a possible robust marker of hypoxic 
exposure and work to identify the unknown metabolites which were shown to be significant in 
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Chapter 1  Introduction 
1.1 Background 
Within endurance sport, the ability to supply the body with energy through aerobic means is 
essential for overall success. Indeed, the measurement of maximal aerobic capacity (V̇O2max) is 
highly correlated with endurance performance [1]; thus, training the aerobic system is a key focus 
for many endurance-based athletes [2-4]. However, when examined in a non-heterogeneous group 
(i.e. trained athletes; V̇O2max: >60 mL.kg-1.min-1), the association between aerobic capacity and 
endurance performance is reduced [5].  In this circumstance other physiological factors have been 
identified as influencing endurance performance [6] including; economy of motion [7], fractional 
utilisation of V̇O2max [8] and the sustained exercise intensity at the onset of blood lactate 
accumulation [1, 9]. Importantly, oxygen carrying capacity has a positive association with all of 
the above-mentioned predictors of performance [10]; thus, techniques (e.g. altitude exposure, 
erythropoietin administration, blood transfusions) which increase red blood cell mass (Hbmass) can 
improve performance [11-14].  
It is well documented that altitude training can improve endurance performance [15-20]  by 
increasing Hbmass [16, 21, 22].  Indeed, altitude training methods such as living and training at 
natural altitudes (> 2500 m), living at altitude and training near sea-level and living within 
artificial altitude environments at sea-level increased both Hbmass and endurance performance [23, 
24]. It is possible; however, that change in Hbmass is not the primary factor influencing endurance 
performance after altitude exposure. In well-trained athletes, Gore et al. (1997) and Levine et al. 
(1997)  observed no change in Hbmass following prolonged altitude exposure [25, 26], while others 
have observed only a minimal association between change in Hbmass and performance after 
altitude training [27]. Furthermore, the individual response to altitude exposure appear to be 
highly variable with some individuals demonstrating increased Hbmass without changes in V̇O2max 
while others have shown a reduction in Hbmass but an increase in V̇O2max [28]. Despite the lack of 
consistency, a recent meta-analysis concluded that for every 100 h spent at moderate altitude of 
3000 m an increase of 1% in Hbmass should be expected [13]. In addition to haematological 
changes, altitude training has been shown to increase skeletal muscle buffering capacity, oxidative 
and anaerobic enzyme concentration and lactate concentration, and result in a shift in substrate 
utilisation [29-31]. From these data, it is clear that adaptation to hypoxia occurs at a systemic 
level; however, to the authors knowledge, no studies have attempted to examine the adaptive 
process to hypoxia using a whole system approach.   
Demonstrating promise in human disease [32] and nutritional [33, 34] research, metabolomics 
is gaining interest in the field of exercise science [35]. Providing the ability simultaneously 
analyse large number of metabolites present in human biological samples, the use of analytical 
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technologies such as nuclear magnetic resonance (NMR) and mass spectrometry (MS) enables 
researchers to examine physiological outcomes using a whole system approach [36]. Within 
exercise science, metabolomic methods have been used to examine metabolites associated with 
glucose, lipids and, amino acids [35, 37], and more recently to create metabolite profiles to 
identify sports class (i.e. power vs. endurance) and training status (i.e. national vs. elite) of athletes 
[38]. Non-targeted metabolomic methods in exercise science have predominately measured 
metabolites related to energy production [35, 39]. Importantly, Pohjanen et al. (2007) used 
untargeted metabolomics to examine metabolite changes following a single exercise bout, 
highlighting 34 significantly altered metabolites (p < 8.1e-05) [40]. While the identified 
metabolites were not unique in biochemical terms, many were unlikely to have been measured 
using traditional methodologies. Metabolomics therefore represents an ideal analytical method to 
examine physiological adaptations to hypoxia. It is likely that using this technique, a greater 
understanding of the system change will be possible; thereby identifying new areas of focus for 
research in hypoxia. 
1.2 Purpose of the research 
Understanding human adaptation to low oxygen carrying capacity is essential for the use 
of this methodology in sport. However, most research has examined the influence of low oxygen 
carrying capacity using a reductionist approach, focusing only on key variables (i.e. Hbmass) 
meaning that our current understanding is limited. The use of metabolomics can provide whole 
system analyses to hypoxic exposure possibly identifying new areas of focus for future research. 
Therefore, the purpose of the thesis is to explore low oxygen carrying capacity and its influence 
on fitness and performance as well as describe the acute and chronic physiological and 
biochemical adaptions to low oxygen carrying capacity. This thesis used two models of hypoxic 
exposure; 1) moderate altitude and 2) whole blood donation. Through this approach, this thesis 
will examine the adaptation to low oxygen carrying capacity during a commonly utilised training 
methodology (Live High Train Low simulated altitude exposure) and during a highly controlled 
decrease in oxygen carrying capacity (blood donation). The purpose of the individual chapters of 
the thesis has been outlined below. 
Chapter Three: 
“Metabolomic profiling of a 14-day altitude exposure in endurance runners” 
The purpose of Chapter Three was to determine the influence of 14 d of normobaric hypoxic 
altitude exposure at ~3000 m on the human plasma metabolite profile in well-trained endurance 
runners. Furthermore, to demonstrate the utility of metabolomic methods to yield insights into 






“Blood removal influences pacing during a 4-minute cycling time trial” 
Given the importance of both aerobic and anaerobic contribution as key to pacing strategies the 
purpose of Chapter Four was to examine the influence of manipulating aerobic contribution 
following blood donation on pacing strategies, performance and the impact on anaerobic energy 
contribution.  
Chapter Five: 
“Purine metabolites are associated with the physiological response to standard blood donation” 
Chapter Five investigated the metabolic changes following blood donation using an untargeted 
metabolomic approach to track the associated changes up to 42 d post blood donation. This study 
represents an extension to the work examined in Chapter Four. 
1.3 Significance of the research 
This research will improve our understanding of reduced oxygen carrying capacity in 
athletes. Little is known about biochemical adaptation during reduced oxygen carrying capacity, 
with many studies measuring only single metabolites, making the interpretation of adaptation 
difficult. Therefore, research is needed to collectively examine metabolite markers to understand 
the biochemical adaptation. A greater understanding of biochemical changes using metabolomic 
analysis will aid in explaining the between athlete variability and associated performance changes 
with reduced oxygen carrying capacity. 
1.4 Research questions 
This thesis addressed the following research questions: 
Chapter Three - Metabolomic profiling of a 14-day altitude exposure in endurance runners 
1. To what extent does 14 d of normobaric, simulated altitude (~3000 m) influence the metabolic 
profile of ten highly-trained middle distance runners? 
2. Can metabolomics reveal differences in adaptive processes of individuals during 14 d altitude 
camp? 
Chapter Four – Blood removal influences pacing during a 4-minute cycling time trial 
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1. Does blood donation affect pacing strategies during a self-paced 4-min cycling time trial in 
trained cyclists?  
2. Does blood donation affect anaerobic and aerobic energy contribution during a self-paced 4-
min cycling time trial in trained cyclists? 
Chapter Five – Purine metabolites are associated with the physiological response to standard 
blood donation 
1. Using an untargeted metabolomic approach, to what extent will the plasma metabolite profile 
change in response to blood donation? 
2. Can metabolomics track metabolic disturbances immediately following and up to 42 d 
following blood donation? 
1.5 Thesis organisation 
This thesis consists of six chapters. Chapter One provides a general introduction to the 
thesis. Chapter Two outlines a review of literature and is separated in two parts with Part I focused 
on; i) outlining the influence of aerobic metabolism on athletic performance, ii) identifying key 
literature focusing on the impact of blood manipulation on aerobic metabolism and exercise 
performance and iii) introducing the role of metabolomics in the field of exercise science 
generally, and specifically blood manipulation. Part II of the review provides background on 
common techniques in metabolomics and highlights important areas of concern for the use of 
metabolomics in exercise and sports science research. Chapters Three, Four and Five present the 
experimental studies. Finally, Chapter Six consists of the thesis summary and also discusses the 
potential limitations and future directions as guided by the thesis. 
Each experimental chapter is presented in manuscript format with its own abstract, 
introduction, methodology, results and discussion section. Experimental chapters appear in the 
format required by the individual journal in which they have been published, are currently under 
review, or for which they are planned to be submitted. Slight variations have been made to 
increase thesis consistency. Additionally, for ease of reading, a single reference style was used 




Chapter 2 Review of the literature 
2.1 Introduction 
Historically, maximal aerobic power (V̇O2max) has been considered as an essential 
component of performance during elite endurance sports [41]. However other measures, including 
lactate and anaerobic thresholds [42], economy of motion [5] and race strategies [43] can also 
influence performance and in some circumstances provide better estimates of success when 
compared with V̇O2max alone [5, 44]. With the exception of race strategy, oxygen carrying 
capacity can influence all of the above-mentioned key variables of endurance performance [10]. 
As such, training strategies, such as hypoxic exposure, have been used with the intent of 
increasing oxygen carrying capacity and therefore endurance performance [45]. However, it is 
possible that other physiological changes associated with hypoxic exposure could influence 
endurance performance in the absence of changes to oxygen carrying capacity [46, 47]. Within 
the current literature, studies have examined the additional changes associated with hypoxic 
exposure (see the review by Gore et al. 2007) [46], with very few taking a whole system approach 
[31, 48, 49]. With the advent of new technologies (i.e. high-resolution mass spectrometry), the 
field of metabolomics may allow in-depth analysis of many of the variables which change with 
hypoxic exposure, thereby identifying new biological pathways of interest.  
The use of metabolomics within human physiology is relatively new [50]; yet, provides 
an exciting avenue to explore both known and unknown changes associated with hypoxic 
exposure. Therefore, the purpose of this literature review is to, in Part I; 1) outline the influence 
of aerobic metabolism on athletic performance; 2) identify key literature focusing on the impact 
of blood manipulation on aerobic metabolism and exercise performance; and 3) introduce the role 
of metabolomics in the field of exercise science but more specifically, blood manipulation. Part 
II of this review will provide a background on the common techniques in metabolomics and 





2.2 Oxygen consumption and endurance performance 
Within endurance sport, the ability to rapidly supply the body with energy via aerobic 
means is essential for overall success. Historically, the measurement of an individual’s maximal 
ability to consume oxygen (V̇O2max) has been used as a predictor of endurance performance [51, 
52] with strong associations observed between V̇O2max and common endurance performance tests 
such as the multi-stage shuttle run (r = 0.93), and 5 and 10 km running time trials (r = -0.95 and -
0.89, respectively) [53]. Additionally, possessing a higher V̇O2max is associated with enhanced 
ability to recover from repeated efforts leading to greater performance and training adaptation 
[54]. When assessed in a homogeneous sample however, the predictive strength of V̇O2max for 
endurance performance is less clear. For instance, in 19 runners with similar fitness levels 
(V̇O2max: 71.70 ± 2.80 mL.kg-1.min-1), V̇O2max explained only 1.4% of the variation in 10 km 
running performance [5], in stark contrast to the 79% observed in a heterogeneous sample [53]. 
These findings indicate that V̇O2max alone cannot be used as a true indicator of performance. 
Specifically, as groups of individuals become more homogenous in fitness, other factors become 
more relevant to performance [5, 55, 56].  Indeed, the power output or running velocity achieved 
at the lactate or anaerobic thresholds are better predictors of endurance performance when 
compared with V̇O2max [57-59]. Nevertheless, dependent on the level of athlete (i.e. untrained vs. 
trained), these thresholds can occur between 50% and 90% of V̇O2max [9]; thus, a well-developed 
aerobic energy system is still essential to allow competitive success. 
2.3 Performance and energy contribution 
Within the literature, time trials are commonly used to assess performance [60-62]. 
Although evidence indicates that a constant pace should be undertaken to ensure the ‘best’ 
performance [63], this technique is rarely achieved, with most individuals adopting a positive 
pacing strategy [64, 65]. During exercise, the selection of a pacing strategy is influenced by both 
psychological [66] and physiological factors [63]; however, the psychological impact is beyond 
the scope of this thesis. During middle distance (i.e. events lasting 2-4 minutes) and endurance 
events, pacing strategies are typically characterised by a high reliance on aerobic metabolism [43, 
67, 68]. Recently, studies have focused on the distribution of energy expenditure during 
competition [43, 60, 69], as the contribution of aerobic and anaerobic energy to power output will 
vary energy expenditure and the pattern of power output during the race. It has been suggested 
that anaerobic energy stores are likely to have greater influence on self-selected pacing. 
Nevertheless, it is thought that a fixed limit of anaerobic work occurs during a middle distance 
event, and as such, the anaerobic power is thought to be the main metabolic pathway to 




Recently, research has sought to explore the influence of anaerobic contribution without 
supplementation. For example, Lima-Silva et al (2013) observed a reduction in overall 
performance (~11%) during a cycling time trial, following a validated protocol designed to lower 
muscle glycogen [71]. The authors attributed the reduction in performance to a decrease in 
duration of the fast start as well as a significant reduction in power output during the final stages 
of the trial. Similarly, Correia-Oliveira et al. (2014) observed increased performance times (432.8 
± 8.3 s) and decreased power outputs (204.9 ± 10.9 W) compared to the control (420.8 ± 6.4 s 
and 218.4 ± 9.3 W) following an exercise protocol designed to reduce glycogen [72]. Together 
these results indicate anaerobic contribution is influenced by energy substrates available during 
the middle distance events. 
2.4 Factors which can limit oxygen consumption 
Endurance sport relies on aerobic metabolism which precipitates the need to understand 
the complexities of this system, specifically the factors which can limit oxygen consumption. This 
review has identified five areas in which limitations can negatively impact performance; 1) 
oxygen availability, 2) pulmonary system, 3) cardiac system, 4) oxygen transport in the blood and 
5) peripheral limitations. A summary in the context of elite performance is provided below. 
2.4.1 Oxygen availability 
Ventilation and ultimately the diffusion of oxygen into the body are primarily driven by 
pressure gradients. At sea level (760 mm Hg), pulmonary ventilation allows for diffusion of high 
concentration of oxygen into the lungs and circulation while removing carbon dioxide. Changes 
in the environmental availability of oxygen, through artificial means (i.e. reduced availability) or 
naturally occurring through reduced atmospheric pressure with altitude exposure can negatively 
impact V̇O2max [73-75] and exercise performance [76, 77]. Indeed, Peltonen et al. (2001) observed 
a decrease in sustainable power output during a series of incremental cycling tests in elite 
endurance males under hypoxic (15% oxygen; 334 ± 41 W) compared with normoxic (20.9% 
oxygen 383 ± 46 W) and hyperoxic (32% oxygen 404 ± 58 W) conditions [78]. The authors 
postulated that the differences in power output between trials could be influenced by a central 
governor [79], where reduced cardiac output and V̇O2max are a result of acute hypoxia. Subsequent 
studies have challenged the central governor theorem. Clark et al. (2007), investigated cycling 
performance (power output and pacing) at four simulated altitudes (200, 1,200, 2,200, 3,200 m) 
using a 5-minute cycling time trial. The authors reported a dose response in power output to 
hypoxia during the 5-minute cycling time trial. Interestingly, pacing strategy remained similar for 
all trials; however, it was noted that those participants starting at higher altitudes participants were 
observed to have reduced power in the later period of the trial, which may indicate an 
inappropriate pace. Similarly, Wehrlin and Hallen (2006), examined six simulated altitudes (300, 
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800, 1300, 1800, 2300 and 2800 m) above sea level on V̇O2max and performance using a hypobaric 
chamber [76]. The authors findings demonstrated a linear decrease in V̇O2max (66 ± 1.6 mL·kg-
1·min-1 at 300 m vs. 55 ± 1.6 mL·kg-1·min-1 at 2800 m) and decreased arterial haemoglobin 
saturation (89.0 ± 2.9% at 300 m vs. 76.5 ± 4.0% at 2800 m). There appears to be an association 
between V̇O2max and arterial saturation [80], where ~70% decrease in V̇O2max is explained by the 
decrease in arterial saturation. The decrease in V̇O2max at moderate altitude levels seemingly 
supports previous research [74, 81], where exercise-induced hypoxemia can occur in endurance 
trained athletes with high V̇O2max even at sea level. Interestingly, the decrease in arterial saturation 
is not apparent in an untrained individual, likely because endurance trained individuals can work 
at the steep end of the oxyhaemoglobin curve, causing greater hypoxaemia [80]. 
2.4.2 Pulmonary limitations 
Pulmonary ventilation (i.e. inhalation and exhalation) of atmospheric air and diffusion of 
oxygen into the pulmonary blood is recognised as a limitation during exercise [82]. Defined as 
transit time issues, reduced efficiency and extraction at the alveoli are thought to be the primary 
causes of pulmonary dysfunction [83, 84]. In professional athletes (77.5 mL·kg-1·min-1), transit 
time issues are more prevalent due to high cardiac outputs resulting in a high velocity of blood 
flow through the pulmonary circulation [84-87]. The combined effect of increased cardiac outputs 
and blood velocity can result in inadequate time for full saturation (i.e. <90% saturation), 
representing a diffusion limitation in elite athletes [88]. The specific pulmonary limitation in 
trained populations was illustrated by Powers et al. (1989) who showed through breathing 
hyperoxic gas mixture (26% O2) could increase the alveolar arterial diffusion gradient, a known 
limitation during maximal exercise. This method allowed for a measurable increase in O2 
saturation from 90.6% to 95.9% as well as V̇O2max (70.1 to 74.7 mL·kg-1·min-1) in professional 
athletes. Interestingly, no impact was observed in a trained population (56.5 mL·kg-1·min-1) [83], 
where cardiac outputs are significantly lower when compared to professional athletes [89]. 
Pulmonary limitations have been documented in altitude environments, where the atmospheric 
O2 partial pressure is reduced, impacting the alveolar arterial diffusion gradient [73, 90]. For 
example, Gore et al. (1997) measured 20 healthy men (11 trained, 9 untrained) to compare mild 
hypobaria (MH; 50 mmHg, 580 m altitude) on V̇O2max [81]. The authors reported a decrease in 
arterial saturation in both groups during maximal exercise; however, the response was greatest in 
the trained group (rest vs. V̇O2max; 97.7 ± 0.1 vs. 90.4 ± 0.5 %). From these studies, evidence 
indicate that pulmonary diffusion does not limit V̇O2max in individuals classified as moderately 
trained. However, in highly trained athletes, where cardiac output is high, pulmonary transit time 




2.4.3 Cardiac limitations 
In healthy populations, the cardiovascular system is considered a limitation for maximal 
oxygen consumption [91, 92] and consequently endurance performance [91, 93]. Through the 
study of endurance training adaptations in healthy populations, 70-85% of the limitations in 
V̇O2max are attributed to maximal cardiac output  [91, 94-96]. As maximal heart rate remains 
relatively unchanged until the age of  ~35 years [97], lower stroke volume has the largest impact 
on cardiac output [92, 98, 99]; thus, factors which either positively or negatively influence stroke 
volume can influence V̇O2max and endurance performance [100]. For example, Ogawa et al. (1992) 
compared two cohorts which were differentiated by age (trained young men age: 28 ± 3 years vs. 
trained old 63 ± 4 years) on measures of V̇O2max, maximal cardiac output and stroke volume [101]. 
The authors demonstrated decreased stroke volume (8%), maximal cardiac output (17%) and heart 
rate all contributed to an age-related decline in V̇O2max (24%). Consequently, as individuals age, 
both maximal heart rate and stroke volume are reduced [101, 102], accounting for the consistent 
age-associated decline (~10 % per decade) in V̇O2max observed after ~30 years of age [103-105].  
2.4.4 Oxygen carrying capacity 
In endurance athletes, a well-developed ability to extract oxygen from the blood (see 
section 2.4.6) means that oxygen delivery is considered the greatest limiting factor to aerobic 
metabolism [106, 107]. Therefore, the oxygen carrying capacity of blood can have a profound 
influence on oxygen consumption [108, 109] and endurance performance [110, 111], even with 
optimally functioning pulmonary and cardiac systems [106-108]. For instance, through the use of 
phlebotomy, Ekblom et al. (1972) observed a 13% decrease in haemoglobin concentration ([Hb]), 
which led to a 10% decrease in V̇O2max (4.54 to 4.09 L.min-1) [112]. Importantly, through the 
sequential removal of whole blood (400, 800 and 1,200 mL), a dose response was established 
between the decrease in [Hb] and V̇O2max [112]. Increasing oxygen carrying capacity can also 
influence endurance performance [113, 114]. In healthy individuals at altitude (10,500 ft or 3200 
m), the transfusion of 1,000 mL of fresh blood immediately increased haematocrit (Hct %) by 
12%, resulting in a 35% increase in exercise tolerance. However, this effect was only transient 
with a return to baseline after 50 d likely due to induced polycythemia, where abnormally 
increased level of red blood cells exist. 
2.4.5 Indicators of oxygen carrying capacity 
Within the literature, multiple measures of oxygen carrying capacity exist including [Hb], 
Hct%, oxygen saturation (SO2), total haemoglobin mass (Hbmass) and red blood cell volume 
(RVC). Highly utilised [115-118], [Hb] and Hct % are relatively easy to measure as they form 
part of common pathology tests and, along with SO2, provide an indication of the amount of 
oxygen available for delivery, per unit of blood volume [119]. By definition, [Hb] refers to the 
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concentration of haemoglobin within the entire blood volume, whereas Hct% is the measure of 
the percentage of red blood cells relative to fluid volume. Both measures have evident 
shortcomings for determination of oxygen transport. In athletic populations, [Hb] is influenced 
by cell compartmental fluid shifts, caused by changes in plasma volume, which can influence the 
accuracy of the measurement and are especially apparent following exercise and during periods 
of sickness [111, 120]. During exercise, shifts in plasma volume can result in haemoconcentration 
(increasing [Hb] per unit of blood) or haemodilution (decreasing [Hb] per unit of blood), both of 
which have been suggested to result in a poor relationship between [Hb] and V̇O2max [121]. Bejder 
et al. (2017) showed a 10% increase in plasma volume following a 250% increase in training load 
[122]. With the increased training load, plasma volume increased by 10%, consequently 
decreasing the concentration of [Hb] by ~6%. The authors reported the time course of recovery 
for both plasma volume and [Hb] concentration as 2 and 4 days respectively, following the 
reversion to baseline training load [122]. Similar to [Hb], Hct% is influenced by plasma fluid 
shifts [123]. For instance, exercise in the heat is associated with fluid loss through sweating [124] 
and an increase in Hct % via dehydration [125, 126]. Within the literature, both [Hb] and Hct% 
continue to be used, yet researchers have collectively agreed that these measures should be viewed 
with some caution [127]. Regardless, increased [Hb] and Hct% can increase V̇O2max [128, 129], 
with Gledhill et al. (1999) proposing that V̇O2max can increase ~1% for each 3 g.L-1 [Hb] [129].  
2.4.5.1 Haemoglobin mass 
Total haemoglobin mass (Hbmass) can be measured independently of plasma volume 
fluctuations; thus, providing a better measure of oxygen carrying capacity when compared with 
[Hb] and Hct%. Indeed, a strong correlation (r = 0.97) has been reported between Hbmass and 
V̇O2max [12, 114, 130]. The development of the optimised carbon monoxide (CO) rebreathing 
method by Schmidt and Prommer [131] provides the ability to measure Hbmass, and is regarded as 
reliable and accurate, with reported typical error (biological and technical) of 2.2% [132] over 2 
days and coefficient of variation of  ~2% over 100 days in recreationally active men [133]. 
Importantly, the CO-rebreathing method can detect changes in Hbmass following whole blood 
removal and reinfusion of red cells using quantities of 1-2 units (450 – 900 mL) [134]. Even 
though CO-rebreathing is highly regarded, it does present with multiple challenges. For instance, 
from an athlete’s perspective, breathing CO during competition periods may be viewed negatively 
and therefore limit the use of this technique. The technique itself is expensive and requires 
logistical considerations (i.e. storage of CO), which again can limit its use in many research 
settings. Further, some researchers have expressed doubts, whether changes in Hbmass can be 
distinguished beyond normal human variation associated with the measure [135]. For example, 
Garvican et al. (2010) showed Hbmass varied by 3.3% in internationally competitive female cyclists 
(V̇O2max 63.3 ± 5.0 mL·kg-1·min-1) during a 6-month competitive cycling season [135]. The 




training load translating to a 1% increase in Hbmass [135]. Other researchers have shown Hbmass to 
vary through injury [136], training and detraining [130, 137] and hypoxia [17, 138]. With 
recognised limitations associated with the measuring of Hbmass, it can be concluded that other 
measures are needed to characterise oxygen carrying capacity changes [125] [139, 140]. 
2.4.6 Peripheral diffusion limitations 
Within skeletal muscle, diffusion of oxygen through the capillary bed may constrain 
oxygen transport in some individuals, with muscle diffusion reliant on a pressure gradient (i.e. 
pressure difference between the surface of the red blood cell and muscle) for transport of oxygen 
[141]. Within the muscle cell, the number of mitochondria determine the level of adenosine 
triphosphate (ATP) that can be generated from oxygen setting the limit to maximal oxygen uptake 
at the muscle level [141]. For example, exercise training studies have increased the capacity for 
ATP supply [142], as well as mitochondrial volume density [143]. Increased mitochondrial 
density can increase the concentration of enzymes such as succinate dehydrogenase, 
phosphofructokinase and lactate dehydrogenase, as well as mitochondrial density can increase 
V̇O2max [144, 145]. Collectively, these studies show the importance of diffusive oxygen transport 
on V̇O2max.  
Capillaries provide the exchange of oxygen between the blood and muscles. Exercise can 
increase capillary density and oxygen exchange at the muscle which can enhance endurance 
performance [146]. Brodal et al. (1977) assessed muscle biopsies using ATPase staining for 
assessment of capillary density in well-trained (V̇O2max 72.0 mL.kg-1.min-1) and recreationally 
trained (V̇O2max 51.3 mL.kg-1.min-1) men [147]. When compared to recreationally trained men, 
muscle capillary density per mm2 (821 vs. 582) and fibre ratio (2.49 vs. 1.77) were significantly 
greater in well-trained men. It was postulated that the increase in V̇O2max was linked to the 
increased number of capillaries at the muscle or improved efficiency of those the athletes already 
had.  
2.5 Manipulations to oxygen carrying capacity   
As V̇O2max depends on cardiac output and the ability to extract oxygen from the blood 
(i.e. arterial–venous oxygen difference), manipulation of either component can influence V̇O2max 
and likely endurance performance [10]. Plasma volume can increase V̇O2max in untrained 
populations through increased stroke volume [96], however in trained populations this effect is 
seemingly decreased [148]. Blood supply as well as Hbmass are two important components which 
determine the oxygen transport capacity [149]. Theoretically, a 1 g increase in Hbmass should result 
in an increase in V̇O2max of approximately 4 mL.kg-1.min-1 [130]. Even though such changes may 
not occur in all individuals [27], this possible advantage has led to a focus on methods to enhance 
oxygen transport and thus aerobic performance [150]. Within the literature, increased Hbmass can 
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be observed in response to training [14, 130] and altitude exposure (see review by Gore et al. 
2013) [13]. Endurance training can lead to an in increase in red blood cells which, can lead to an 
increase in blood oxygen carrying capacity [91]. Other methods, such as blood transfusion have 
shown to increase  V̇O2max by 5 – 10 % [12], thus researchers have sought various training  
modalities which may enhance oxygen carrying capacity in the blood.  
2.5.1 Haematological response to exercise 
Plasma represents ~55% of total blood volume and is responsive to endurance training 
[122] and able to influence exercise performance [151-153]. For instance, plasma volume 
expansion has been observed to occur both during acute exercise (14 % expansion) [154] and 
chronically (12-20 %) as a response to training [96]. The acute increase in plasma volume has 
been linked to augmentation of fluid intake, likely influenced by electrolyte imbalance, changes 
in thirst and enhanced activation of the renin-angiotensin-aldosterone system [110]. Prolonged 
training adaptations appear to elevate intravascular blood volumes and training hypovolemia 
[155]. In untrained populations, plasma expansion can increase V̇O2max due to increased stroke 
volume [96], however, this finding is not consistent in highly trained athletes [148]. Investigations 
to increased plasma volume through the use of training programs have provided varying results. 
Some studies have reported no change in V̇O2max, despite increased stroke volume and cardiac 
output, indicating the unchanged V̇O2max is likely offset by the effects of haemodilution on oxygen 
transport [156, 157]. Nevertheless, plasma volume expansion has been shown to prolong 
submaximal exercise performance in trained individuals [158], likely due to the increase in stroke 
volume [159]. 
Changes in plasma volume occur during exercise and after training; however, maturation 
of erythroid precursor cells to reticulocytes transpires slowly and is reliant on several months of 
training for significant changes to occur [111]. The intensity of exercise is important for the 
release of reticulocytes, with increased reticulocytes typically occurring immediately following 
strenuous exercise bouts [109].  Recently, hypoxia-inducible factors (HIF) proteins have been 
identified as markers for activation of genes following strenuous exercise and has been shown to 
activate erythropoietin as well as phosphofructokinase, vascular endothelial factor and lactate 
dehydrogenase following regular exercise training [160].  
2.5.2 Hypoxia 
Hypoxia can be mediated through exposure to natural altitude, or through the use of a 
simulated altitude room. Hypobaric hypoxia is achieved through acescent to altitude, where there 
is a notable decrease in partial pressure of oxygen, lowering the absolute oxygen available in the 
atmosphere. At sea level, barometric pressure is 760 mmHg and, oxygen concentration are 
constant at 20.9%. However, at altitude, barometric pressure is lower, falling to approximately 




Simulated hypoxia, commonly referred to as normobaric hypoxia is where there is a decrease in 
the percentage of oxygen in the air, without an associated decrease in barometric pressure. This 
type of hypoxia is caused through increased nitrogen content and is the foundation for many 
simulated altitude rooms [161].  
Regardless of the type of hypoxia, the aim is to decrease the arterial oxygen saturation to 
induce physiological responses which are likely to improve performance. There is currently no 
preference to hypoxic stimulus (i.e. hypobaric vs. normobaric); however, hypobaric hypoxia is a 
more severe condition and is regarded as superior to the other when the application is to improve 
performance and haematological change [162]. Hypoxic exposure can provide systemic stress, 
resulting in the up-regulation of HIF-1a, which binds to target genes, simulating an erythropoietic 
response and resulting in the release of EPO [163]. Erythropoietin release appears to be governed 
by the level of hypoxia, and the length of exposure and at an altitude of ~ 2500 m [164]. 
Erythrocyte volume expansion is mediated through accumulation of HIF-1a, which appears to be 
intensity dependent with greater responses consistent with higher stress situations [164]. Current 
literature indicates acute hypoxic exposure methods are insufficient to stimulate erythropoiesis 
(EPO) activity with at least 3-5 d continuous hypoxic exposure necessary to stimulate the 
maturation of an erythroid cell and to form an immature red blood cell (i.e. reticulocyte) [165]. 
As such, prolonged altitude training models have been explored and will be briefly outlined 
below.  
2.5.3 Altitude training 
The use of traditional prolonged exposure to hypoxia can be linked with increased aerobic 
power and anaerobic metabolism [46], erythrocyte volume expansion [21] and endurance 
performance [166]. This type of hypoxic exposure can be achieved through the Live High-Train 
High (LHTH) model, where athletes live and train at moderate altitudes (1500 to 3000 m) [46]. 
Alternatively, those athletes who are wanting to maintain training intensity, due to the decrease 
in V̇O2max of ~7% per 1,000 m [77]  can use Live High-Train Low (LHTL) model, where athletes 
live and sleep at moderate altitudes, but train at or near sea level. In both scenarios, prolonged 
exposure to hypoxia results in an up-regulation of HIF-1a, activating both EPO production, 
leading to an increase in Hbmass, potentially influencing V̇O2max,  glucose metabolism adaptions 
(i.e. glycolytic enzymes and glucose transporters) and causing a shift in substrate utilisation [30]. 
The cascade of non-haematological events will be discussed in detail in section 2.5.4. 
Much of the research on LHTH has produced equivocal results, with several studies 
pointing towards an improvement in performance [167, 168], while several other studies have 
failed to show improvements in performance [22, 25]. For example, Gore et al. (1998) failed to 
observe changes in Hbmass in world-class track cyclists following 31 d of altitude training at 2690 
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m, even though a 4 % improvement in post-exposure 5-min time trial performance was recorded 
[169]. In an observational study by Robertson et al. (2010c), no differences in performance and 
insignificant change in Hbmass and V̇O2max were observed [22]. It should be noted this study was 
conducted over 10 nights with an average of 9-10 h exposure per night which, is below the 
recommended 14 nights and 16 h exposure per night to elicit a response [13]. While living and 
training at altitude is the traditional hypoxic model, living at altitude and training as close to sea 
level has become the preferred method for many endurance athletes [170]. Using this hypoxic 
training model, athletes can maintain training intensity, yet still get the effects of altitude through 
sleeping at moderate altitude [25]. Therefore, LHTL offers many advantages over LHTH, with 
athletes being able to maintain higher training intensities. 
Many studies have achieved positive influence on performance and Hbmass when using the 
LHTL model [22, 171-173]. For example, Stray-Gunderson et al. (2001), demonstrated after 27 
d of LHTL, increased V̇O2max and Hbmass in elite runners, and 3 km time trial performance 
improved by 1.1%. In another LHTL study, Garvican et al. (2011) examined the influence of 26 
d of simulated altitude training (exposure for ~ 16 h·d-1 at 3000 m with training at 600 m) on 
cycling performance and observed a 4% increase in sustainable power output during a 4-min time 
trial, which coincided with a 5% increase in Hbmass [174]. While the findings from these studies 
are positive, the studies which have demonstrated performance changes have recognised 
methodological issues, such as no control groups. Unfortunately, in these studies, it is not possible 
to determine whether the change in performance were due to the altitude intervention, or the 
training camp. Furthermore, these findings indicate that changes in performance after altitude 
exposure are not solely due to increased Hbmass, a point noted by Garvican et al. (2011) and are 
likely influenced by other factors such as increased glucose metabolism or currently unknown 
physiological changes [174].   
2.5.4 Non-haematological adaptions 
In the absence of changes in Hbmass, improved endurance performance observed after 
altitude exposure must be mediated by other mechanisms [174]. It is possible that an increase in 
levels of 2,3-diphosphoglycerate (2,3-DPG) within erythrocytes can decrease the affinity of 
haemoglobin to oxygen, shifting the oxygen dissociation curve to the right [175]. Indeed, the shift 
in the oxyhaemoglobin curve is more pronounced in trained populations than untrained at both 
sea-level and altitude environments [175]. The mechanisms behind this occurrence remain 
unknown. One possible explanation is that during endurance exercise, increased nucleotide 
degradation results in an up-regulation of 2,3-DPG [176]. In support of this hypothesis, nucleotide 
supplementation can increase 2,3-DPG in neonatal rats, resulting in increased delivery of oxygen 
to the periphery [177]. In humans, research examining nucleotide supplements is difficult due to 
poor absorption of nucleotides using oral administration [176]. Moreover, activation of HIF-1a 




phosphorylation [179], H+ buffering capacity and improved perception of physical ability [180], 
all which could impact endurance performance and will be discussed below.   
Blood lactate is greater during sub-maximal workloads (i.e. prescribed power output 100 
W) during early exposure to moderate to high altitudes [181]. However, with acclimation, blood 
lactate concentration can decrease with no apparent rise in V̇O2max [181], giving rise to the term 
‘lactate paradox’ [182]. Lundby and colleagues investigated the ‘lactate paradox’ phenomenon in 
relation to duration spent at altitude (Basecamp of Mt Everest ~5400 m). Their findings revealed 
acute lactate levels increased (9.9 ± 0.3 mmol.L-1), and fell significantly following 7 days 
acclimatisation at 5400 m (5.6 ± 0.5 mmol.L-1) [183]. Interestingly, lactate levels increased with 
altitude exposure times with the authors reporting lactate levels at 4 weeks acclimatisation (7.8 ± 
1.0 mmol.L-1) and after 6 weeks acclimatisation following a sojourn from the summit (10.4 ± 1.1 
mmol.L-1). These results indicate that the ‘lactate paradox’ occurs during the acute stage as shown 
with increased lactate concentration and adrenaline and seemingly diminished with increased 
altitude time [184]. Other metabolic changes associated with the ‘lactate paradox’ have been 
suggested to be related to skeletal muscle hypoxic response, where working muscles release an 
increased concentration of lactate into blood circulation, allowing the body to use as fuel during 
the initial exposure to hypoxia [185]. However, it should be noted, lactate is regarded as a 
precursor to other major pathways, such as gluconeogenesis, thus interpretation of lactate is 
complicated because it can be affected by many different variables, such as altitude, diet and stress 
levels [186]. Furthermore, the measure is often one given data point and is a balance between 
lactate production and lactate uptake and removal from the body by other tissues [187].   
During exercise at altitude, carbohydrates are the preferred fuel due to the high level of 
ATP generated per mole of oxygen [188]. Irrespective of altitude, it is recognised that the rate of 
fuel use is relative to exercise intensities, which determine metabolic fuel selection [189]. An 
increase in carbohydrate fuel sources inhibit free fatty acid uptake and glycerol release [190]; 
however, carbohydrate stores are limited, particularly during altitude exposure. Greater restriction 
on carbohydrate storage are possibly due to increased basal metabolic rate and insufficient energy 
intake, which have been observed at altitude [191]. Although not preferred, the body can utilise 
fat and protein metabolism during strenuous periods when carbohydrate stores are inadequate 
[192].  
At the muscle level, it is recognised that very few measurable changes occur during 
altitude acclimatisation, with no increase in ATP concentration, oxidative enzyme activity and 
liver and muscle glycogen during altitude exposure [193]. Interestingly, Edwards et al. (2010) 
found aerobic muscle capacity and muscle cross-sectional area decreased in response to high 
altitude, despite the absence of mitochondrial function changes, indicating that skeletal muscle 
function can be maintained [193]. Recently, using nuclear magnetic resonance (NMR), Tissot et 
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al. (2009) profiled blood plasma of 16 individuals following exposure to ~4300 m, revealing an 
increase in lactic (29%) and succinic acid (158%) concentration, indicating an altitude reactive 
shift towards anaerobic energy production [194]. Increased lactate concentration indicates 
increased anaerobic glycolysis, whereas alterations to succinate indicate modified activity of the 
tricarboxylic acid cycle (TCA). Collectively, increased concentration in lactate and succinate 
lowered levels of glutathione (35%), indicating that individuals were under oxidative stress [195]. 
It is clear from the literature that physiological adaptions are affected by environmental changes 
and further investigation into these markers could advance understanding of human physiology.  
2.6 Blood donation as a model of hypoxia 
The objective of both normobaric and hypobaric hypoxia is to reduce oxygen saturation 
level in the blood which can induce hypoxemia [196]. Comparably, a reduction in whole blood 
volume can induce a level of hypoxemia which can be controlled through careful extraction of 
known quantities of whole blood [112]. For example, removal of ~10% of total blood volume in 
healthy adults can decrease oxygen carrying capacity, reflected by reduced [Hb] [117] or Hbmass 
[197], with a resulting impact on both V̇O2max [198-200] and exercise performance [117, 201]. 
Donating one unit of blood (~470 mL) can result in a loss of ~ 75 g (95% CI 68-80 g) of Hbmass 
[197]. To illustrate the relationship between Hbmass and performance  Balke et al. (1954), used a 
standard blood donation (500 mL) to show V̇O2max could be reduced by 9 % immediately 
following donation and that full recovery could be achieved in as little as 3 days [202]. Subsequent 
studies have demonstrated a negative correlation between blood removal and V̇O2max and, this 
finding has been demonstrated in a recent systematic review by Remoortel et al. (2016) where 
V̇O2max was decreased at 24 and 48 hrs after blood donation  (-7% (95% CI – 11% to -3%) [117]. 
A proportional decrease (~8%) in Hbmass can occur, with Pottgiesser et al. (2008) demonstrating 
reduced grams of Hbmass (baseline 860 ± 105 g vs. 785 ± 104 g post donation) [197].  
Similar to altitude, erythropoietin concentration can increase with time during 
hypoxemia. For example, Meurrens et al. (2016) investigated the effects of three repeated blood 
donations during a 12-month period on V̇O2max and Hbmass [203]. The authors findings showed 
increased serum erythropoietin concentration by 50% at day 2 and 100 % at 1 week of baseline 
levels yet, no change was observed in the placebo group. To the authors knowledge no studies 
have measured changes in HIF-1a which, is known precursor for accumulation of erythropoietin 
when using blood donation methods to lower oxygen carrying capacity. Theoretically, under 
normoxic conditions (i.e. oxygen levels 21% and oxygen saturation 94 – 100 %) the level of HIF-
1a is decreased which prevents accumulation of EPO; however, in a hypoxic state HIF-1a level 
is increased binding to target genes and stimulating erythropoiesis [204, 205]. Therefore, 
regulation of HIF-1a is necessary to allow for red blood cell production, resulting in an increased 




substrate utilisation and mitochondrial function are all likely to be involved in the red blood cell 
restoration process [206]. Logically, with a reduction in oxygen carrying capacity following blood 
removal, an increased reliance on anaerobic contribution may reveal specific metabolic 
adaptations, such as H+ buffering, which has been observed during hypoxic exposure [46]. 
Therefore, using blood donation as an experimental model may well induce similar responses to 
those of hypoxic environments and improve current understanding of changes associated with 
decreased oxygen carrying capacity. 
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Part II  
2.7 Metabolomics in sport 
As highlighted in Part I of this review, decreasing oxygen carrying capacity, be it through 
reduced oxygen availability or Hbmass, is associated with a range of compensatory physiological 
responses [30, 163]. While increased RBCs is a key response to hypoxia [130], shifts in substrate 
utilisation [30], as well as changes to aerobic and anaerobic enzyme concentration [46] can occur 
in unison. Hypoxic exposure and blood removal provide a systemic insult; thus, it is likely that 
several unexplored physiological changes occur during these times. Currently, the lack of 
understanding associated with the physiological response to decreased oxygen availability 
warrants additional research. The use of techniques consistent with metabolomics (Gas 
Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry 
(LC-MS) and Nuclear Magnetic Resonance (NMR)) may help to better understand the 
physiological response to hypoxia by providing the ability to monitor systemic changes through 
a metabolic profile. Part II of this literature review will provide a pipeline (Fig 2-1) for the use of 
metabolomics in this field. The approach to metabolomics will be discussed in reference to sample 
type(s) and the preparation and analytical techniques used to perform metabolomics. The post-
acquisition tools required to analyse the data will also be discussed, followed by the practical 
applications of metabolomics in the field of exercise physiology specifically about the field of 
sports sciences. 
2.8 Metabolomics: Application to exercise physiology 
Metabolites are defined as low molecular weight reactants, intermediates or products of 
enzyme-mediated reactions and can be influenced by both physiology and environmental factors 
such as altitude, exercise, diet and disease [207]. In recent years, the development of analytical 
techniques and bioinformatics approaches has allowed for untargeted detection of thousands of 
metabolites in a single biological sample. This evolving approach, known as metabolomics, is an 
ideal platform for discoveries, as it may provide metabolic fingerprints for altered physiological, 
environmental and biochemical factors. Metabolomics, a cousin to genomics, transcriptomics and 
proteomics, is the closest measure of the human phenotype and seeks to profile all the low 
molecular weight (<1.5 kDa) metabolites in a particular system (e.g. biofluids). In physiological 
studies, important metabolic products include amino acids, lipids, carbohydrates and nucleotides, 
all involved in processes required for survival [207]. These metabolites can be studied to 
determine changes in an individual’s health, as they are considered the end product following a 
biological change, either at the system or environmental level. Exercise physiology is in need of 
a holistic approach to studying changes occurring at any given time. Until recently, biological 




component); however, with the emergence of advanced analytical technologies, biological 
systems are now investigated with a holistic view [208]. It is through simultaneous profiling of 
metabolites that metabolomics has the potential to show great benefit, as many endogenous 
compounds can be readily assessed by a variety of biological fluids (i.e. serum, plasma, seminal 
fluid, tissue and saliva), which form part of a standard collection within the field [207]. It is 
possible to combine the results from physiological testing and the measures taken using 
metabolomics to understand biological systems and move towards the systems biology approach.  
2.8.1 Approaches to metabolomics 
There are currently two well-defined basic approaches to metabolomics research, termed 
‘targeted’ and ‘untargeted’ analysis [207]. Using mass spectrometry to develop a ‘targeted’ 
protocol/profile, specific metabolites are unambiguously identified in pilot experiments, and 
associated methods for their quantification are developed. The benefit of this approach is that it 
can yield quantitative information on hundreds of polar and lipid species in a single analysis, an 
attractive experimental approach. Run times can be reduced (i.e. high-throughput) through 
monitoring of target metabolites through isolation and fragmentation of precursor ions and 
isolation of subsequent product ions; a workflow known as multiple reaction monitoring (MRM) 
[209]. There are shortcomings to this approach: i) metabolites that are not targeted will not be 
detected, potentially reducing discovery opportunities; ii) major development (i.e. multiple 
analytical runs) is required to create a library database of targeted compounds before the technique 
can be used; and iii) purchasing of authentic analytical standards is expensive. Of these, the 
second and third remain the major impediments for many analytical laboratories. 
An alternative approach to the above method is ‘untargeted’ analysis, or metabolic 
profiling, which comprises a scouting method to achieve the broadest possible metabolite 
coverage, typically m/z 50-1000, capturing up to thousands of metabolites within a biological 
system [210]. The advantage of this approach is that it allows for the detection of previously 
unpredicted metabolite perturbations associated with a certain environment or condition. The 
design of an untargeted method differs to a targeted one in that it aims to produce an unbiased 
detection of as many metabolites as possible, to highlight ‘features’ that can discriminate between 
conditions (e.g. normal compared to altered blood profile). The major benefit of untargeted 
analysis is that it does not require prior knowledge of biologically relevant metabolites, and is 
usually referred to as hypothesis generating or discovery phase experimentation [211]. However, 
generating a list of potential target metabolites will strengthen experimental design as well as 
understanding of the biological sample. One limiting factor to untargeted metabolomics, and still 
regarded as a significant ‘bottleneck’ to metabolomics research, is the ability to identify 
metabolites post-data acquisition. For instance, for a metabolite to be classified as ‘identified’, a 
number of orthogonal parameters such as accurate mass, isotope abundance, MS/MS spectrum 
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and retention time are required and should match an authentic standard run in identical analytical 
conditions [212, 213]. This can be time-consuming and implausible when looking at a large 
number of biologically important metabolites; thus, the Metabolomics Initiative Standard has 
proposed the use of a scoring system, to display identification confidence [212]. 
Robust experimental design and handling of samples is needed to ensure the best possible 
reproducibility. This can be achieved through standard operating procedures, which are necessary 
for any multi-site testing, common to the field of exercise physiology. The following sections will 
outline study design considerations for incorporating metabolomics into the field of exercise 
physiology. 
2.8.2 Sample collection 
A range of biological samples have been used for metabolomic studies, each providing 
different information. The sample type should be chosen according to availability and the specific 
aims of the study, with the most common types being blood [34, 214], urine [215], cerebrospinal 
fluid [216], saliva [217], feces [218], breath condensates and tissue extracts taken from biopsies 
[219]. To date, most metabolomic investigations have used blood or urine, due to the relative ease 
of collection and minimal invasiveness [220]. In particular, blood is classed as an ‘integrative 
fluid’, meaning that it represents the system as whole, potentially indicating variation in every 
tissue and organ within the body [221]. However, while biofluid samples are more easily obtained, 
they do not explain the pathophysiological changes that may be occurring at the cell or tissue 
level, which may relate to changes in physiological state. For instance, skeletal muscles play a 
major role in overall metabolism, being the largest insulin-sensitive organ in the human body 
[222]. It has therefore been suggested that muscle biopsies could reveal greater 
pathophysiological insights into metabolic diseases and endurance exercise, as it may link to the 
source of substrate utilisation. Alves et al. (2014) evaluated skeletal muscle biopsy samples before 
and after 1 h of exhaustive exercise to assess the extraction of metabolites from ~10 mg of muscle 
[219]. Using a multi-platform analytical approach (LC- and GC-MS) and principal component 
analysis, a clear separation was observed between exercised and non-exercised states. Levels of 
short- and long-chain acylcarnitines were increased, presumably a result of increased substrate 
utilisation of fatty acids via b-oxidation, a common metabolic pathway for transport into the 
mitochondria [219].  Skeletal muscle samples can provide useful information, although they do 
have technical and ethical challenges [223], which need to be considered when choosing sample 
type for a specific study.  
Time intervals between collection of a biological specimen, separation (centrifugation) 
and freezing can impact on metabolite composition [224]. This process should be tightly regulated 
by standard operating procedures to reduce effects on sample quality. It has been suggested that 




immediately in a cooled centrifuge (4°C), as metabolites will continue to change with time [221]. 
Indeed, lactate concentration in plasma continue to increase as a result of continued metabolism 
at room temperature [225]. Furthermore, consideration needs to be given to the type of collection 
tube, as optimal time will vary depending on separation method. Practically, all samples should 
be separated within 2 h of phlebotomy and should be completed at the latest by 4 h [214]. Both 
plasma- and serum-yielding tubes are commonly used in exercise physiology for many 
biochemical and clinical tests and as such, clotting and anti-coagulant reagents are necessary. 
Tubes for plasma collection contain reagents such as lithium heparin, sodium citrate and 
ethylenediamine-tetra-acetic acid (EDTA), all of which stop blood from coagulating before cell 
separation by centrifugation. While tubes for serum separation contain no introduced 
interferences, whole blood needs to clot at room temperature, potentially causing changes in 
metabolite profile [226]. Yin, Lehmann and Xu (2015) provide a summary of plasma and serum  
metabolic differences, with increases in amino acids, nucleotides and lipids concentration in 
serum compared to plasma when using clotting protocols of 30 vs. 60 min [221]. It is therefore 
recommended that only samples with strictly controlled clotting times be used for metabolomic 
analysis, as variation in metabolite profiles exist with varying lengths in clotting time [225].  
Relative centrifugation force (RCF) and spinning time also need consideration, as they 
can influence untargeted metabolomic analysis [224]. Two routine plasma centrifugation 
protocols (1500 ´ g, 10 min; 3000 ´ g, 5 min) were assessed using NMR and high-resolution 
mass spectrometry for potential differences in biochemical signature [224]. The differences were 
primarily identified from lipid classes (i.e. phosphocholines and sphingomyelins). Through the 
use of two centrifugation protocols, small individual fold changes were observed, primarily in 
lipid classes (i.e. phosphocholines and sphingomyelins) and was sufficient to separate metabolite 
profiles using multivariate statistical models.  
After the separation of cells, it is common practice for samples to be stored in freezers to 
stop changes in metabolites prior to extraction and analysis. Metabolites can continue to be 
affected by enzymes and other proteins contained within serum and plasma. Small but significant 
changes were observed in plasma following exposure to ambient room temperature (37°C) for 24 
h [227]. Specifically, Yang et al. (2013) observed increased and decreased concentration in 
plasma metabolites when analysed using LC-MS/MS and principal component analysis (PCA) 
[227]. The endogenous metabolites most affected were broadly classified as amino acids, 
carnitines, lysophosphatidycholines, lysophosphatidylethanolamines, carbohydrates, organic 
salts, bile acids, nucleosides, hormones and choline [227]. In comparison, the authors showed 
time-dependent changes in blood were not observed when blood samples were maintained at 4°C. 
Therefore, the results of Yang et al. (2013) indicate when immediate processing cannot be 
performed, samples should be maintained at 4°C; however, caution must be applied to some 
40 
metabolites (i.e. amino acids and acylcarnitines) which can exhibit changes in the first 24 h at 4°C 
[227]. Optimal temperature and length of storage is an area that requires further investigation. 
Samples are commonly stored between -20°C and -80°C, however -80°C is preferred for long 
term storage [228].  
2.8.3 Sample preparation 
Once the biofluid or tissue has been collected, metabolites need to be extracted and 
isolated for analysis. Sample preparation is crucial in order to obtain good metabolome coverage 
and reproducibility within a given study. The extraction solvent used needs to be tailored to the 
needs of the study and the number of steps kept to a minimum to ensure ‘unbiased’ selection of 
metabolites [214]. For many untargeted metabolomic analyses, sample preparation includes a 
clean-up step for protein precipitation. Organic solvents such as methanol, acetonitrile, 
isopropanol and chloroform are the most commonly used for both extraction of metabolites and 
protein precipitation (i.e. sample clean-up) [229, 230]. Currently, there are well-established 
protocols for extraction of semi-polar and polar metabolites [214], lipids [231] and other 
metabolite species. However, extraction protocols may need to be reviewed depending on 
metabolites of interest. In a recent study, Rico et al. (2014) investigated eight extraction protocols 
using organic solvents (i.e. methanol and acetonitrile) for separation of polar and non-polar 
metabolites for metabolomic studies [230]. Reversed-phase chromatography and mass 
spectrometry were performed on varying solvent ratios (e.g. 2:1 and 3:1 with plasma), solid–
phase extraction or a combination of both. From this study, it was recommended that acetonitrile 
in a 2:1 ratio with plasma (v/v) offered the best coverage of the blood metabolome and provided 
the cleanest extracts. This finding (e.g. solvent ratio 2:1) is important and relevant to exercise 
physiology, as many discovery-based studies often yield a large number of samples (>200). In 
these cases, it is important that samples are clean in order to reduce instrumental contamination 
and resultant loss of sensitivity.  
Since urine is regarded as the end product of metabolism, it is considered ideal for 
metabolomics, with urine samples being considerably less complex than blood (i.e. fewer 
proteins), often not requiring metabolite extraction. However, homeostatic control of urine is 
inferior when compared to other biofluids, so consideration is required when analysing by 
metabolomics. Unlike other biological fluids, urine is comprised of waste products from the entire 
body and is associated with high variability attributed to concentration differences. A number of 
normalisation methods have been proposed and can be categorised into pre- [232], where a 
specific dilution or injection volume is made and post-acquisition [233] (i.e. data treatment). In 
LC-MS metabolomics experiments a combination of pre- and post-acquisition methods is 
performed, where samples are diluted pre-acquisition, followed by a post-acquisition 
normalisation to the concentration of creatinine. A significant shortcoming to this approach is the 




abundant metabolites) [234]. Despite the methods popularity, it is not the preferred in athlete 
populations since variability in creatinine levels can occur with increase intake of both protein 
and creatine. Alternatively, mathematical methods such as the probabilistic quotient 
normalisation have been implemented as it assumes the change in concentration of metabolites 
influence only specific areas of the spectra [233]. However, a significant flaw to the PQN method 
is normalisation only works if each of your metabolites are quite similar in response. Therefore, 
normalisation to specific gravity via refractometry is superior due to the technique being routinely 
used in exercise physiology and the ability minimise variance, ultimately improving the outcome 
of urinary metabolomic studies and is gaining increasing traction in urine analysis [232].  
2.8.4 Analytical technologies 
Currently, the human metabolome is known to consist of more than 100,000 small 
molecules, as documented by the Human Metabolome Database (HMDB: http://www.hmdb.ca/). 
These endogenous molecules, comprised of carbohydrates, fatty acids, proteins, organic acids, 
nucleosides and nucleotides [235], vary substantially in polarity, size and concentration (i.e. µM, 
nM, pM).  Metabolites range from hydrophilic, polar metabolites with low molecular weight (e.g. 
amino acids) to hydrophobic, non-polar metabolites with a much higher molecular weight (e.g. 
lipids). This diversity means that the unbiased detection, identification and quantification of the 
entire metabolome is difficult [236]. There is currently no single analytical approach that can 
detect or quantify all metabolites present in human samples. However, multiple analytical 
techniques have been employed to provide complementary coverage of a range of metabolites 
[237]. The combination of 1H-nuclear magnetic resonance spectroscopy (NMR) with mass 
spectrometry (MS) has proven to be particularly effective at increasing metabolite coverage, 
through specificity, sensitivity and dynamic range [238, 239]. The combination of NMR and MS 
technologies has been central to biomarker discovery [240] and the investigation of metabolites 
within biological fluids such as urine, blood (plasma and serum) and saliva.  
1H-Nuclear magnetic resonance spectroscopy is an analytical platform that allows for the 
reliable detection and quantification of a wide range of metabolites in biological fluids. NMR has 
proven to be reproducible, due to its non-destructive and non-invasive characteristics and is well 
suited as a diagnostic and discovery tool, as it can resolve the structure of molecules present in a 
sample [241]. Typically, samples analysed by NMR are in solution, however it has been reported 
to successfully analyse tissue samples that remain intact [242]. In both cases, this allows samples 
to be analysed with no or minimal processing, thus NMR is deemed a non-destructive technique. 
NMR allows simultaneous detection of different metabolites through magnetic properties (e.g. 
spin), which help to identify the type of molecule and its chemical characteristics. NMR spectra 
provide an insight into structural components and enable confident identification of metabolites 
within a sample through the monitoring of chemical shifts. While NMR spectroscopy does offer 
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precise structural information, allowing for relatively quick identification [243], it has a relatively 
low sensitivity related to magnetic strength, as the bigger the magnet, the greater number of 
metabolites detected, typically ~100 metabolites in human samples [235]. This is a disadvantage 
when compared to mass spectrometry, as it only allows for the detection of high abundance 
metabolites (typically > 100 nM to 1 µM), thus profiling of the blood metabolome becomes 
limited, as many metabolites are present in low abundance.  
Mass spectrometry, coupled with separation techniques such as liquid (LC) or gas 
chromatography (GC), has a higher sensitivity than NMR and the potential to detect a substantial 
number of low abundance metabolites (as low as 1 pM) [207]. The initial chromatography step, 
coupled with extremely high resolution modern instruments, such as the Orbitrap or Quadrupole-
Time-of-Flight (QTOF), means that thousands of molecular features can be resolved in a single 
analytical run. For chromatography, the sample will exist in either gas or liquid form (mobile 
phase) and is then forced through a stationary phase held within a column. The stationary phase 
is usually an inert substance that does not react with the mobile phase to allow for partitioning of 
compounds between the two phases, based on their chemical properties. Typical analytical 
sensitivity of MS will be in the range of fM to high aM using a triple quadrupole (QQQ) 
instrument, and nM using a high resolution (QTOF) instrument [244]. In mass spectrometry, 
molecules are charged or ionised during an ionisation process (i.e. eluent entering the ion source), 
and these charged molecules and their fragments are separated according to their mass–to-charge 
ratio (m/z) [207]. Similar to NMR, the mass spectrometer type (i.e. QQQ, QTOF and Orbitrap) 
determines the mass accuracy and resolution, which are critical for structural elucidation.  
While NMR spectroscopy was the tool of choice in the early phases of metabolomics, 
mass spectrometry based techniques are continuing to gain popularity for metabolite profiling 
studies because improved analytical capabilities permit much deeper metabolite coverage 
compared to earlier studies (1970s) in this field [245]. Mass spectrometry is not without 
limitations, with metabolomic applications requiring multiple ionisation states (i.e. positive and 
negative) and instrumental variations occurring during experimental periods as well as the 
formation of instrumental artefacts (i.e. adducts) [207, 246]. Retention times and signal intensities 
are instrument and sample dependent, requiring standardised sample preparation steps to avoid 
unwanted variation. Implementation of quality control samples (QCs) or internal standards within 
each experimental set is common to correct for small levels of variation and to quantitatively 
measure technical reproducibility [247]. Despite these limitations, metabolomics employing mass 
spectrometry is the method of choice for those seeking low abundance metabolites or resolution 




2.8.5 Data pre-treatment  
A number of technical issues can be generated throughout the study pipeline (see Fig 2-
1) and consequently introduce artefacts (noise and unwanted variance) into metabolomic data 
sets. Most artefacts relate to MS, as a great strength of NMR is the robustness and reproducibility 
of each sample [249]. Small scale studies (n < 100) allow for a single sample batch to be analysed 
by MS in a relatively short time. By contrast, large sample studies (n > 100) require more care as 
they can often require several days or weeks of analysis. In these circumstances, individual 
batches need to be limited to 50-150 samples, as signal attenuation will occur over time [250]. 
Regular instrument cleaning should be carried out, and it has been recommended that for every 
5-8 experimental samples, one quality control (QC) sample should be run [247]. Regular QC 
samples allow the user to check for analytical consistency and correct for any systematic drift. 
QC samples can be: i) small aliquots taken from each study sample to give maximal 
representation; ii) commercially obtained metabolites (standards) which represent metabolites of 
interest; or iii) purchased human serum, processed identically to study samples. Of these three, 
the preference is the first, due to the cost associated with commercial serum and standards. 
However, quality control and implementation within metabolomic studies remains an area of 
interest to many, as the community is yet to decide on a single standard procedure.  
Metabolites exist in a given system with a wide range of concentration. High 
concentration metabolites will often have higher sample variance compared to low concentration 
metabolites. As such, in order to equalise the “weighting” of each metabolite in an unbiased 
statistical model, metabolites are usually scaled to unit variance (each metabolite divided by its 
standard deviation) [251]. After unit variance, each metabolite may be further scaled to adjust for 
the difference between very high and low abundance metabolites [251]. Finally, a mathematical 
transformation (e.g. log transformation) may be applied to make skewed data more normally 
distributed.  
2.8.6 Data analysis 
Metabolomic studies generate extensive amounts of data in a structure that is large and 
very complex. Statistical methods then need to be implemented to transform data into useful 
biological knowledge. To take into account differences in many individual metabolites, 
researchers can apply a reproducibility screen using defined criteria, typically a relative standard 
deviation (RSD) of < 20% for UHPLC-MS and < 30% for GC-MS [214, 252]. This is a 
provisional univariate step to remove unreproducible metabolites, which will typically remove 
10-30% of all detected metabolite features from the dataset [247]. Other univariate methods such 
as Student’s t-test and ANOVA (or non-parametric equivalents) can be useful for establishing 
significant differences between individual metabolites associated with different groups however, 
to avoid making spurious observations due to the number of statistical repeats required, additional 
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measures need to be incorporated. Post-hoc statistical tests such as the Bonferroni correction and 
Benjamini-Hochberg False Discovery Rate procedure can compensate for multiple comparisons 
[253, 254]. When using untargeted metabolomics methods, it is suggested that the Benjamini-
Hochberg False Discovery Rate is employed to maximise discovery of metabolites as the p value 
correction is weighted on ranking, whereas the Bonferroni method applies a ‘harsh’ correction 
across all p values, limiting discoveries [254]. However, a major limitation to a univariate 
approach is that it will treat variables independently, making it difficult to determine correlations, 
which are important for understanding biological progressions. Changes at the system level are 
often due to many metabolites, and it is these larger changes that can uncover biological 
differences between groups. For this reason, it is common practice to use multivariate statistics in 
metabolomic studies to aid in finding patterns within a complex data matrix.  
Principal component analysis (PCA) is an unsupervised multivariate method, used to 
reveal structures within a data set by reducing its complexity into fewer dimensions. This method 
is completely unsupervised (i.e. no group information is given) and is ideal for untargeted 
metabolomics, as the outcome is to compute new variable scores based on maximum variability 
of the data set. Latent variables or principal components (PCs) are used to explain variability in 
the data with the first PC accounting for the most variability in a given direction. Subsequent PCs 
represent the next mathematically orthogonal direction of maximum variance that is not counted 
in the preceding PCs [255, 256].  Often the end result is observed clusters of biochemically similar 
species with associated loadings, which reflect the importance of each of the metabolites.  These 
loadings can be used to interpret the data set due to the clustering of samples with similar 
biological relevance. 
PCA is considered the most basic multivariate projection approach, as it is only optimised 
to handle natural variance from within the dataset. One significant downside to this approach is 
that the model may not observe less obvious differences in groups of biological samples.  Popular 
alternatives to PCA are partial least squares discriminant analysis (PLS-DA) and orthogonal PLS-
DA, which are data dimension reduction strategies also commonly used in metabolomic studies 
[255-257]. Unlike PCA, PLS-DA is a supervised multivariate method, containing class 
information used to create a model of maximum variance between samples contained in ‘Class 1’ 
and ‘Class 2’. Although PLS-DA is commonly used for metabolomic modelling, it may be limited 
in human samples as it can fail if the number of class observations exceeds six [258]. Also, PLS-
DA requires class observations to be ‘close-fitting’, which is often difficult in metabolomic 






Figure 2-1 Generalised workflow for untargeted metabolomics experiments. 
2.9 Critically analysing the metabolomic techniques for best practice 
When interpreting the abundance of metabolomic studies, it is important to consider 
standardised workflow for sample processing, data acquisition, and data processing which, have 
not yet been achieved within the field. Metabolic profiling is typically performed using one of 
two contrasting analytical strategies depending on the amount of a priori biological knowledge. 
If very little is known then an untargeted strategy is implemented to measure a wide range of 
metabolites present in multiple metabolite classes, or metabolic pathways. This type of approach 
needs to be matched with an unselective sample preparation such as an organic solvent crash 
which can remove interferences such as proteins; yet, provide good solubilisation for a wide range 
of metabolites. Due to the chemical diversity of the metabolome, truly comprehensive 
metabolomic research requires LC-MS technologies due to the breadth of coverage it can provide 
(i.e. non-polar to polar metabolites). Of importance to discovery metabolomics is high instrument 
resolution, mass accuracy and measurement precision, across a full mass range. This enables 
metabolite identification and precise quantification of metabolite abundance. Currently, the Time 
of Flight and Orbitrap technologies are the gold standard for mass spectrometry metabolomics. 
Within this thesis untargeted metabolic profiling will be performed. Therefore, great care is 
needed in reducing all possible confounding variables in each of the given studies. The sensitivity 
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of metabolomic analysis is such that differences in metabolome can readily be detected based on 
inconsistent sample collection methodology, storage conditions and analytical protocols. To that 
end the following methods have been carefully designed and curated to avoid making false 
discoveries. 
2.10 Metabolomics in exercise physiology research 
Metabolic changes and physiological adaptations are common events in exercise 
physiology, constantly occurring to maintain homeostasis following exercise, environmental 
stimuli and stress that will innately change biochemical pathways. To date, only a handful of 
studies have explored the use of metabolomics in the field of exercise sciences [40, 259-265], 
including one of the first in the field published in 2010 [35]. Using an untargeted LC-MS 
metabolomics approach, the authors investigated the complex networks of events that were up-
regulated following completion of single bouts of acute and prolonged exercise. In this study, 
subjects completed either cardiopulmonary exercise testing (Bruce protocol) or the Boston 
marathon (42.195 km) in which bloods were collected pre- and immediately post-event. Identified 
metabolites were linked to increased utilisation of fuel substrates, as measured in metabolic 
pathways including amino acid metabolism, glycolysis, lipolysis and adenine nucleotide 
metabolism. As expected, these findings supported previous literature of increased fuel substrate 
utilisation, such as glucogenic amino acids (i.e. alanine, threonine serine, proline). Unexpected 
metabolites involved in tryptophan pathway (kynurenate, quinolate and anthranilate) were found 
to increase following the completion of the marathon. Through the use of metabolomic analysis, 
this study was able to reveal additional small molecules which have not been previously detected.  
Furthermore, these findings provide rationale for the use of metabolomics, as some of the detected 
metabolites (e.g. glucose-6-phosphate and 3-phosphoglycerate) are typically only documented 
when using invasive techniques, such as skeletal muscle sampling [266].  
Physiological changes following bouts of aerobic exercise are of interest to research fields  
such as sport science research and clinical populations, as an increase in cardiorespiratory fitness 
is indicative of health status and performance [267]. Recently, mass spectrometry has been 
applied to exercise intervention studies to reveal metabolic changes, which may be linked with 
aerobic conditioning. For example, Pohjanen et al. (2007) monitored the acute effect of strenuous 
cycling exercise in the blood metabolome in 24 regularly trained males and observed 34 
metabolites of significant difference between pre- and post-exercise [40]. Yan et al. (2009) 
showed variation between senior and junior rowers through exploration of their blood 
metabolome, yet when using conventional biochemical parameters, no differences were observed 
[37]. The lack of difference observed using conventional biochemical analysis was possibly due 
to the homogeneity of the groups, despite participants being separated in training years (2.8 vs. 




training intervention. Yet, following one and two weeks of training (technical and aerobic 
exercise) and strict control of diet (nutrient composition: protein 130 g; carbohydrates 700 g; fat 
90 g), differences were observed between the cohorts. Contributing to the differences were 
alanine, glutamic acid, tyrosine and several metabolites involved in glucose metabolism. A more 
recent study employed LC/Orbitrap-MS based metabolomic analysis before and after submaximal 
cycling for a duration of 45 min, and observed significantly increased level of purine metabolites 
(guanine, hypoxanthine, inosine, xanthosine and deoxyinosine) in ten healthy recreationally 
active adults [268]. These studies have shown that metabolomics can map multiple pathways, as 
well as provide further physiological insight when compared to other biochemical tests.  
Metabolomics has also been used to examine metabolic markers which could predict 
V̇O2max. Lustgarten et al. (2013) used a random forest regression to look at the association of mass 
spectrometry metabolites with V̇O2max [265]. The authors identified through random forest 
regression (model R2 = 0.576), metabolic markers, 4-vinylphenol sulfate, pyroxidate, 2-
hydroxybutyrate showed significant associations with V̇O2max in a cohort of 77 subjects [265]. 
Interestingly, when these markers were combined with blood chemistry analytes (i.e. SCOT, 
blood urea nitrogen) it was possible to explain 58% and 80% of V̇O2max scores in males and 
females. More recently, a single urinary metabolic marker, putatively identified as oxo-
aminohexanoic acid (OHA), was observed to have a strong correlation with V̇O2max (r  = 0.86) 
[268]. It should be noted that the biological context is yet to be determined, with the authors 
suggesting follow-up studies to confirm the identity of the OHA.  Although the two studies are 
not linked, the finding of these correlations highlights the ability of metabolomics and the role it 
could have in assessing overall fitness in exercise physiology studies. 
Considering the substantial changes associated with blood metabolites during exercise, 
metabolomics is regarded as a powerful tool to discover mechanisms associated with hypoxia. 
One of the first studies to explore hypoxia using metabolomics was conducted by Lou et al. (2014) 
investigating the effects of acute (2 h) exposures to simulated altitudes (12 % vs 15% vs. 21% 
oxygen) on the human urine metabolome [269]. The authors identified a dose dependent 
separation when using partial least square discriminant analysis and contributed the differences 
to an increase in purine markers (i.e. hypoxanthine and xanthine) and free carnitines and acetyl 
carnitines which may indicate a shift in energy metabolism. Importantly, the findings from this 
study indicate detectable metabolic adaptions occur within 2 h of exposure to altitude. More 
recently a metabolomics approach was adopted to assess metabolite adaption to high altitude 
(5300 m) and the retention of adaption follow a period of low altitude exposure (~1500m) [270]. 
Blood samples were collected and analysed using LC-MS during the study period. The results 
demonstrate an immediate metabolic adaption in the first few hours of ascending to 5000 m with 
increases in purine metabolites and glycolysis. Interestingly, metabolic adaptions remained 
following the one-week descent (~1500 m) which were consistent with improved physical 
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performance. Most recently Messier et al. (2017) investigated metabolic exercise performance in 
endurance trained individuals at sea level and at moderate terrestrial altitude (2150 m) using NMR 
[31]. Blood plasma analysis using NMR indicated a decrease in glucose and branched-chain 
amino acids after exercise at altitude, indicating a reliance on protein pathway to maintain 
glycaemia during exercise at moderate altitudes. Although regarded as a repeatable and reliable 
measure, NMR is considered complementary to MS, due to the sensitivity of the instrument 
which, can reduce discovery opportunities.  Furthermore, it should be noted in these studies 
pooled QC samples were not implemented; thus, it is not possible to quantitively determine 
analytical precision [247, 271]. The importance of data quality checks has been stressed in the 
metabolomics community, illustrated through the formation of the Data Quality task group within 
the metabolomics society [272]. This is to ensure, researchers can monitor stability and 
reproducibility of the analytical process and correct small levels of drift in signal within batch and 
between batches [247]. Most importantly, the use of QC’s can allow for the calculation of 
metabolites precision by using strategies for data filtering and signal correction on QC samples 
to reduce the potential of false discoveries. As such, the findings from these studies should be 
viewed cautiously as the potential for false discoveries can be increased without the use of reliable 
strategies. 
The application of metabolomics in hypoxia-based research is relatively new and has 
demonstrated significant potential. Considering the stress created through altitude, it is 
unsurprising that altered metabolite profiles exist and demonstrate intra and inter-individual 
responses to altitude exposures. Considering the multifaceted nature of hypoxia, metabolomics 
presents as a unique technique to investigate the metabolic adaption to low oxygen carrying 
capacity environments.  
2.11 Summary 
The effect of low oxygen carrying capacity, either through removal or natural increase 
via hypoxic exposure, is yet to be examined beyond the typical reductionist approach, where 
haematological markers or individual metabolic markers have been assessed. However, with 
recent analytical and technological advances and improvements in study design, metabolomic 
studies can provide much stronger characterisation of altered physiological states, as it provides 
a close representation of an individual’s current physiological state. Apart from the handful of 
abovementioned studies, there have been very few comprehensive untargeted metabolomic 
methods within the field of exercise physiology. A single comprehensive study by Lewis et al. 
(2010) conducted on the effects of exercise, has provided a backbone for metabolomic research 
within the field [35]. The application of newer technologies such as high-resolution mass 
spectrometry will allow for greater metabolite coverage to assess metabolic changes and 




The relatively new application of mass spectrometry metabolomic studies will be used to 
assess a broad range of metabolites taken from healthy human participants before and after blood 
removal (Chapter Five) and during simulated altitude exposure (Chapter Three), while the 
physiological impact of oxygen carrying capacity on cycling performance will be investigated in 
Chapter Four. This PhD will be the first study to investigate changes in haematological and 
physiological parameters using an untargeted metabolomics approach and high-resolution mass 
spectrometry in association with blood removal and altitude exposure. 
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Chapter 3 Metabolomic profiling of a 14-day altitude 
exposure in endurance runners 
This chapter has been drafted to conform to the author guidelines for the Experimental Physiology 
journal. 
Lawler, N.G., Abbiss, C.R., Gummer, J.P.A., Broadhurst, D.I., Govus, A.D., Fairchild, 
T.J., Garvican-Lewis, L.A., Gore, C.J., Maker, G.L., Trengove, R.D., Peiffer, J.J. (2018) 
3.1 Abstract 
Purpose: The purpose of this study was to determine the influence of 14 d of normobaric 
hypoxic altitude exposure at ~3000 m on the human plasma metabolite profile Method: Over 14 
d, ten well trained endurance runners (six males, four females; 29 ± 7 y) lived at ~3000 m 
simulated altitude accumulating 196.4 ± 25.6 h of hypoxic exposure and trained at ~600 m. 
Resting plasma samples were collected prior to altitude (baseline), 3 d and 14 d of altitude camp. 
Plasma samples were analysed using liquid chromatography high resolution mass spectrometry 
(LC-HRMS) to construct a metabolite profile of altitude exposure. Results: Mass spectrometry 
of plasma identified 36 metabolites of which eight were statistically significant (pFDR 0.1) from 
baseline to either 3 d or 14 d. Specifically, changes in plasma metabolites relating to amino acid 
metabolism (tyrosine and proline), glycolysis (adenosine) and purine metabolism (adenosine) 
were observed during the altitude exposure. Principle component canonical variate analysis 
showed significant discrimination between group means (p < 0.05) with canonical variate (CV) 1 
describing non-linear recovery trajectory from baseline to 3 d and then back to baseline by 14 d. 
Conversely, CV2 described a weaker non-recovery trajectory and increase from baseline to 3 d, 
with a further increase from 3 d, to 14 d. Conclusion: The current study demonstrates that 
metabolomics can be a useful tool to monitor metabolic changes associated with altitude 
exposure. Furthermore, it is apparent that altitude exposure alters multiple metabolic pathways, 





Endurance athletes commonly use moderate altitude exposure (2000 – 3000 m) [273]  to 
increase their oxygen carrying capacity and subsequent athletic performance [13]. Indeed, 100 h 
of hypoxic exposure at ~2,200 m can increase haemoglobin mass by ~1% [13] through the 
upregulation of erythropoietin [164]. Under these conditions, up to a 4% increase in performance 
at sea level and altitude have been observed [166]. In addition to the expansion of red blood cell 
mass, non-haematological changes including improvements in exercise economy, skeletal muscle 
buffering and increased oxidative and glycolytic enzymes have all been observed following 
moderate altitude exposure and are associated with a post-exposure increase in performance [46]. 
However, improvements in performance after prolonged altitude exposure have also been 
observed in the absence of changes to haematological and/or non-haematological variables [273-
275]. It is possible that unknown physiological adaptations following altitude exposure are 
responsible for the observed increase in performance or that it is not possible to accurately 
quantify the magnitude of change in the identified haematological and non-haematological 
variables [274]. 
Metabolomics is the comprehensive analysis of metabolites which are the end product of 
gene expression in a biological system [207], and may provide a viable technique to expand  
current understanding of the physiological adaptations associated with altitude exposure. Indeed, 
as oxygen is the terminal electron acceptor in the mitochondrial respiratory chain, and central 
energy metabolism is intricately linked to global metabolism, characterising the metabolic 
changes that occur during prolonged altitude exposure may identify previously unknown 
pathways of change that could influence exercise performance. Liquid chromatography-high 
resolution mass spectrometry (LC-HRMS) is a commonly employed analytical method for the 
untargeted measurement of metabolites due to its ability to resolve thousands of metabolite 
features with a single analysis of a biological sample. This technique enables accurate mass 
determination (ppm error) without compromising detection sensitivity, ensuring the detection of 
many metabolites from complex matrices such as blood. In addition, metabolomics requires only 
small sample volumes (~50 µL), thus enabling the collection of biological fluids more frequently 
on human participants in a variety of contexts. Recently, metabolomic studies using nuclear 
magnetic resonance (NMR) and mass spectrometry (MS) have enabled investigation into the 
effects of hypoxia in human, animal and cell models [48, 49, 269, 270], revealing changes in 
biochemical pathways such as central carbon, purines and lipid metabolism.  
Although a large volume of research has been conducted in an attempt to understand the 
haematological and non-haematological changes associated with altitude exposure, there are large 
inter- and intra-individual differences [276] in the physiological response to moderate exposure 
indicating that further research is necessary. The primary aim of this study was to use liquid 
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chromatography-high resolution mass spectrometry (LC-HRMS) analysis of human plasma 
samples to examine: the influence of 14 d normobaric, simulated altitude (~3000 m) on the 
metabolic profile of ten highly-trained middle distance runners. 
3.3 Methods 
3.3.1 Ethical approval 
Experimental procedures were approved by the human research ethics committee of Edith 
Cowan University, the Australian Institute of Sport Human Ethics Committee and conducted in 
accordance with the Declaration of Helsinki. All individuals provided written informed consent 
prior to participation. 
3.3.2 Participants 
Ten well-trained, healthy middle distance runners (six males and four females) were 
recruited from the Canberra local running community [mean ± standard deviation (SD) age: 28.6 
± 6.7 y; body mass: 62.6 ± 7.6 kg; maximal oxygen consumption (V̇O2max): 65.6 ± 8.1 mL·kg-
1·min-1] to participate in this study. Participants were included if they had at least two years of 
competitive running experience and trained at least three times per week. Participants were 
screened prior to the study for iron deficiency and excluded if deemed to be stage 2 iron deficient 
(serum ferritin < 20 µgˑL-1) [277]. Participants were instructed to maintain normal training 
schedule during the study, but to refrain from caffeine, alcohol and strenuous physical activity on 
the day of blood sampling. All participants self-reported compliance with these requirements. 
Data for this study was collected as part of a larger observational study examining the influence 
of 14 d altitude exposure (~3000 m) from which changes in haemoglobin mass, haematocrit %, 
haemoglobin concentration and erythropoietin have been reported elsewhere [16]. 
3.3.3 Altitude exposure 
Participants were exposed to 14 consecutive days of normobaric hypoxia (~3000 m) as 
part of an ‘altitude training camp’. The hypoxic environment was maintained within a purpose-
built altitude house facility using nitrogen dilution (Kinetic Performance Technology, Canberra, 
Australia). The goal of the training camp was to expose participants to at least 200 h [13] of 
hypoxic exposure (e.g. 14 h d-1). Participants maintained their normal training schedules during 
the 14 d experiment with all training conducted at terrestrial altitude (600 m). In addition to 
normal training, all participants completed four running interval-based training sessions (6 ´ 1000 
m at vV̇O2max) on separate days (two in normoxic conditions and two in hypoxic conditions) 
during the week preceding the 14 d of altitude exposure, and at 11 d and 14 d of hypoxic exposure. 
The normoxic sessions were conducted on 400 m synthetic running track (600 m terrestrial 




treadmill. Each interval session commenced with a 15 min warm-up, comprised of self-paced, 
continuous low intensity running, followed by 2 min dynamic stretching.  
3.3.4 Sample collection 
Blood sampling was performed at three time points (baseline, 3 d and 14 d) during the 14 
d altitude camp. Participants provided 2 mL of blood from the antecubital vein immediately after 
10 min of supine rest to normalise plasma volume shifts [115] into 1 × 2 mL lithium heparin 
vacutainer tubes. The tube was immediately centrifuged 2200 × g for 10 min and plasma was 
collected into 500 µL aliquots and stored -80 °C until metabolite isolation. 
3.3.5 Sample preparation for metabolomics analyses 
Metabolites were isolated from plasma samples using the Bligh and Dyer method [278] 
in randomised batches of 24. In brief, samples were thawed on ice and a 200 µL aliquot was 
combined at a ratio of 3:1:1 (v/v) of MS grade methanol (MeOH)/ chloroform (CHCL3)/ plasma, 
followed by two volumes of analytical grade water. To measure extraction efficiency and monitor 
mass spectrometry performance, the internal standard trans-cinnamic acid-β,2,3,4,5,6-d6 (Sigma 
Aldrich St Louis, MO, USA) was added to the MeOH before extraction. Samples were mixed by 
vortex at each solvent addition for approximately 15 s and shaken for 10 min at 4 ˚C and 1400 
rpm in an Eppendorf Thermomixer (Eppendorf, Hamburg, Germany). The bi-phasic extract was 
then centrifuged for 10 min at 4˚C at 16.100 × g. The polar phase of the metabolite extract was 
transferred to micro-centrifuge tubes and the MeOH was removed using a rotary vacuum 
concentrator. The remaining aqueous extracts were snap frozen using liquid N2, lyophilised to 
dryness, and stored at -80 ˚C until analysis. Prior to instrumental analysis, the dried extracts were 
reconstituted in 50 µL of 0.1% formic acid (in MS-grade water) and maintained at 10 ˚C in the 
autosampler. Prior to data acquisition, the analytical sequence was randomised by participant, and 
then time point. To monitor analytical drift and assess precision, quality control (QC) samples 
were injected after every 5th sample [247]. QC samples were prepared by combining 20 µL of 
each plasma sample into a single pool; 50 µL aliquots were then dispensed and as described for 
the study samples.  
3.3.6 Liquid chromatography – mass spectrometry analysis 
Samples were analysed using a Waters ACQUITY ultra performance liquid 
chromatograph UPLC (Waters Corp, Milford, MA) system coupled to a SCIEX TripleTOF 5600 
mass spectrometer (SCIEX, Framingham, MA). Chromatographic separation was performed 
using the Waters Acquity BEH C18 column (2.1 × 100 mm, 1.7 µm particle size) (Waters Corp, 
Milford, MA). The elution gradient using 0.1% formic acid (in MS-grade water; Solvent A) and 
0.1% formic acid (in MS-grade acetonitrile Solvent B) was as follows: isocratic step at 1% B for 
1 min, 1 to 99.5% B in 36 min, maintained at 99.5% B for 2 min, returned to initial conditions for 
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1 min, and then equilibration at initial conditions for 5 min. The flow rate was 0.3 mL min-1, 
injection volume was 10 µL, and the column oven was maintained at 35˚C. 
Full scan mass spectrometry data in high resolution were acquired in both electrospray 
ionisation positive and negative (ESI+/-) using a mass range of 50 – 1000 m/z according to the 
following parameters: nebulizer gas (N2) 45 psi, heater gas (N2) 50 psi, curtain gas 30 psi and ion 
source temperature of 550˚C. An IonSpray voltage of 5500 V was used for positive-ion 
acquisition and –4500 V was used for negative-ion acquisition. MS/MS spectra were collected on 
all acquired samples to aid in metabolite identification. Independent data acquisition was used on 
the TripleTOF 5600 to obtain MS/MS spectra for the 5 most abundant precursor ions following 
each survey scan. A sweeping collision energy setting of 35 ± 15eV was applied in the collision 
cell using nitrogen as the collision gas. An exact mass calibration was conducted automatically 
before each batch analysis and at every 6th sample thereafter. The instrument was calibrated before 
the analysis (calibration error less than 3 ppm) using 0.5 mM sodium formate for both positive 
and negative ionisation. The TripleTOF 5600 mass spectrometer used Analyst control software 
v1.6 for data acquisition. 
3.3.7 Data pre-processing 
Data from each MS ionisation mode were grouped and pre-processed separately. Raw 
MS files were converted to universal mzXML format using MSconvert [279], then processed 
using XCMS [280] in R (R 3.1.1; http://cran.r-project.org/). Peak detection and alignment were 
completed using the following parameters:  method = ‘centWave’, ppm = 10, peak width = 5 – 
20, snthresh = 6, mzdiff = 0.01, retention time correction method = ‘obiwarp’, and mzdiff = 0.01. 
Experimental drift was corrected using the Quality Control-Robust Spline Correction (QC-RSC) 
algorithm [281]. Relative standard deviations were calculated for the pooled QC acquisition data 
(RSDQC) and the sample acquisition data (RSDSample); and the ratio of RSDsample to RSDQC was 
also calculated. Features with > 25% RSDQC or RSD ratio < 2 were considered not sufficiently 
reproducible and removed prior to statistical analysis.  
To suppress the mathematical confounding effect of highly collinear data (and to roughly 
group chemically similar features, such as adducts and isotopes) metabolite features were 
combined into a single peak using a simple clustering algorithm. First, a Pearson’s correlation 
matrix was calculated, mapping the pair-wise correlation between each metabolite feature. 
Second, a retention time difference matrix was calculated, mapping the pair-wise difference in 
retention time between each metabolite feature. Features that had a pair-wise correlation > 0.8 
and pair-wise retention time difference < ± one-second were grouped into a single metabolite 
“cluster”. For each cluster, the feature with the largest peak area was then used for quantification. 




3.3.8 Metabolite identification 
Metabolite identifications were established prior to statistical analysis by matching 
against online spectral libraries (mzCloud, Metlin, HMDB and Massbank). A level-2 putative 
match was reported when only the MS1 scan and MS/MS spectra matched that of an online 
spectral library, but the identification was not confirmed via an in-house authentic standard. This 
process corresponds with the minimum reporting standards for chemical analysis proposed by the 
Metabolomics Standards Initiative [282]. Identified metabolites are indicated in the statistical 
table (level 2), including information of most probable identity and m/z. 
3.3.9 Statistical analysis 
The metabolite cluster data from both positive and negative ionisation modes were 
combined into a single data matrix. Missing values were imputed using the k-nearest-neighbour 
methodology (k = 3) [283]. Data were log transformed, both to stabilise variance and to 
approximate the multivariate normal distribution needed for parametric univariate and 
multivariate statistical modelling. 
Before any formal models were tested, principal components analysis (PCA) was 
performed on the complete data set, with scores plot labelled by QC and Subject. Here the aim is 
to assess the natural multivariate variance of the data. If the experiment has been reproducibly 
performed, it is expected for the QC samples to tightly cluster, such that the QC variance is less 
than the total sample (biological) variance. This is also an opportunity to identify and remove 
sample outliers resulting from either poor sample preparation or instrument error. 
Metabolites were separated into identified and unidentified data sets. For each metabolite 
in turn, the null hypothesis that there were no differences in population means across the three 
consecutive time-points was tested using repeated measures analysis of variance (RM-ANOVA). 
The method described by Storey et al. (2003) was used to control for the probability of false 
discovery, which is unavoidably inflated through multiple parallel statistical comparisons [284]. 
A false discovery rate (FDR) of 0.1 was considered appropriate as a first-pass screen to avoid 
false positive biomarkers, whilst at the same time avoiding false negative results. For the 
identified metabolites, results were presented in a table of F-scores, p-values, FDR probabilities 
and mean fold differences (± 95% confidence interval) for 3 d/baseline and 14 d/baseline. Where 
appropriate, univariate data was also presented as plots of estimated marginal means relative to 
the factor Time. 
The identified ion features were then combined into a single multivariate discriminant 
model using Principal Component projection followed by Canonical Variate Analysis (PC-CVA) 
[285]. PC-CVA was performed to visualise the multivariate covariance in the data and uncover 
multivariate latent structure therein. Often univariately weak, but correlated, variables can 
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become significant when combined into a multifactorial biomarker signature. The number of PCs 
to be projected into CVA space was determined by identifying the inflection point in the PCA 
scree plot. Bootstrap resampling/remodelling was used (n = 500) to determine which metabolites 
significantly contributed to the optimal model (p £ 0.05).  
3.3.10 Data mining of unidentified metabolite features 
To determine the strength and the direction of the linear relationship between all 
identified and unidentified significant metabolite features (pFDR £ 0.1), undirected network 
analysis was performed in the form of a spring-embedded plot [254]. First, a Pearson’s correlation 
matrix was calculated, mapping the pair-wise correlation between each significant metabolite 
feature. The results of the correlation matrix were graphically presented as a network of “nodes” 
linked by “edges”. Each node represents a metabolite, such that the size of the node is 
proportional to the significance of the metabolite (the larger the node, the lower the p-value). 
Edges represent a spring constant that is proportional to the correlation coefficient between two 
metabolites. Edges were only included if the correlation coefficient was positive and significant 
at a critical p-value of 0.001. Once the network was constructed, it was allowed to “relax”- the 
connected spring-edges compete against each other to pull nodes in a given direction based on 
the spring constant (i.e. the higher the correlation, the stiffer the spring, and higher the clustering 
power). The resulting spring embedded plot was viewed as a multivariate cluster analysis, with 
highly correlated metabolites clustering closer together. To aid interpretation of the network, non-
significant but identified metabolites were included in the spring plot (labeled in grey), based on 
the premise that metabolites performing a similar function, or belonging to a similar class, will 
cluster. Networks were coded using the graph visualization software Graphviz 
(www.graphviz.org) using the ‘neato’ virtual physics model. All statistical analysis was 
performed using Matlab scripting language, vR2017a (Mathworks, Natick, MA, USA). 
3.4 Results 
3.4.1 Altitude exposure 
Over 14 d participants accumulated 196.2 ± 25.6 h of normobaric hypoxic exposure. 
3.4.2 Metabolomics data 
After data cleaning and similarity clustering, the LC-HRMS data resulted in the 
reproducible detection of 1105 metabolite features in positive ionisation mode and 1896 
metabolite features in negative ionisation mode. Of the reproducible features, 36 were identified 
and confirmed metabolites, from classes including amino acids, tryptophan metabolism, 




Principal components analysis (PCA) showed (Fig. 3-1) that the QC samples clustered, 
and that the QC-variance was much smaller than the sample-variance. Additionally, it can be 
observed that across the total measured metabolome the between-subject variance was much 
greater than within-subject variance. There were no sample outliers detected. 
 
Figure 3-1 Principal components analysis (PCA) scores plot showing all experimental 
samples of the 3001 reproducible peaks. The quality control (QC) samples (red circles) formed 
from pooling small quantities from each sample and tightly cluster in the plot. 
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Table 3-1 Putatively annotated metabolic features during ~3000 m altitude exposure. The table consists of i) the metabolite name, ii) measure m/z, iii) the ANOVA 
F score, iv) p-value, v) corrected p-value, (vi) & (vii) mean fold change with 95% confidence intervals, & (viii) & (ix) canonical variate scores.   
     Day3/1 Day14/1 Canonical variate analysis 
Putative Metabolite M+H F (2,18) p-value pFDR Mean fold (95% CI) Mean fold (95% CI) CV1 (95%CI) CV2 (95% CI) 
Bilirubin 585.2706 10.80 0.001 0.04 1.71 (1.36 − 2.16)*** 1.25 (-1.01 − 1.57) -0.26 (-0.46 − -0.06) * 0.1 (-0.08 − 0.28) 
Adenosine 268.1045 8.87 0.001 0.04 -2.55 (-4.55 − -1.43)** -2.32 (-3.92 − -1.37)** 0.13 (-0.13 − 0.4) -0.18 (-0.34 − -0.03) * 
Glycocholic acid 464.2996 7.63 0.01 0.06 -3.34 (-7.56 − -1.48)** -1.52 (-2.86 − 1.23) 0.24 (0.09 − 0.38) * -0.04 (-0.24 − 0.16) 
Glycoursodeoxycholic acid 448.3049 6.67 0.01 0.06 -3.15 (-6.67 − -1.48)** -2.15 (-4.16 − -1.12) * 0.21 (0.05 − 0.37) * -0.06 (-0.24 − 0.12) 
Proline 116.0716 6.95 0.01 0.07 -1.34 (-1.68 − -1.06) * 1.03 (-1.13 − 1.19) 0.23 (0 − 0.45) * 0.1 (-0.18 − 0.39) 
Tiglylcarnitine 244.1547 5.59 0.01 0.08 1.22 (1.01 − 1.48) * 1.27 (1.09 − 1.48)** -0.05 (-0.36 − 0.26) 0.17 (-0.06 − 0.39) 
Tyrosine 180.0662 5.99 0.02 0.08 -1.49 (-1.93 − -1.16)** -1.04 (-1.33 − 1.22) 0.22 (0.06 − 0.38) * -0.03 (-0.24 − 0.18) 
Lactic Acid 89.0251 4.93 0.02 0.08 -1.38 (-1.78 − -1.07) * -1.07 (-1.34 − 1.18) 0.22 (0.03 − 0.42) * 0.03 (-0.19 − 0.25) 
Cortisol 363.2173 3.83 0.05 0.17 1.36 (1.02 – 1.81) * 1.03 (-1.22 − 1.28) -0.2 (-0.42 − 0.02) -0.01 (-0.22 − 0.19) 
Hypoxanthine 137.0464 3.32 0.06 0.18 1.36 (1.01 − 1.84) * 1.12 (-1.16 − 1.47) -0.18 (-0.41 − 0.05) 0.11 (-0.12 − 0.33) 
Methionine 150.0587 3.54 0.06 0.18 -1.29 (-1.74 − 1.05) 1.02 (-1.19 − 1.25) 0.19 (-0.03 − 0.41) 0.1 (-0.12 − 0.31) 
2-Octenoylcarnitine 286.2016 3.26 0.07 0.18 1.95 (1.2 − 3.16) * 1.27 (-1.52 − 2.43) -0.18 (-0.33 − -0.04) * 0.04 (-0.19 − 0.26) 
Dodecanedioc acid 229.1438 3.66 0.08 0.19 -2.08 (-5.36 − 1.24) 1.01 (-1.96 − 2) 0.22 (0.01 − 0.42) * -0.01 (-0.23 − 0.21) 
Linoleic acid 281.2480 2.49 0.11 0.26 1.72 (-1.03 − 3.06) 1.24 (-1.35 − 2.07) -0.08 (-0.3 − 0.13) 0.09 (-0.12 − 0.3) 
Phenylalanine 166.0867 2.26 0.14 0.30 -1.32 (-1.83 − 1.06) -1.16 (-1.55 − 1.15) 0.1 (-0.09 − 0.28) -0.01 (-0.23 − 0.2) 
Tetradecanedioc acid 520.3400 2.28 0.16 0.31 -1.21 (-1.55 − 1.06) 1.1 (-1.15 − 1.4) 0.19 (-0.04 − 0.42) 0.08 (-0.18 − 0.35) 




N-Phenylacetylglutamine 265.1185 1.75 0.21 0.37 1.28 (-1.11 − 1.82) 1.08 (-1.3 − 1.52) -0.11 (-0.35 − 0.13) 0.02 (-0.22 − 0.26) 
Pseudouridine 243.0613 1.64 0.22 0.37 1.1 (-1.05 − 1.28) 1.01 (-1.13 − 1.15) -0.14 (-0.35 − 0.07) -0.07 (-0.26 − 0.12) 
N-Acetyl-L-Carnosine 269.1245 1.39 0.28 0.44 1.19 (-1.04 − 1.47) 1.08 (-1.17 − 1.37) -0.12 (-0.35 − 0.11) 0.08 (-0.15 − 0.3) 
Tryptophan 203.0822 1.34 0.29 0.44 -1.11 (-1.24 − 1.01) -1.06 (-1.23 − 1.09) 0.13 (-0.03 − 0.29) -0.06 (-0.2 − 0.09) 
5-Hydroxytryptophan 219.0768 1.25 0.30 0.44 1.15 (-1.04 − 1.37) -1.02 (-1.39 − 1.33) -0.17 (-0.41 − 0.06) -0.09 (-0.36 − 0.17) 
Ocatanedioic acid 173.0815 1.21 0.32 0.44 -1.28 (-1.99 − 1.21) -1.14 (-1.62 − 1.25) -0.01 (-0.22 − 0.19) 0.02 (-0.19 − 0.23) 
Citric Acid 191.0194 0.74 0.44 0.58 1.01 (-1.23 − 1.25) -1.2 (-1.99 − 1.39) 0.01 (-0.23 − 0.24) -0.16 (-0.37 − 0.06) 
N-N'-Diphenylguanidine 212.1185 0.69 0.46 0.59 1.08 (-1.98 − 2.3) -1.85 (-10.63 − 3.11) 0 (-0.18 − 0.19) -0.02 (-0.22 − 0.19) 
5-methoxyindole acetic acid 206.0815 0.71 0.49 0.59 -1.1 (-1.27 − 1.05) -1.03 (-1.26 − 1.19) 0.04 (-0.15 − 0.23) 0 (-0.24 − 0.24) 
cis-Aconitic acid 175.0242 0.60 0.50 0.59 1.34 (-1.66 − 2.97) 1.29 (-1.61 − 2.7) -0.02 (-0.23 − 0.18) -0.02 (-0.19 − 0.14) 
Hexadecanedioic acid 285.2057 0.55 0.54 0.62 -1.09 (-1.64 − 1.37) 1.13 (-1.56 − 1.99) 0.16 (-0.09 − 0.41) 0.06 (-0.16 − 0.28) 
Succinic Acid 117.0193 0.42 0.63 0.69 -1.08 (-1.25 − 1.08) -1.03 (-1.22 − 1.14) -0.05 (-0.31 − 0.2) -0.13 (-0.42 − 0.16) 
Benzyl cinnamate 239.1069 0.39 0.64 0.69 1.41 (-1.68 − 3.33) 1.53 (-2.49 − 5.83) 0.01 (-0.24 − 0.26) 0.15 (-0.12 − 0.41) 
kynurenine 209.0927 0.32 0.69 0.71 1.02 (-1.24 − 1.28) -1.06 (-1.23 − 1.1) -0.14 (-0.33 − 0.06) 0.07 (-0.15 − 0.3) 
Indole-3-acetic acid 176.0711 0.01 0.98 0.98 1.02 (-1.39 − 1.45) 1.01 (-1.24 − 1.28) 0.03 (-0.18 − 0.24) 0.06 (-0.17 − 0.28) 
Note: Significant metabolite response defined as *** p £ 0.001. ** p £ 0.01 and * p £ 0.05.  Data are presented as the fold-change of the median (95% CI). Median fold-
change and CI were estimated using 500 iterations of bootstrap resampling.
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After RM-ANOVA using a critical p-value of 0.03 (pFDR = 0.1), 173 metabolites were 
found to be statistically significant when compared to baseline (70 in ESI (+) mode and 103 in 
ESI (-) mode). Of the 36 identified metabolites, eight were statistically significant when compared 
to baseline. Five metabolites showed a significant disruption followed by recovery trajectory 
(bilirubin increased at 3 d and then returned to normal at 14 d; glycocholic acid, proline, tyrosine, 
lactic acid decreased at 3 d and then returned to baseline at 14 d). Three metabolites displayed a 
significant non-recovery trajectory (adenosine and glycoursodeoxycholic acid decreased at 3 d, 
but then showed only a slight return to baseline at 14 d; tiglylcarnitine increased at 3 d and then 
continued to increase to 14 d). 
Using a four principal components projection, the results of PC-CVA (Fig. 3-2 & 3-3) 
indicate significant multivariate discrimination between group means (p < 0.05). CV1 described 
a non-linear recovery trajectory from baseline, to 3 d, and then back to the initial position at 14 d. 
Conversely, CV2 described a weaker, but orthogonal, non-recovery trajectory, increasing from 
baseline to 3 d, with a further increase from 3 d to 14 d. Examining the CVA loadings plots (Fig. 
3-3) confirms this observation. The eight significant metabolites in CV1 show a clear correlated 
recovery trajectory, with bilirubin & 2-octenoylcarnitine observing an initial increase in 
metabolite concentration then recovery, rather than the initial decrease and then recovery 
observed in glycocholic acid, glycoursodeoxycholic acid, proline, tyrosine, lactic acid and 
dodecanedioic acid. Only adenosine was significant in CV2, which reflects the already observed 






Figure 3-2 Principal Component-Canonical Variate Analysis (PC-CVA) of metabolite levels 
during the course of hypoxic exposure. Red circles, controls; green triangles, 3 days hypoxic 
exposure; blue squares, 14 days hypoxic exposure. X, mean of each time point; dashed circles 
95% confidence interval of the mean of each time point. 
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Figure 3-3 Principal Component-Canonical Variate Analysis (PC-CVA) loadings plot of 
putatively identified metabolites during the course of hypoxic exposure. Metabolites 
contributing to CV1 (left) and CV2 (right). Red metabolites that significantly (p <0.05) contribute 





The spring embedded correlation plot (Fig. 3-4) included unidentified significant 
metabolite features (pFDR < 0.1) together with all identified metabolites. Three clusters were 
identified. One small cluster (blue) was composed of metabolites in which metabolite 
concentration linearly decreased over time and correlated with identified metabolites classes from 
purine pathways, including adenosine. The second cluster (light blue/green) decreased between 
baseline and 3 d but then observed clear recovery toward normal metabolite concentration. The 
third cluster (red – red/green/yellow) increased between baseline and 3 d, then metabolites in the 
centre of the cluster (dark red) continued to increase at 14 d (this sub-cluster had no associated 
identified metabolites), whereas the metabolites at the periphery of this cluster showed clear 
recovery toward normal concentration. This outer cluster includes metabolites associated with 
steroid metabolism (cortisol), haem breakdown (bilirubin) and purines (hypoxanthine). 
64 
 
Figure 3-4 Spring embedded correlation plot of the identified and significant peaks 
following altitude exposure. Metabolites (circles) and the associated correlations 
(lines/springs). Size of the circle is proportional to the significance of the metabolite (i.e. the larger 
the circle the more significant the metabolite) and the spring relates the amount of correlation (i.e. 
the shorter the spring the more correlated the response of the metabolite to its neighbour). The 
direction of change is indicated by colour, red is increased in concentration and blue is decrease 
in concentration relative to baseline. Node colour directly maps to the linear correlation coefficient 






This study examined the metabolic changes following 14 d of normobaric hypoxia 
(~3000 m) in well-trained endurance runners. Using metabolomics and multivariate methods, 
revealed a metabolic profile associated with acute altitude exposure. There was a significant shift 
in the plasma metabolite profile following 3 d of acute altitude exposure with partial return 
towards baseline by 14 d. The metabolites contributing to this change in metabolic profile 
following altitude exposure followed two separate trajectories. 
While several haematological and non-haematological changes are well defined 
following hypoxic exposure [46, 286], to our knowledge the present study is the first to 
demonstrate a clear perturbation in an athlete’s metabolite profile during 14 d or 196.2 ± 25.6 h 
of moderate altitude exposure. Univariate statistical analysis revealed that 173 (p-value of 0.03 
[pFDR = 0.1]) metabolites were altered at 3 d, 14 d or both.  Altered metabolites were observed 
from distinct metabolite classes: amino acids, tryptophan, glycolytic, heme and nucleotide 
metabolic pathways. Changes in plasma amino acids were observed to decrease and may reflect 
metabolic remodelling in order to meet energy requirements. Decreased concentration of several 
plasma amino acids, such as proline and tyrosine during altitude exposure may reflect utilisation 
of glucogenic substrates [49, 287]. Horsecroft and Murray [288] recently suggested promotion of 
amino acids as energy substrates are favoured during high altitude exposure. Interestingly, no 
evidence of an increased lactate concentration was measured during moderate altitude exposure 
(fold change -1.38 at 3 d and -1.07 at 14 d), indicating anaerobic metabolism may have been 
unaffected at the blood sampling time points. These findings support the ‘lactate paradox’ theory 
where lactate concentration decreased with increased period of exposure to altitude [184]. 
Alternatively, increased oxidisation may have occurred to prevent blunting of EPO response 
during early altitude exposure [289] (Table 3-1). Additionally, when compared to baseline, we 
observed no differences in citrate or succinate, indicating normal TCA cycle activity which is not 
in agreement with previously published data. For example, Liao et al. (2016) reported increased 
concentration of blood lactate, succinate and citrate in 60 healthy male volunteers exposed to 
5300 m of altitude [49]. It is possible that differences between our findings and those of Liao et 
al. (2016) are methodological in nature as varying effects on metabolic pathways have been 
observed between moderate (2000 – 3000 m) and high (3000 – 5500 m) altitudes [269]. It is 
therefore likely the use of moderate altitude exposure in the current study would likely have 
promoted different physiological responses when compared with studies completed at higher 
altitudes. 
Canonical Variate Analysis (CVA) revealed that the plasma metabolome was 
significantly altered during (3 d) and following (14 d) moderate altitude exposure of ~3000 m 
(Fig. 3-2). This finding was expected as altitude exposure places considerable stress on the body 
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to maintain oxygen driven energetic pathways and redox homeostasis. Importantly, changes in 
the plasma metabolites were observed at 3 d, with a return to baseline levels by 14 d. The 
trajectory of the CVA aligns with the acclimatisation response that typically occurs during the 
first 14 d of altitude exposure [290]. During this period, a process of biochemical and metabolic 
changes essential for adaptation to lower oxygen environments occur [290]. Although many of 
the metabolites contributing to alteration in the athlete’s metabolome remain unidentified, our 
findings highlight two distinct adaptation patterns occurring in athletes exposed to moderate 
altitude. For example, whilst CV1 demonstrates that metabolites initially decreased during the 
early phase of altitude adaptation, these metabolites appeared to return to baseline levels by 14 d. 
In comparison, whilst the second trajectory (CV2) initially appeared to either increased or 
decreased, it did not return to baseline. To this end, further investigation of these metabolites 
during moderate altitude exposure may help to more accurately describe the complex 
physiological and metabolic adaptions that occur in athletes during prolonged, moderate altitude 
exposure, which may in turn provide further insights into the physiological basis of the intra- and 
inter- individual differences reported in athletes during altitude exposure [276]. 
Using spring embedded correlation plot (Fig. 3-4), identified metabolites that congregate 
around similar clusters likely share related biological functions and/or metabolic pathways. 
Accordingly, it is possible to infer that unidentified metabolites that also congregate around 
clusters of identified metabolites potentially have a similar biological function. We observed 
tightly clustered metabolites for the identified and significant non-identified metabolites 
suggesting that these clusters were of similar biochemical relevance. For example, the close 
clustering of several identified and unidentified amino acids suggests that these metabolites are 
involved in a similar biological pathway. However, other metabolites originating from the same 
pathway, whilst detected, were either unable to be identified or not significant, possibly due to 
the small size (n = 10) within this study.  Additionally, the lack of a control group and diet control 
in the experimental design of this study meant that the biological origin of highly significant 
features were unknown. To this end, studies tracking larger sample of endurance athletes during 
sojourns to moderate altitude may provide a more complete description of the complex interaction 
between hypoxia and the athlete’s metabolome. Finally, as this was an observational study it was 
not possible to analyse athletes’ training volume as covariates into our statistical model, thus it is 
recommended future studies account for these factors when determining the influence of altitude 
exposure on the blood metabolome.  
While preliminary, this study demonstrates the potential for identifying an athlete’s 
unique metabolic signature associated with the typical haematological and biochemical 
perturbations resulting from moderate altitude exposure.  However, the influence of the prolonged 
hypoxia on the athlete’s metabolome remains incomplete, and further research is necessary to 




For example, future studies could include more sampling time points to yield a more complete 
understanding of the adaptation trajectory of metabolites. To this end, developing less invasive 
biofluid sampling mediums/matrices such as urine and blood spots, could allow metabolic 
changes to be more easily quantified during moderate altitude. Furthermore, monitoring an 
athlete’s metabolomic response in the weeks after altitude exposure may permit a better 
understanding of the physiological factors underlying improved endurance performance upon 
return to sea level.   
3.6 Conclusion 
In conclusion, a metabolomic analysis was able to identify that 204 significantly 
perturbed metabolites contributed to differences in the plasma metabolome during moderate, 
simulated altitude exposure. It is apparent from the present study that many metabolites remain 
perturbed beyond 14 d of exposure and further investigation using more targeted methods may 
provide novel insights into the physiological responses to altitude exposure. Finally, the outcomes 
of this study demonstrate the potential for metabolomics to provide more detailed information 
about the physiological adaptations associated with moderate altitude training. 
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Chapter 4 Blood removal influences pacing during a 
4-minute cycling time trial 
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Link: Findings from Chapter 3 indicate acute metabolic adaptions occur in response to low 
oxygen carrying capacity during moderate altitude. A finding such as a shift in substrate utilisation 
during acute hypoxia is important. However, the relevance of the shift on both performance is 
unknown.  Given the importance of anaerobic contribution within performance trials the second 





Purpose: To examine the influence of manipulating aerobic contribution following 
whole blood removal on pacing patterns, performance and energy contribution during self-paced 
middle distance cycling. Methods: Seven male cyclists (33 ± 8 y) completed an incremental 
cycling test followed 20 min later by a 4-min self-paced cycling time trial (4MMP) on six separate 
occasions over 42 d. The initial two sessions acted as a familiarisation and baseline testing after 
which 470 mL of blood was removed with the remaining sessions performed 24 h, 7 d, 21 d and 
42 d following blood removal. During all 4MMP trials, power output, V̇O2, and aerobic and 
anaerobic contribution to power were determined. Results: 4MMP average power output 
significantly decreased by 7 ± 6%, 6 ± 8% and 4 ± 6% at 24 h, 7 d and 21 d following blood 
removal, respectively. Compared with baseline, aerobic contribution during the 4MMP was 
significantly reduced by 5 ± 4%, 4 ± 5% and 4 ± 10% at 24 h, 7 d and 21 d, respectively. The rate 
of decline in power output upon commencement of the 4MMP was significantly attenuated and 
was 76 ± 20%, 72 ± 24% and 75 ± 35% lower than baseline at 24 h, 21 d and 42 d, respectively. 
Conclusion: The results indicate that the removal of 470 mL of blood reduces aerobic energy 
contribution, alters pacing patterns and decreases performance during self-paced cycling. These 
findings indicate the importance of aerobic energy distribution during self-paced middle distance 
events.  





The influence of blood manipulation on exercise performance is complex and likely 
associated with both haematological and non-haematological alterations that influence aerobic 
and anaerobic metabolism [174]. For instance, enhancing oxygen delivery through increasing 
haemoglobin mass (Hbmass) via chronic altitude exposure [27, 173, 291], red blood cell infusion 
[292, 293], or erythropoietin administration [12] can increase aerobic capacity and exercise 
performance. Whereas reductions in plasma volume and Hbmass, following the removal of blood 
[112, 118, 198, 201, 294], the partial blockade of oxygen binding with haemoglobin through 
carbon monoxide administration [295], and decreasing arterial oxygen content through acute 
altitude induced hypoxemia [77] can compromise maximal aerobic capacity (V̇O2max) and 
exercise performance. This influence may be especially apparent in middle distance events, which 
are characterised by a high reliance on aerobic metabolism and where a high level of aerobic 
fitness is common [43]. 
Despite the importance of V̇O2max to middle distance events, it is possible that anaerobic 
energy stores may have a considerable influence on self-selected pacing. Indeed, it has been 
hypothesised that individuals will manipulate pace throughout an event in order to spare their 
‘anaerobic energy reserve’ for the final 10 – 15% of the effort [43]. Manipulation of diet [67, 296] 
(i.e. caffeine intake) and motivation [297] augment the distribution of anaerobic energy 
contribution, resulting in altered pacing and improving performance during middle distance 
events. Due to the high aerobic demand during middle distance events, it is plausible that reducing 
aerobic delivery through decreasing blood volume may alter overall pacing through an increased 
reliance on anaerobic metabolism. However, to date, the influence of altering aerobic energy 
contribution on the distribution of energetic resources and pacing during middle distance 
performance is unclear.  
The purpose of this study was to determine the influence of voluntary blood donation on 
pacing and energy resources during self-paced middle distance cycling in trained cyclists. We 
hypothesised that blood removal would decrease V̇O2max and exercise performance as well as alter 
the overall pacing profile. We further hypothesised that the changes in haematological measures 
in the 42 d following the blood removal would result in a gradual recovery in V̇O2max as well as 
performance and the aerobic contribution during the self-paced cycling task.  
4.3 Methods 
4.3.1 Participants 
Seven trained male cyclists (mean ± SD; age: 33 ± 8 y, height: 1.8 ± 0.1 m, body mass: 
72.1 ± 6.9 kg, V̇O2max: 60.7 ± 5.5 mL·kg-1·min-1, maximal aerobic power: 401 ± 38 W) 




time trials and were regarded as trained based on previous classifications [59]. Individuals with a 
history of hypertension, taking prescribed medications, or deemed as ineligible to donate blood 
as per the Australian Red Cross blood donation questionnaire were excluded from the study. 
Participants were asked to maintain regular training commitments and record (hours and distance 
per week) throughout the duration of the study, and to refrain from heavy exercise in the 24 h 
period preceding each test and fast (water allowed) for at least 8 h prior to each trial.  Participants 
were informed, verbally and in writing, of the possible risks and benefits associated with the study 
and signed informed consent was obtained prior to data collection. Ethical approval for this study 
was obtained from the Human Research Ethics Committee of the participating institution prior to 
study commencement.  
4.3.2 Experimental Design 
On separate days, over a period of 50 d, participants made one visit to an Australian Red 
Cross donation centre and attended six laboratory sessions at the same time of day (± 1 h) in a 
rested state. During all laboratory visits, participants performed identical exercise consisting of 
an incremental cycling test followed 20 min later by a maximal 4-min cycling time trial (4MMP). 
During the initial familiarisation session, participants performed an incremental cycling test and 
4MMP habituation trial. This session was followed 7 d later by the baseline testing session. 
Approximately 24 h after completing baseline testing, participants then attended the Australian 
Red Cross donation centre for the removal of ~470 mL of whole blood. Following blood donation 
(24 h, 7 d, 21 d and 42 d) participants repeated the exercise testing session (i.e. incremental cycling 
test and 4MMP).   
In all testing sessions, with the exception of the familiarisation session, a capillary blood 
sample via finger stick was obtained prior to the start of exercise for the assessment of 
haemoglobin concentration ([Hb]) and haematocrit (Hct). To avoid the influence of plasma 
volume shifts,[115] participants remained in a seated upright position for 10 min prior to and 
during the blood sampling. Haemoglobin concentration was measured using a Hemocue blood 
photometer (Hemocue® Hb 201, Angelholm, Sweden). Haematocrit was measured using 
heparinised Micro-Hematocrit capillary tubes centrifuged at 13,500 x g for 5 min and assessed 
using a micro capillary reader.  
4.3.2.1 Incremental Cycling Test 
Participants completed an incremental cycling test on an electronically braked Velotron 
cycle ergometer (RacerMate; Seattle, WA, USA) to determine maximal aerobic power (MAP) 
and V̇O2max. The test commenced at 70 W and increased 25 Wˑmin-1 until exhaustion. Throughout 
the test, expired gases were continuously measured using a calibrated metabolic cart 
(ParvoMedics, TrueOne 2400, Sandy, UT, USA). Measures of oxygen consumption were 
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obtained as 30 s mean values with (V̇O2max) determined as the greatest 30 s mean value recorded 
during the test. Heart rate was measured using a Polar heart rate monitor (Polar Electro, Kempele, 
Finland) and power output was measured via Velotron internal software at a frequency of 1 Hz. 
Immediately following the incremental cycling test, participants were required to complete 5 min 
of active recovery on the cycle ergometer and then 15 min of passive seated rest prior to the start 
of the 4MMP.  
4.3.2.2 4-Minute Self-Paced Time Trial (4MMP) 
Participants performed the 4MMP on the same Velotron cycle ergometer as the 
incremental cycle test. During the 4MMP, participants were instructed to produce the highest 
average power output possible over the 4 min duration. As the performance trial was completed 
after the incremental cycling test, no additional warm-up was provided. All participants started 
the trial from a standing position using a standardised simulated gear ratio of 52 × 19. During the 
4MMP, participants were able to alter their power output by altering their pedalling cadence and 
gear ratio as required. Only elapsed time was provided to the participants during the trial. 
Throughout the 4MMP, expired gases, power output and heart rate were measured continuously. 
Ratings of perceived exertion were measured at 2 min and 4 min using the Borg 10 point scale 
[298].  
4.3.3 Data Processing 
Mean power output and cardiorespiratory data (V̇O2, heart rate and respiratory exchange 
ratio) were calculated for the entire 4MMP cycling trial. In addition, the pacing responses of each 
trial were assessed using eight 30 s serial splits (e.g. 30 s, 60 s,….., and 240 s). Mean 30 s data 
were calculated for power output, heart rate, respiratory exchange ratio and V̇O2. To further 
investigate pacing pattern, a linear regression was fitted to the power output during the first four 
30 s splits to determine starting strategy and the rate of decline during the first 2 min of the 4MMP 
[299].  
Metabolic aerobic power was calculated by multiplying oxygen consumption with the 
oxygen equivalent (as per previous research [300]): 
Metabolic Power (W) = V̇O2 (Lˑmin-1) · ((4.94 kJ·L-1 · RER + 16.04 kJ·L-1) / 60)  
Where V̇O2 is the oxygen uptake in L·min-1 and RER is the respiratory exchange ratio. 
During the 4MMP cycling trials, RER values in excess of 1.0 were adjusted to 1.0 in the 
calculation of metabolic work per unit of time. 
Subsequently, the mean power output and V̇O2 during each split were used to calculate 
the aerobic contribution (Paer) to power output by multiplying metabolic work by gross efficiency. 




to those in this study [301]. The anaerobic contribution (Pan) to power output was calculated by 
subtracting the Paer from total power output  [70]. 
Pan = power output - Paer 
4.3.4 Statistical Analysis  
Weekly training volume, Hct, [Hb], V̇O2max, maximal heart rate, as well as MAP during 
the incremental exercise test were compared between trials using a one-way repeated measures 
analysis of variance (ANOVA). Similarly, mean heart rate, rating of perceived exertion and the 
linear regression fitted to power output during first four splits of each 4MMP cycling trial (i.e., 
slope) were analysed using a one-way repeated measures ANOVA. Dependent variables during 
the 4MMP (power output, V̇O2, Paer and Pan) were compared between trials and splits using linear 
mixed modelling with trials (baseline, 24 h, 7 d, 21 d and 42 d) and splits (i.e. 30 s, 60 s) set as 
fixed factors. Where a significant main effect or interaction was observed, Fisher’s least 
significant difference post-hoc was used to identify where differences occurred. Furthermore, 
power output was compared between trials by the interaction effect between trial and splits for 
determination of pacing patterns. Effect sizes (ES) were calculated to determine the magnitude of 
differences between trials for Hct, [Hb], V̇O2max, MAP from the incremental cycling test and for 
the mean power output, V̇O2, Pan, and Paer measured during the 4MMP at the 95% confidence level. 
ES estimates of 0.2, 0.5, 0.8, and 1.3 were interpreted as small, moderate, large and very large, 
respectively [302]. Hedges G correction was applied to account for bias from the small sample 
size [303]. Statistical tests were conducted using SPSS (Version 21; Chicago, IL), with 
significance accepted at p £ 0.05. Data are presented as mean ± 95% CI. 
4.4 Results 
4.4.1 Exercise 
Results of the one-way ANOVA revealed no differences in weekly training volume 
across the 42 d period (6.86 ± 3.55 h·wk-1, p = 0 .409).  
4.4.2 Haematological Parameters 
Results of the one-way repeated measures ANOVA revealed no significant effect for trial 
on [Hb] (P = 0.107; Table 4-1). However, moderate ES were calculated for the differences in 
[Hb] when compared to baseline at 24 h [ES: -0.64 (95% CI = -1.71 to 0.43)], with large ES 
observed at 7 d [ES: -1.25 (95% CI = -2.40 to -0.11)], which continued to 42 d post donation [ES: 
1.26 (95% CI = -2.41 to -0.11)].  
 A difference was observed for Hct (p = 0.001). Post-hoc analysis revealed that Hct was 
lower when compared with baseline at 24 h (p = 0.006) and 7 d (p = 0.001) with no differences 
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observed at 21 d (p = 0.121) or 42 d (p = 0.856). Calculated ES magnitudes for the change from 
baseline were very large at 24 h [ES -2.00 (95% CI = -3.28 to -0.72)], 7 d [ES -1.74 (95% CI = -
2.97 to -0.51)], and large for 21 d [ES -1.04 (95% CI = -2.16 to 0.08)], with no effect observed at 
42 d [ES 0.11 (95% CI = -1.16 to 0.94)]. 
The one-way repeated measures ANOVA revealed a reduction in V̇O2max measured 
during the incremental cycling test (P = 0.003; Table 4-1). Post-hoc analysis revealed that when 
compared to baseline, absolute V̇O2max was lower at 24 h (p = 0.010). No differences were 
observed at 7 d (p = 0.061), 21 d (p = 0.285) and 42 d (p = 0.959), when compared to baseline. 
Calculated ES magnitudes for the change from baseline were medium at 24 h [ES -0.70 (95% CI 
= -1.78 to 0.38)], and small at 7 d [ES -0.33 (95% CI = -1.38 to 0.73)], with trivial effects observed 
at 21 d [ES -0.19 (95% CI = -1.24 to 0.86)] and 42 d [ES 0.00 (95% CI = -1.05 to 1.05)].  
Absolute MAP measured during the incremental cycling test was reduced following 
blood removal (p = 0.001; Table 4-1). Post-hoc analysis revealed MAP when compared to 
baseline was lower at 24 h (p = 0.001) and 7 d (p = 0.001), however, no differences in MAP were 
observed at 21 d (p = 0.306) or 42 d (p = 0.150). Calculated ES magnitudes for the change from 
baseline were medium at 24 h [ES: -0.70 (95% CI = -1.78 to 0.38)], 7 d [ES -0.55 (95% CI = -
1.61 to 0.52)], and small at 21 d [ES: -0.21 (95% CI = -1.26 to 0.85)] with a trivial effect observed 




Table 4-1 Incremental cycling test and haematological measures. Results for baseline and 24 hours, 7 days, 21 days, and 42 days after blood removal, mean 
(95% CI), N = 7 
 Length of time after blood removal 
 
Baseline 24 h 7 d 21 d 42 d 
Maximal aerobic power (W) 401 (372 – 429) 371 (341 – 401)* 378 (351 – 406)* 392 (359 – 424) 396 (365 – 426) 
Maximal aerobic power (W ˑ kg-1) 5.5 (5.1 – 5.9) 5.2 (4.7 – 5.6)* 5.3 (4.9 – 5.5)* 5.3 (4.9 – 5.7)* 5.5 (5.1 – 5.7) 
Oxygen uptake (L·min-1) 4.3 (3.9 - 4.6) 4.0 (3.7 - 4.3)* 4.2 (3.8 – 4.5) 4.2 (3.8 – 4.7) 4.3 (3.9 – 4.7) 
Heart rate (bpm) 183 (176 - 190) 185 (177 – 192) 178 (168 – 188) 180 (174 – 186) 179 (172 – 186) 
Haematocrit (%) 46 (44 - 47) 42 (40 – 43)* 42 (40 – 43)* 42 (42 – 45) 43 (43 – 47) 
Haemoglobin (g·dL) 151 (146 – 156) 145 (137 – 153) 138 (129 – 146) 137 (126 – 148) 142 (137 – 147) 
*Significantly less than baseline (p £ 0.05) 
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4.4.3 4-Minute Self-Paced Time Trial (4MMP) 
When compared to a baseline a main effect of trial was observed for mean power output 
during the 4MMP (p = 0.002; Table 4-2). A decrease in mean power output was observed for 
trial at 24 h (p = 0.001), 7 d (p = 0.001) and 21 d (p = 0.028), however, no differences were 
observed at 42 d (p = 0.156). Calculated ES magnitudes for the change in mean power output 
were small at 24 h [ES: -0.37 (95% CI = -1.42 to 0.68)], which continued on to 21 d [ES: -0.23 
(95% CI = -1.28 – 0.82)] post donation. Likewise, a main effect for trial was observed for V̇O2 
measured during the 4MMP (p = 0.001; Table 4-2). Oxygen consumption was lower 24 h, 7 d 
and 21 d, (p = 0.001) respectively. No differences were observed at 42 d (p = 0.975). Calculated 
ES magnitudes for the change in mean V̇O2 were classified as small at 24 h [ES: -0.43 (95% CI = 
-1.49 to 0.63)] and 7 d [ES: -0.32 (95% CI = -1.37 to 0.74)].  
No main effects or interactions were observed for the trial by split analysis of mean power 
output (Fig. 4-1) or V̇O2 (p = 0.690 and p = 0.100). The one-way ANOVA for the rate of decline 
in power output during the initial 2 min of the 4MMP indicated a difference between trials (p = 
0.022; Fig. 4-2). Post-hoc analysis revealed that rate of decline in power output was lower when 
compared to baseline at 24 h (p = 0.039), 21 d (p = 0.038) and 42 d (p = 0.045), but was not 
different at 7 d (p = 0.157).  
No differences in ratings of perceived exertion (p = 0.457) or heart rate (p = 0.072) were 
observed in any of the trials when compared to baseline (Table 4-2).  
4.4.4 Energy Contribution 
A main effect for trial was observed for Paer (p = 0.001; Fig. 4-3 a) with a decrease in Paer 
observed at 24 h, 7 d and 21 d, (p = 0.001), when compared with baseline values. No interactions 
were observed Paer (p = 0.100) between trial and splits. No main effects for trial (P = 0.161) or an 
interaction (p = 0.736) were observed for Pan (Fig. 4-3 b).  Calculated ES magnitudes for Paer were 
classified as small at 24 h [ES: -0.38 (95% CI = -1.44 to 0.67)] through to 21 d [ES: -0.32 (95% 





Figure 4-1 Average power output during the 4-minute self-paced cycling time trial (4MMP). 
Power output (mean ± 95% CI) at baseline and at 24 hours, 7 days, 21 days, and 42 days after 
blood removal. *p ≤ 0.05; main effect for trial compared with baseline. 
 
Figure 4-2 Average decline in power output during the first 2 minutes of a 4-minute self-
paced time trial (4MMP). Data obtained at baseline, 24 hours, 7 days, 21 days, and 42 days 
after blood removal. *p ≤ 0.05; significantly different from baseline trial. 
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Figure 4-3 Plots of average aerobic (Paer) and anaerobic energy (Pan) contributions to power 
output during the 4-minute self-paced time trial (4MMP).  Aerobic (A) and Anaerobic (B) 
measures obtained at baseline, 24 hours, 7 days, 21 days, and 42 days. *p ≤ 0.05; main effect 






Figure 4-4 Plots of effect-size estimates measured at 30 seconds and 60 seconds of the 4-
minute self-paced time trial (4MMP). Differences (± 95% CI) in (a) power output (b) aerobic 
power, and (c) anaerobic power between 24 hours (filled triangles), 7 days (open triangles), 21 
days (diamonds), and 42 days (open squares). 
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Table 4-2  Overall results for the 4-minute self-paced cycling time trial (4MMP). Results at baseline and 24 hours, 7 days, 21 days, and 42 days after blood 
removal, mean (95% CI), N = 7 
 Length of time after blood removal 
 
Baseline 24 h 7 d 21 d 42 d 
Mean power (W) 339 (297 – 381) 317* (275 – 356) 315 (268 – 361)* 324 (279 – 370)* 330 (293 – 366) 
Oxygen uptake (L·min-1) 3.6 (3.2 – 3.9) 3.4 (3.1 – 3.6)* 3.4 (3.1 – 3.7)* 3.4  (3.1 – 3.8)* 3.6 (3.3 – 3.9) 
Rating of perceived exertion 9.6 (9.0 - 10) 9.9 (9.6 – 10) 9.6 (9.1 – 10) 9.3 (8.8 – 9.8) 9.9 (9.5 – 10) 
Heart rate (bpm) 163 (154 – 172) 163 (155 – 172) 162 (153 – 170) 156 (145 – 167) 160 (154 – 167) 
Aerobic energy (W) 229 (205 - 252) 217 (199 – 235)* 219 (198 – 241)* 218  (195 – 240)* 229 (210 – 248) 
Anaerobic energy (W) 110 (85 – 135) 94 (67 – 120) 96 (69 – 122) 107 (76 – 137) 100 (80 – 121) 





The purpose of this study was to determine the influence of manipulating aerobic 
contribution via whole blood removal (470 mL) on pacing patterns, performance and energy 
contribution during self-paced middle distance cycling. In addition, we examined the influence 
of blood removal on haematological measures and V̇O2max over the following 42 d. The main 
findings were: i) V̇O2max returned to baseline values by 7 d despite Hct concentration remaining 
significantly decreased, ii) the decrease in performance and mean V̇O2 during the 4MMP persisted 
for 21 d, iii) the rate of decline in power output upon commencement of the 4MMP was less 
following blood removal, and iv) Paer energy contribution during the 4MMP was reduced for 21 
d following blood removal. 
Removal of 470 mL of blood resulted in an immediate decrease (24 h) in V̇O2max (-7.5%) 
measured during the incremental cycling test and is consistent with previous studies [117] 
reporting -7% [95% CI -11% to -3%] decrease in V̇O2max 24 h – 48 h after removing a similar 
volume of blood. A decrease in Hbmass (~75 ± 15 g) occurs following the removal of 470 mL of 
whole blood [197] and supports the notion that reduced oxygen carrying capacity is the primary 
mechanism responsible for the decline in V̇O2max observed at 24 h. The return of V̇O2max to 
baseline values at 7 d is likely attributed to plasma volume expansion as a consequence of 
haemodilution [154] and a resultant increase in stroke volume and cardiac output [304]. In support 
of this hypothesis, we observed a decrease in Hct at 7 d (Table 4-1), and despite no statistical 
differences, calculated ES estimates for the magnitude of change in [Hb] compared to baseline 
indicated moderate (ES=-0.64) and large (ES=-1.26) effects at 24 h through to 42 d, respectively.  
Power output and V̇O2 during the 4MMP were reduced up to 21 d following blood 
removal, highlighting the importance of aerobic capacity during middle distance cycling events 
[60]. Furthermore, despite that the linear mixed modelling revealed no significant differences in 
power output between trials for any of the 30 s splits (Fig. 4-4 a), ‘large to moderate’ ES estimates 
were calculated for the differences between baseline compared with all other conditions at 30 s 
and 60 s. These findings indicate individual pacing patterns were likely influenced by the removal 
of blood, however, due to the small sample size (n = 7) of our study we were unable to statistically 
observe these differences. Supporting this interpretation, a greater rate of decline (p = 0.022) in 
power output over the first 2 min of the 4MMP were observed at baseline, when compared with 
24 h, 21 d and 42 d following blood removal (Fig. 4-2). Further, these differences were the result 
of greater power output observed at the start of the baseline trial, when compared with all other 
trials (Fig. 4-2). One possible reason for this change, is a reduction in arterial oxygen content 
and/or altered V̇O2 kinetics caused by blood removal. Indeed, greater power output upon 
commencement of middle-distance events is associated with a greater magnitude and/or rate of 
oxygen consumption [305].  
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An alternative explanation for the greater decline in power output observed at 
commencement of the baseline trial was the result of participants adopting a more cautious pacing 
strategy during subsequent trials. Indeed, the decline in power output at 21 d and 42 d was still 
lower than baseline, despite markers of aerobic capacity (i.e. V̇O2max and Hct) returning to 
baseline by 7 d and 21 d, respectively. Within the present study, participants were familiarised 
with the exercise task and had previous experience performing time trials prior to the baseline 
4MMP and as such we hypothesise that changes in pacing at 24 h were not directly caused by a 
learnt effect. However, it was not possible to blind participants to blood removal or familiarise 
participants with the trial following blood removal. As such, it is plausible that the cautious pacing 
at 21 d and 42 d following blood removal were a ‘learnt effect’ in response to the difficulties 
encountered during earlier trials (i.e. 24 h). Further research is needed in order better understand 
the time course by which an intervention may influence subsequent pacing strategies/decisions. 
Pacing is dependent on the regulation of energy expenditure [306]. To examine this 
hypothesis, we measured the contribution of Pan and Paer energy resources and relational 
mechanical power output during the 4MMP. Although the linear mixed modelling revealed no 
statistical differences in overall Pan between trials, we did observe ‘large to moderate’ ES for 
differences in Pan at the 30 s and 60 s time splits (Fig. 4-4 c). Similar differences were observed 
for Paer (Fig. 4-4 b), however, unlike Pan, overall Paer contribution throughout each 4MMP 
significantly decreased following blood removal but returned to baseline by 42 d. Our findings 
indicate, following blood removal, the differences in Paer likely contributed to the conservative 
pacing strategy at the commencement of the efforts ultimately resulting in a decrease in 
performance. These findings are similar to Lima-Silva et al. (2013), Correia-Oliveira et al. (2014), 
who observed conservative power output distribution following muscle glycogen depletion 
accompanied by a reduction in Paer [71, 72]. Interestingly, given that total anaerobic energy 
contribution did not change over the duration of this study, it appears that blood removal does not 
result in compensatory peripheral adaptations to enhance anaerobic capacity as found following 
chronic hypoxic exposure [275].  
This study provides important insight into the influence of blood donation on 
performance and pacing during self-paced middle distance events. However, we acknowledge 
limitations with the study design may have influenced our findings and some interpretation of the 
data. Following blood removal, performance during the incremental cycling test was reduced, as 
measured by reduced total time-to-fatigue, V̇O2max (24 h) and MAP (24 h and 7 d; Table 4-1). As 
this test preceded the 4MMP, it is possible that these differences could have influenced the 4MMP 
results. However, in all instances, we believe participants cycled to fatigue during the incremental 
cycle test. As such, any differences in total time-to-fatigue, V̇O2max or MAP would have had a 
minimal influence on the between trial differences in 4MMP performance. The lack of statistical 




statistical power. In the absence of additional participants, the inclusion of 95% CI and ES 
calculations (using hedges G correction) have been provided to highlight findings that, although 
without statistical relevance, provide insight into the influence of blood removal on pacing and 
exercise performance. Another potential limitation to this study was the use of an estimated gross 
efficiency (19.5%) in the calculation of Paer and Pan.  Although values of gross efficiency were 
obtained from published data using participants with similar characteristics to this study [301], it 
is possible the estimated values did not accurately reflect our participants. We would argue, 
however, that the use of 19.5% efficiency during this study did not impact our findings as the 
current study was a single group design and inaccuracies in gross efficiency would have minimal 
influence in the between condition outcomes.  
4.6 Practical Applications 
Based on the findings in this study athletes and coaches should be aware that aerobic 
capacity and performance were impaired following the removal of 470 mL. In this study, such 
impairments to aerobic capacity were evident for up to 42 d following blood removal. Adequate 
planning should therefore be considered for athletes donating blood prior to competition. 
4.7 Conclusions 
Results of the present study indicate that the removal of 470 mL of blood reduces V̇O2, 
performance and overall aerobic energy contribution during a 4MMP. Further, ES indicate 
variations in pacing patterns during self-paced middle distance events may be associated with 
changes in the distribution of both, Pan and Paer energy resources. Starting strategies appear to be 
associated with energy distribution as indicated by the decrease in aerobic metabolism following 
blood removal. Thus, reductions in performance during this study highlight the importance of 
aerobic energy distribution during middle distance self-paced events.  
Acknowledgements: The authors would like to thank all the cyclists who volunteered to 
take part in this study. At the time the study was conducted, N.L. was a recipient of an Australian 
Postgraduate Research Scholarship (Department of Education, Science and Training, Australia). 




Chapter 5 Purine metabolites are associated with 
the physiological response to standard 
blood donation 
This chapter has been drafted to conform to the author guidelines for the Journal of Science and 
Medicine in sport. 
Lawler, N.G., Abbiss, C.R., Gummer, J.P.A., Raman, A., Fairchild, T.F., Maker, G.L., 
Broadhurst, D.I., Trengove, R.D., Peiffer, J.J. (2018) 
 
Link: Chapter 4 demonstrated the importance of aerobic energy contribution during middle 
distance cycling events and showed that a substrate shift can occur in low oxygen environments 
is unable to compensate for a decrease in aerobic capacity.  While an acute (14 d) increase in 
anaerobic energy was observed in Chapter 3, this study (Chapter 5) sought to explore the 






Purpose: The purpose of this study was to determine the metabolic changes following 
blood removal using an untargeted metabolomic approach. Methods: Thirteen recreationally 
trained males (age: 29 ± 7 y) attended eight testing seasons (Baseline, 24 h, 7 d, 14 d, 21 d, 28 d, 
35 d and 42 d) and, attended one standard blood donation. At each of the time points, plasma 
samples were collected and stored at -80°C and measures of haemoglobin concentration and 
haematocrit were taken. At baseline, 24 h, 7 d, 21 d, 42 d, incremental cycling test and cycling 
time trials were performed. Plasma samples were measured using liquid chromatography high 
resolution mass spectrometry (LC-HRMS) and analysed using untargeted metabolomics analysis. 
Results: Decreases to maximal power output (7 d), maximal oxygen consumption (24 h), 
haemoglobin and haematocrit (14 d) as well as average time trial power output (7 d) and oxygen 
consumption decreased (24 h), p £ 0.05. Metabolomics analysis on the 104 plasma samples 
identified 152 metabolites of which 40 were deemed significant. Hierarchal Cluster Analysis 
(HCA) revealed eight metabolite group trajectories. A significant trajectory was identified as 
purine pathway, which was observed to immediately increase post blood donation followed by a 
slow transient recovery to baseline levels ~ 42 d. Conclusion: Consistent with previous studies, 
blood removal decreased key haematological parameters for oxygen transport and maximal 
aerobic capacity. However, changes in V̇O2 and performance during the cycling time trial were 
not consistent with one another, indicating that fitness and performance are not intrinsically 
linked. Untargeted metabolomics revealed possible compensatory mechanisms, such as changes 




Blood removal (i.e. blood donation) results in acute decrease in haemoglobin 
concentration [Hb] leading to a decline in aerobic capacity [112, 197-199].  Indeed, data from a 
recent meta-analysis indicates that 24 h following a blood donation (~470 mL) [Hb] and maximal 
aerobic capacity (V̇O2max) are reduced some 7% and 3.5%, respectively [117]. The acute (≤ 14 d) 
impact of blood donation has been examined extensively (see review [117]); with only one study 
examining the influence of blood donation over the normal red blood cell recovery period (~40 
d) (Chapter 4). In a group of trained cyclists, the removal of 470 mL of whole blood resulted in 
an immediate (24 h) decrease in V̇O2max and peak power output during a graded exercise test; with 
only V̇O2max demonstrating recovery by 7 d. Additionally, during a self-paced four-min cycling 
time trial, performance (mean power output) and aerobic contribution (mean V̇O2) were reduced 
up to 21 d corresponding with a reduction in [Hb] (Chapter 4). From these findings, it can be 
concluded that changes in [Hb] alone, after blood removal, are not solely responsible for the 
observed changes in maximal and submaximal performance. As such, further investigation is 
warranted.  
Metabolomics has a history of use in human biological samples [34, 307, 308] and more 
recently in the area of exercise sciences [35, 246, 260, 263, 309]. This technique provides the 
ability to comprehensively characterise system level changes in metabolism at a given time point 
[207]; thus, allowing the description of changes of a metabolic profile to external stimuli. 
Metabolomics, therefore, represents an ideal analytical technique to understand the impact of 
blood removal on the human physiology and performance by allowing the visualisation of all of 
metabolic changes occurring in unison. Indeed, D’Allessandro et al. (2016) have demonstrated 
the usefulness of this technique during 16 d of high altitude exposure (comparative to blood 
donation), observing an increase in purine metabolites, adenosine, hypoxanthine and adenosine 
monophosphate all of which are associated with metabolic adaptions within red blood cells [270].  
Blood donation is vitally important to worldwide healthcare [310]. However, individuals 
who exercise regularly may be reluctant to donate as currently very little data is available for the 
impact of blood removal on donor physiology and performance beyond 14 d [117]. Furthermore, 
previous data (Chapter 4) [311] indicates that changes in aerobic capacity and submaximal 
performance following blood removal are likely modulated by different factors, that as of yet have 
not been fully identified. Therefore, the primary aim of this study was to investigate the metabolic 
changes immediately following and up to 42 d post blood removal using an untargeted 
metabolomics approach. The secondary aim, was to describe the effect of a single whole blood 
donation (i.e. 470 mL) on maximal aerobic power, V̇O2max, cycling time trial performance and 
key haematological parameters over 42 d. This study represents an extension to previously 






Thirteen recreationally trained males (mean ± SD; age: 29 ± 7 y, height, 1.8 ± 0.1 m, body 
mass: 76.8 ± 6.9 kg, V̇O2max: 53.0 ± 10.9 mL·kg-1·min-1, maximal aerobic power: 363 ± 61 W) 
were recruited to the study. Individuals were excluded from the study if at enrolment they had 
previously donated blood £3 months, had taken prescribed medications, had history of 
hypertension, or were found to have [Hb] <130 g.L-1. In addition, participants needed to meet 
requirements to donate blood as per the Australian Red Cross blood donation criteria. One week 
prior, and during the 42 d, participants were asked to record a daily diet diary (Easy Diet Diary) 
and to refrain from physical activity and caffeine 24 h prior to experimental trials; all participants 
self-reported compliance with these measures. Participants were provided with possible risks and 
benefits of their participation in this study and written consent was obtained prior to data 
collection. Approval for the investigation was obtained from Murdoch University (Western 
Australia, AUS) Human Research Ethical Committee. 
5.3.2 Experimental design 
This study used a quasi-experimental design consisting of a single group with repeated 
measures. Participants were required to complete a familiarisation session and a baseline testing 
session, no greater than 7 d apart. Within 24 h of completing the baseline testing, participants 
attended an Australian Red Cross donation centre for the removal of ~470 mL of whole blood. 
Additional testing sessions were completed 24 h, 7, 14, 21, 28 35, and 42 d after the blood 
donation. The testing sessions at 24 h, 7, 21 and 42 d consisted of; (a) venous and capillary blood 
sampling, (b) an incremental cycling test and (c) 4-min cycling time trial (4MMP) cycling test. 
On days 14, 28 and 35 participants were only required to provide a blood sample. 
5.3.2.1 Incremental cycling test 
Participants completed an incremental cycling test on a Velotron cycle ergometer 
(RacerMate; Seattle, WA, USA) commencing at 70 W and increasing 25 W·min-1 until volitional 
exhaustion. Expired gases were continuously measured using a calibrated metabolic cart 
(ParvoMedics, TrueOne 2400, UT, USA). Measures of oxygen consumption were calculated as 
30 s mean values with (V̇O2max) determined as the greatest 30 s mean value recorded. Heart rate 
was continuously measured using a Polar heart rate monitor (Polar Electro, Kempele, Finland) 
and power output (W) was measured via Velotron internal software at a frequency of 1Hz. 
Maximal aerobic power (MAP) was measured as the power output corresponding to the last 
completed stage plus pro rata value for any incomplete stage.  
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5.3.2.2 4-Minute self-paced time trial (4MMP) 
Twenty min after completing the incremental cycling test, and using the same cycle 
ergometer, participants completed a 4MMP. During this test, participants were instructed to 
produce the highest average power output possible during the 4MMP test. No restrictions were 
placed on cadence or gear ratio throughout the test and only elapsed time was provided to 
participants as feedback. Power output was continuously collected at a frequency of 1 Hz using 
Velotron internal software, while heart rate and V̇O2 were measured as 30 s mean values using a 
metabolic cart.  
5.3.2.3 Blood sampling 
During all experimental sessions, participants arrived at the laboratory following a nine-
hour fasting period (9 ± 1 h). In the laboratory participants were asked to remain seated upright 
for ten min prior to, and during sampling to avoid plasma volume fluctuations.  Blood sampling 
consisted of capillary sample via finger prick for assessment of [Hb] and (Hct %). Haemoglobin 
concentration was measured using a Hemocue blood photometer (Hemocue® Hb 201, 
Angelholm, Sweden). Haematocrit % was measured using heparinised Micro-Hematocrit 
capillary tubes centrifuged at 13,500 x g for 5 min and assessed using a micro capillary reader. In 
addition, a blood sample (4 mL) was collected from the vein of the antecubital fossa into lithium 
heparin vacutainer tube (BD Vacutainer) for metabolomics analysis. Whole blood obtained via 
venepuncture was immediately centrifuged at 1800 ´ g for 10 min. Resulting plasma was aliquot 
and stored at -80°C for metabolomics analysis. 
5.3.3 Sample preparation for metabolomics analyses 
Plasma samples (50 µL) were thawed and extracted using the Bligh and Dyer method 
[278], such that, metabolite extraction was achieved by adding 3:1:1 (v/v) of ice-cold analytical 
grade methanol (MeOH)/ chloroform (CHCL3)/ plasma followed by two volumes of analytical 
grade water. An internal standard, trans-Cinnamic acid-β,2,3,4,5,6-d6 Sigma Aldrich (St Louis, 
MO, USA) was dissolved in MeOH and added to each plasma sample.  Samples were incubated 
for ten min in an Eppendorf Thermomixer (Eppendorf, Hamburg, Germany) at 4 ˚C and 1,400 
rpm. Two volumes of analytical grade water were then added and the mixture incubated for ten 
min at 4 ˚C at [1400 rpm] and then centrifuged ten min at 4˚C at 16100 ´ g. The supernatant was 
transferred to micro-centrifuge tube and the MeOH was removed using a rotary vacuum. Samples 
were snap frozen using liquid nitrogen, lyphilised by freeze-drying, and stored at -80 ˚C until 
analysis. Pooled plasma (quality control) from the 13 participants from all sampled time points 
(i.e. 104 samples) were prepared and analysed throughout the experimental batches to monitor 
the analytical variation of the LC-MS system [247]. Before data acquisition, the analytical 




5.3.4 Liquid chromatography – mass spectrometry 
Plasma extract samples were reconstituted in 50 µL of 0.1% formic acid in water before 
LC-HRMS analysis. The samples were analysed using a Waters ACQUITY UPLC (Waters Corp, 
Milford, MA) system coupled to an electrospray SCIEX TripleTOF 5600 mass spectrometer 
(SCIEX, Framingham, MA). All samples were analysed separately in positive and negative ion 
modes. Quality Control (QC) samples were analysed for the first ten injections and then every 
fifth injection with the final two injections as QC’s. Metabolite separation was performed 
following a 10 µL sample injection onto a Waters Acquity UPLC™ column (BEH C18 2.1 x 100 
mm, 1.7 µm; Waters Corp, Milford, MA) with the column temperature set at 35 ˚C. The two 
solvents applied were solvent A – 0.1% formic acid in water and solvent B – 0.1% formic acid in 
acetonitrile at a flow rate 0.3µL min-1. Solvent A was held at 99.5% for one min followed by an 
increase to 99.5% solvent B over 36 min, which was then held at 99.5% for two min. At 39 min, 
it was changed to 99.5% solvent A and held at 99.5% solvent a to equilibrate for five min. All 
eluent was collected by the mass spectrometer using full scan using a mass range of 50 – 1000 
m/z. 
Profile mass spectra were acquired in ‘high resolution’ according to the following 
parameters: nebulizer gas (N2) 45 psi, heater gas (N2) 50 psi, curtain gas 30 psi, and ion source 
temperature of 550˚C. An IonSpray voltage of 5500 V was used for positive-ion acquisition and 
–4500 V was used for negative-ion acquisition. Independent data acquisition was performed on 
representative QC samples, randomly allocated in the acquisition list, to aid in metabolite 
identification. MS/MS spectra for the five most abundant precursor ions following each survey 
MS1 scan were collected.  A sweeping collision energy setting of 35 ± 15eV was applied in the 
collision cell using nitrogen as the collision gas. An exact mass calibration was conducted 
automatically before each batch analysis and at every 6th sample thereafter. The instrument was 
calibrated before the analysis (calibration error less than 3 ppm) using 0.5 mM sodium formate 
for positive and negative ionisation, respectively. The TripleTOF 5600 mass spectrometer used 
Analyst control software version 1.6 for data acquisition. 
5.3.5 Data pre-processing 
Data from each MS ionisation mode were grouped and pre-processed separately. Raw 
MS files were converted to universal mzXML format using MSconvert [279], then processed 
using XCMS [280] in R (R 3.1.1; http://cran.r-project.org/). Peak detection and alignment were 
completed using the following parameters:  method = ‘centWave’, ppm = 10, peak width = 5 – 
20, snthresh = 6, mzdiff = 0.01, retention time correction method = ‘obiwarp’, and mzdiff = 0.01. 
Systematic error in peak-area measurement with respect to injection order, was corrected using 
the Quality Control-Robust Spline Correction (QC-RSC) algorithm [281]. To suppress the 
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mathematical confounding effect of highly collinear data all chemical adduct and isotope peaks 
were removed from the datasets, where possible. 
5.3.6 Metabolite identification 
Metabolite identifications were established prior to statistical analysis, by matching 
against online spectral library using ions from the experimental samples. Those with a match of 
molecular weight (m/z), were hand checked against online spectral libraries (mzCloud, Metlin, 
HMDB and Massbank) for MS spectral match. To increase identification yield, QC samples were 
run through an Q-Exactiveä high resolution mass spectrometer (Thermo Fisher Scientific, San 
Jose, USA) using standard protocols and settings. Data was processed using Compound 
Discovererä software (Thermo Scientific). The resulting metabolite identifications were mapped 
back to the original data set with a mass tolerance of +/- 3ppm. A definitive, level-1, match was 
reported when a given peaks’ retention time, MS1 scan and MS/MS spectra matched that of an 
authentic standard analysed on the same instrument. A level-2 putative match was reported when 
only the MS1 scan and MS/MS spectra matched that of an online spectral library, but the 
identification was not confirmed via an in-house authentic standard. This process corresponds 
with the minimum reporting standards for chemical analysis proposed by the Metabolomics 
Standards Initiative [282].  Identified metabolites are indicated in the statistical table, including 
information of most probable identity, m/z, retention time (RT), elemental formula, and ppm 
error. 
5.3.7 Statistical Analysis 
All statistical analyses were performed using Matlab scripting language, version R2017a 
(Mathworks, Natick, MA, USA). Statistical comparisons between V̇O2max, (MAP) obtained during 
the incremental cycling test were compared between time points using a repeated measures 
Analysis of Variance (RM-ANOVA). Similarly, haematological measures Hct %, [Hb], and 
variables measured during the 4MMP were calculated (mean V̇O2 and power output (W)) and 
compared between time points using RM-ANOVA. Where significant main effects were 
observed, Bonferroni’s post-hoc were performed. Significance was set as p £ 0.05, and data were 
presented as mean ± 95% CI. 
The metabolite data from both the positive and negative ionisation modes were combined 
into a single data matrix. Missing values were imputed using the k-nearest-neighbour 
methodology (k=3) [283]. Data were log transformed, both to stabilize variance and to 
approximate the multivariate normal distribution needed for univariate parametric and 
multivariate statistical modelling. Before any formal models were tested, the natural multivariate 
variance of the data was assessed using Principal Components Analysis (PCA) performed on the 




Metabolites labelled with a putative identification were assessed for significance across 
the eight consecutive time points using RM-ANOVA. The method described by Storey et al. 
(2003) was used to control for the probability of false discovery, which is unavoidably inflated 
through multiple parallel statistical comparisons [284]. For the identified metabolites, results were 
presented in a table of F-scores, p-values. Where appropriate, univariate data was also presented 
as plots of estimated marginal means relative to the factor Time. 
Unsupervised two-way Agglomerative Hierarchical Cluster Analysis (HCA) assessed 
multivariate similarities between individual’s metabolomic profiles. This algorithm used a 
multivariate Euclidean distance metric and Ward’s group linkage. The results were displayed as 
a circle dendrogram plot with metabolite labels set as black = p > 0.05, and red= p < 0.05. The 
cluster dendrograms revealed the lower the linkage in the “tree”, the more similar the feature. The 
emergent clusters have the most similar characteristics and were labelled from A through to H. 
5.4 Results 
5.4.1 Haematological data 
Compared with baseline values, Hct% was lower at 24 h (p < 0.01) and 14 d (p = 0.01), 
with no other difference observed between time points. Compared with baseline values, [Hb] was 
less at 14 d (p = 0.04; Table 5-1), with no other differences noted between time points.   
5.4.2 Incremental Cycling test 
V̇O2max decreased following the removal of ~470 mL of whole blood (p < 0.01; Table 5-
1). Compared with baseline, V̇O2max was less at 24 h (p = 0.02) with values returning to baseline 
by 7 d (p > 0.05). Absolute (MAP) during the incremental cycling test was reduced following 
blood removal (p < 0.01; Table 5-1) with lower values at 24 h (p < 0.01) and 7 d (p = 0.01) when 
compared with baseline. 
5.4.3 4-Minute Self-Paced Time Trial (4MMP) 
Mean power output from the 4MMP decreased from baseline (p < 0.01; Table 5-1) with 
lower power output observed at 24 h (p = 0.02) and 7 d (p = 0.03). A decrease in mean oxygen 
consumption (V̇O2) measured during the 4MMP was observed (p = 0.02), with lower V̇O2 values 
at 24 h (p < 0.01; Table 5-1) compared with baseline. 
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Table 5-1 Summary of haematological measures, incremental cycling test measures and 4-minute self-paced cycling trial (4MMP). Measures obtained baseline 
and 24 h, 7 d, 21 d, and 42 d after blood removal, (mean [95% CI]), N = 13 
  Length of time after blood removal 
 Baseline 24 h 7 d 14 d 21 d 28 d 35 d 42 d 
Haematocrit (%) 46 [45-47] 
42 
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5.4.4 Metabolomics Data 
Following data cleaning, 2,645 reproducible metabolite features (1,313 ESI POS and 
1,332 in ESI NEG) were subject to statistical analysis. Principle components analysis (PCA) of 
the total data set showed (Fig. 5-1) that the QC samples clustered tightly together indicating no 
batch-to-batch variation and, the QC variance was much smaller than the sample variance. There 
were no outliers detected. Of the 2,645 features 152 were putatively identified as unique 
metabolites. RM-ANOVA was performed to select those metabolites that significantly changed 
post-intervention (i.e. after removal of ~470 mL of blood). In total 40 putatively identified 
metabolites were statistically altered (corrected p-value £ 0.05); see Table 5-2. It is important to 
note that the presented metabolite annotations are putative and should only be discussed as 
preliminary annotations until chemical validation using chemical standards and two orthogonal 
properties (i.e. retention time) as defined by the Metabolomics Standard Initiative [282]. In cases 
where multiple annotations could be assigned, metabolite ID was given based on chemical 
properties and being the most probable annotation. 
 
Figure 5-1 Principal components analysis (PCA) scores plot showing all experimental 
samples of the 2999 reproducible peaks.  The quality control (QC) samples (blue circles) 
formed from pooling small quantities from each sample and tightly cluster in the plot. Red triangles 
represent samples of each individual obtained at baseline, 24 h and 7 d, 14 d, 21 d, 28 d, 35 d 
and 42 d after blood removal. 
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Table 5-2 Putatively annotated metabolic features originating from plasma samples. The 
table consists of i) the metabolite name, ii) molecular formula, iii) the ANOVA F score, iv) p-
value, v) corrected p-value, (vi) cluster group.  
Label Formula F_time p_time q-value Cluster 
Adenosine C10H13N5O4 2.645 0.016 0.032 A 
Adenosine monophosphate C10H14N5O7P 3.772 0.001 0.004 A 
Guanosine C10H13N5O5 4.281 0.000 0.002 A 
Hypoxanthine* C5 H4 N4 O 2.710 0.013 0.029 A 
Inosine C10H12N4O5 4.068 0.001 0.002 A 
Tetrahydrofolic acid C19H23N7O6 1.858 0.086 0.108 A 
Thymidine 5'-triphosphate C10H17N2O14P3 3.334 0.003 0.008 A 
2-Oleoylglycerol C21 H40 O4 33.570 0.000 0.000 B 
3-Hydroxyanthranillic acid C7H7NO3 0.274 0.963 0.475 B 
4-Aminohippurate C9H10N2O3 2.162 0.045 0.070 B 
5-Methoxytryptamine C11H14N2O 0.479 0.847 0.436 B 
Arginine* C6 H14 N4 O2 0.193 0.986 0.477 B 
Benzoic acid C7H6O2 5.900 0.000 0.000 B 
Caproylglycine C12 H23 N O3 8.566 0.000 0.000 B 
Creatine C4H9N3O2 0.979 0.452 0.299 B 
dehydroepiandrosterone sulfate C19H28O5S 0.651 0.712 0.392 B 
Glutamine* C5 H10 N2 O3 0.839 0.558 0.341 B 
Methylmalonic acid C4H6O4 1.455 0.193 0.186 B 
N-Methyl-2-pyrrolidone* C5 H9 N O 1.522 0.170 0.175 B 
N-Undecanoylglycine C13 H25 N O3 23.695 0.000 0.000 B 
Nonanoic acid C9H18O2 5.824 0.000 0.000 B 
Pantothenic acid C9H17NO5 0.980 0.451 0.299 B 
Pentandioic acid C5H8O4 1.156 0.336 0.263 B 
Resveratrol C14H12O3 2.230 0.039 0.065 B 
Urea CH4N2O 2.626 0.016 0.032 B 
Uridine 5'-diphosphoglucuronic 
acid C15H22N2O18P2 1.049 0.403 0.285 B 
1,3,7-Trimethyluric acid* C8 H10 N4 O3 0.371 0.917 0.462 C 
1,7-Dimethyluric acid* C7 H8 N4 O3 0.135 0.995 0.477 C 
3-Methylxanthine* C6 H6 N4 O2 0.956 0.468 0.304 C 
Caffeine* C8 H10 N4 O2 0.344 0.931 0.466 C 
Gluconic acid C6H12O7 0.261 0.967 0.475 C 
n-acetylserotonin C12H14N2O2 1.959 0.069 0.095 C 
Theobromine* C7 H8 N4 O2 0.944 0.477 0.307 C 
16-hydroxypalmitic acid C16 H32 O3 5.053 0.000 0.000 D 
2-Aminoadipate C6H11NO4 2.196 0.042 0.068 D 
2-hydroxybutyric acid C4H8O3 3.135 0.005 0.012 D 
25-Hydroxyvitamin D3 C27H44O2 1.434 0.201 0.189 D 
Bilirubin* C33 H36 N4 O6 0.790 0.598 0.356 D 
Cholic acid* C24 H40 O5 1.258 0.280 0.232 D 
Citrulline C6H13N3O3 1.252 0.283 0.232 D 
Deoxycholic acid C24H40O4 1.004 0.434 0.295 D 
Dodecanedioic acid* C12 H22 O4 1.419 0.207 0.189 D 
Enterolactone C18H18O4 1.527 0.168 0.175 D 
Estradiol C18H24O2 2.004 0.063 0.091 D 
Folic acid C19H19N7O6 3.851 0.001 0.004 D 
Glycocholic acid* C26 H43 N O6 1.171 0.328 0.260 D 
Glycoursodeoxycholic acid* C26 H43 N O5 0.772 0.612 0.362 D 




N-Arachidonoyl Dopamine C28H41NO3 0.124 0.996 0.477 D 
Palmitic acid C16H32O2 1.988 0.065 0.092 D 
Pipecolic acid C6H11NO2 1.064 0.393 0.281 D 
Pyroglutamic acid C5H7NO3 0.681 0.687 0.384 D 
Suberic acid C8 H14 O4 0.669 0.698 0.387 D 
Taurocholic Acid C26H45NO7S 1.014 0.427 0.295 D 
Tetradecanedioic acid C14 H26 O4 1.937 0.073 0.097 D 
Uric Acid C5H4N4O3 0.644 0.719 0.393 D 
Ursodeoxycholic Acid C24H40O7S 1.496 0.179 0.181 D 
11-deoxycortisol C21H30O4 0.931 0.487 0.310 E 
5-Hydroxyindole-3-acetic 
acid* C10 H9 N O3 1.004 0.434 0.295 E 
5-Hydroxyindoleacetic acid C10H9NO3 0.563 0.784 0.416 E 
AcetylLysine C8H16N2O3 2.077 0.054 0.081 E 
Arabinose C5H10O5 0.686 0.684 0.384 E 
Carnitine* C7 H15 N O3 1.677 0.124 0.145 E 
Ceramide (C24:0) C42H83NO3 1.893 0.080 0.104 E 
Choline C5 H13 N O 0.998 0.438 0.295 E 
Cortisol* C21 H30 O5 0.706 0.667 0.379 E 
Creatinine C4H7N3O 1.490 0.181 0.181 E 
Cytidine 5'-diphosphocholine C14H26N4O11P2 1.023 0.420 0.294 E 
Erythrose 4P C4H0O7P 0.900 0.510 0.317 E 
Fructose 1,6-diphosphate C6H14O12P2 0.973 0.455 0.299 E 
Glucosamine 6-phosphate C6H14NO8P 0.634 0.727 0.394 E 
Hippuric acid* C9 H9 N O3 2.173 0.044 0.070 E 
Histidine C6H9N3O2 0.376 0.914 0.462 E 
Kynurenic acid C10H7NO3 2.484 0.022 0.041 E 
Kynurenine C10H12N2O3 0.811 0.580 0.350 E 
Lysine* C6 H14 N2 O2 0.927 0.490 0.310 E 
Methionine* C5 H11 N O2 S 0.556 0.790 0.416 E 
Methyl indole-3-acetate* C11 H11 N O2 1.357 0.233 0.202 E 
myo-Inositol 1,4,5-
trisphosphate C6H15O15P3 2.011 0.062 0.091 E 
Myristamide C14 H29 N O 3.666 0.002 0.005 E 
N-Acetyl-L-carnosine* C11 H16 N4 O4 1.353 0.235 0.202 E 
Oleic acid C18 H34 O2 4.301 0.000 0.002 E 
p-Coumaric acid C9H8O3 1.234 0.293 0.237 E 
Phenylalanine* C9 H11 N O2 0.754 0.627 0.365 E 
Pipecolinic acid* C6 H11 N O2 1.121 0.357 0.270 E 
Proline* C5 H9 N O2 0.523 0.815 0.426 E 
Saccharopine C11H20N2O6 1.766 0.104 0.127 E 
Sphingosine-1-phosphate 
(18:1) C18H38NO5P 3.643 0.002 0.005 E 
Symmetric dimethylarginine* C8 H18 N4 O2 0.481 0.846 0.436 E 
Thymine C5H6N2O2 3.142 0.005 0.012 E 
trans-Cinnamic acid C9H8O2 1.062 0.394 0.281 E 
Tryptophan* C11 H12 N2 O2 1.346 0.238 0.202 E 
Tyrosine* C9 H11 N O3 0.900 0.510 0.317 E 
Valine* C5 H11 N O2 0.867 0.536 0.330 E 




C28 H52 N O7 P 4.497 0.000 0.001 F 
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1-heptadecanoyl-sn-glycero-3-
phosphocholine C25 H52 N O7 P 3.479 0.002 0.006 F 
3-Hydroxykynurenine C10H12N2O4 1.718 0.115 0.138 F 
4-Aminophenyl b-D-
galactopyranoside 
C12H17NO6 0.053 1.000 0.477 F 
Adenosine 3',5' cyclic 
monophosphate 
C10H12N5O6P 2.287 0.034 0.059 F 
Aldosterone C21H28O5 3.471 0.002 0.006 F 
Androst-4-en-3-one C19 H28 O 3.785 0.001 0.004 F 
Dihydrotestosterone C19H30O2 0.571 0.778 0.415 F 
Glycerophospho-N-palmitoyl 
ethanolamine* C21 H44 N O7 P 1.670 0.126 0.145 F 
Indole-3-acetic acid* C10 H9 N O2 1.372 0.227 0.199 F 
Indole-3-lactic acid* C11 H11 N O3 1.953 0.070 0.095 F 
Lyso-PAF C16 C24H52NO6P 3.022 0.007 0.015 F 
Lyso-PAF C18 C26H56NO6P 2.282 0.035 0.059 F 
myo-Inositol C6H12O6 1.110 0.363 0.270 F 
N-Phenylacetylglutamine* C13 H16 N2 O4 0.286 0.958 0.475 F 
Nicotinuric acid C8H8N2O3 1.128 0.353 0.270 F 
Propionylcarnitine* C10 H19 N O4 0.616 0.741 0.399 F 
Shikimic acid C7H10O5 1.473 0.187 0.182 F 
Thiamine C12H17N4OS 0.394 0.904 0.462 F 
trans-Urocanic Acid C6H5N2O2 1.685 0.122 0.145 F 
Tricaprylin C27H50O6 2.149 0.046 0.071 F 
Uridine C9H12N2O6 2.702 0.014 0.029 F 
Uridine 5'diphospho-N-
acetylglucosamine 
C17H27N3O17P2 1.414 0.209 0.189 F 
α-Aminocaprylic acid* C8 H17 N O2 0.757 0.625 0.365 F 
2-Hydroxyglutaric acid C5 H8 O5 11.450 0.000 0.000 G 
2-Ketobutyric acid C4H6O3 4.056 0.001 0.002 G 
3-Hydroxyisovalerylcarnitine C12 H23 N O5 76.775 0.000 0.000 G 
5-Hydroxy-L-tryptophan C11H12N2O3 4.648 0.000 0.001 G 
cis-11-Eicosenoic acid C20H38O2 4.413 0.000 0.001 G 
Heptanoylcarnitine C14 H27 N O4 11.037 0.000 0.000 G 
N-formylkynurenine C11 H12 N2 O4 4.080 0.001 0.002 G 
Pentonic acid C5 H10 O6 5.439 0.000 0.000 G 
Tiglylcarnitine C12 H21 N O4 10.819 0.000 0.000 G 
11,14-eicosadienoic acid C20H36O2 1.420 0.207 0.189 H 
12-Hydroxyeicosatetraenoic 
acid C20H32O3 1.097 0.372 0.274 H 
13-Hydroxyoctadecadienoic 
acid C18H32O3 1.123 0.356 0.270 H 
3-Hydroxydecanoic acid C10 H20 O3 1.413 0.210 0.189 H 
5-Methoxytryptophol C11H13NO2 1.564 0.156 0.173 H 
5-pregnen-3B-ol-20-one C21H32O2 1.532 0.166 0.175 H 
Acetyl-L-carnitine* C9 H17 N O4 1.823 0.092 0.115 H 
Arachidonic acid C20H32O2 1.568 0.155 0.173 H 
Citric acid* C6 H8 O7 1.378 0.224 0.199 H 
Decanoylcarnitine (C10:0) C17H33NO4 1.543 0.163 0.175 H 
Dodecanoate C12H24O2 6.076 0.000 0.000 H 
Elaidic Acid C18H34O2 1.077 0.385 0.280 H 
Linoleic Acid C18H32O2 1.264 0.277 0.232 H 
Linolenic acid C18H30O2 1.546 0.162 0.175 H 
Myristic acid C14H28O2 3.815 0.001 0.004 H 




Oleoylcarnitine (C18:1) C25H47NO4 2.627 0.016 0.032 H 
Palmitoleic acid C16H30O2 0.810 0.582 0.350 H 
Palmitoylcarnitine (C16:0) C23H45NO4 1.117 0.359 0.270 H 
Progesterone C21H30O2 1.872 0.083 0.107 H 
Prolylleucine* C11 H20 N2 O3 0.729 0.648 0.374 H 
Retinol C20H30O 1.473 0.187 0.182 H 
Testosterone C19H28O2 1.170 0.328 0.260 H 
 Note: Significance was based on q-value (FDR-adjusted p-values) and significance set at q £ 
0.05. All significant metabolites are bolded. * Indicates MS/MS spectra match to the mzCloud 
library. 
The HCA dendrogram (Fig. 5-2) grouped metabolites with similar post-intervention 
metabolite trajectories into eight clear metabolite clusters (labelled A to H). Each of these eight 
clusters demonstrates a unique trajectory from pre-intervention through to 42 d. Four of the 
clusters showed significant group-trajectory characteristics. The metabolites in Cluster A (n=7) 
describe an immediate increase post blood removal (24 h) and a gradual return to pre-intervention 
levels by 42 d. The metabolites were identified as originating from the purine metabolite pathway. 
Cluster B (n=19) followed a steady decrease in metabolite concentration with no recovery. 
Significant metabolites in this group were: Urea, Benzoic Acid, Nonanoic Acid, and minor 
metabolites of fatty acids. Cluster H (n = 24) demonstrated a delayed recovery trajectory, where 
no significant change in metabolite concentration occurred until 20 d, followed by a sharp increase 
until 35 d and then a return to normal levels at 42 d. This cluster consisted of mainly classes of 
fatty acid metabolites. Finally, Cluster-G (n=9) shows a similar delayed response, but with a steep 
increase observed from 7 d to 14 d, continuing to 35 d before a slight decrease at 42 d. These 
metabolites were identified as carnitines and tryptophan metabolism. Clusters C, D, E and H 
displayed erratic behaviour in which no clear trajectory characteristics can be discerned; however, 
there were individual metabolites in clusters D, E and F, that displayed significantly changing 
trajectories. Cluster C, included caffeine metabolites and many derivatives and was observed as 




Figure 5-2 Hierarchical cluster plot showing dendrograms (A-H) and showing the 
relationship between putatively identified metabolites originating from plasma samples.  
Relation between metabolites is indicated by the length/distance. Metabolites labelled red (p < 









The current study examined the impact of blood donation (~470 mL) on acute (i.e. 24 h) 
and chronic (up to 42 d) changes to metabolic, physiological, haematological and performance 
measures in recreationally trained males. The main outcomes were; 1) blood removal decreased 
[Hb] and Hct % until day 14, 2) V̇O2max and performance decreased acutely post-blood removal 
and demonstrated different patterns of recovery, 3) using an untargeted metabolomics approach, 
eight key clusters of metabolites were identified with four clusters demonstrating protracted, or 
non-recovery by 42 d and 4) purine metabolites increased immediately post-blood removal with 
a gradual recovery to baseline levels by 42 d. 
Acutely (24 h) following blood removal, we observed a decrease in Hct % (-9 %) and a 
reduction in V̇O2max (-6 %), maximal aerobic power (-6 %), and 4MMP power output (-7 %). 
These findings are not unexpected [198, 199], and have been outlined in a recently published 
meta-analysis by Van Remoortel, De Buck [117]. Furthermore, and consistent with our previously 
published sub-group analyses [311], V̇O2max had returned to baseline values by the 7th d while 
maximal aerobic power and the 4MMP mean power output remained below baseline values. 
These findings support the hypothesis that immediate changes in V̇O2max and performance after 
blood removal are likely modulated by central limitations (i.e. oxygen availability) [91, 146], 
whereas continued decrements in performance are less associated with oxygen availability and 
therefore mediated by additional factors. Of note, the addition of six moderately trained 
individuals in this cohort resulted in the recovery of 4MMP performance by 21 d, a finding not 
previously observed [311]. As fitness levels increase, the capacity to consume oxygen during 
exercise become more delivery dependent [81, 312]. As such, the addition of lesser trained 
individuals to this cohort likely diminished the influence of changes in oxygen delivery during 
later time points.  
As hypothesised above, it is likely that additional factors beyond oxygen availability 
influence performance immediately following blood removal and during the normal red blood 
cell maturation phase (~42 d). As such, a major focus of this study was to examine changes in the 
metabolic profile after blood removal. This was achieved through the use of untargeted 
metabolomic analysis to detect intact small molecules over a wide concentration. From this, we 
identified 152 putatively annotated metabolites (Table 5-2), of which 40 demonstrated significant 
change following the removal of whole blood (Fig. 5-2). It should be noted that final 
confirmations of metabolite identifications with standards are still needed. Furthermore, it is 
possible that not all 40 metabolites demonstrating change in this study are of interest. For instance, 
‘Cluster G’ (Fig. 5-2) demonstrated several significant metabolites; however, it was not possible 




multiple physiological pathways. Future studies employing larger metabolite libraries and a 
control group will help narrow down the metabolites in this list.  
In the absence of clear metabolite identification through comparison with standards, we 
performed an unsupervised HCA to classify metabolites into similar response groups from which 
eight sub-cluster trajectories were identified (Fig. 5-2). Of interest, cluster-A metabolites 
demonstrated an immediate and significant increase with a prolonged return towards baseline 
over the 42 d (Fig. 5-3). Within this cluster we identified five metabolites as nucleotides and 
nucleosides; inosine, hypoxanthine, adenosine, adenosine monophosphate and guanosine, of 
which all are associated with the purine metabolic pathway. Little is known regarding the 
influence of blood removal on nucleotides; however, during hypoxic exposure or severe energy 
depletion, these metabolites have been shown to be important in energy utilisation [176, 270]. 
From this study, we cannot determine what influence changes in purine metabolism had on our 
fitness and performance data; however, in animal studies, dietary supplementation with 
nucleotides including inosine and guanosine have been shown to increase levels of 2,3-
diphosphoglycerate [176, 177]. An increase in 2,3-diphophoglycerate can result in a rightward 
shift of the oxygen dissociation curve [313]; thus, reducing the affinity of haemoglobin to oxygen. 
It is possible that in the present study, purine metabolism under decreased oxygen availability 
(i.e. reduced Hct% and [Hb]) could have acted in a compensatory manner to increase levels of 
2,3-diphosphglycerate thereby enhancing oxygen delivery to the periphery. This hypothesis 
supports our observation that both V̇O2max and V̇O2 during the 4MMP test returning to baseline 
values at 7 d, during a period when red blood cell regeneration would have been incomplete [197]. 
This study provides import insight into the influence of blood donation on the metabolic 
changes immediately following and up to 42 d post blood removal. However, there are some 
noted limitations to the present study. Although activity monitors were worn for the duration of 
the study, it is important to acknowledge that a limitation of such measure is they do not provide 
information on non-ambulatory activity (i.e. resistance training or swimming), intensity or type 
of physical activity. Another limitation to this study was the influence of diet on metabolite 
findings. As such participants dietary choice during the 42 d could influence the metabolome 
[314]. However, it should be noted participants were asked to replicate their diet as close as 
possible to their previous trials and undertook 8 h fast before the experimental trials which, is a 
level of control consistent within the metabolomic literature [260, 315]. 
5.6 Conclusions 
In conclusion, the removal of 470 mL of whole blood acutely (24 h) impacts oxygen 
carrying capacity and exercise performance. However, differences in the recovery of V̇O2max and 
performance suggest that these two measures are not intrinsically linked. The recovery of V̇O2max 
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did not coincide with the recovery of [Hb] indicating possible compensatory mechanisms, such 
as changes in purine metabolism, occur to enhance oxygen availability to working muscles. 
Without the analytical standards necessary to confirm the identity of all metabolites, these finding 





Chapter 6 Thesis summary 
Historically the measurement of an individual’s maximal ability to consume oxygen 
(V̇O2max) has been used as a predictor of endurance performance [51, 52]. As such, training 
strategies such as hypoxic exposure have been used with the intent of increasing oxygen carrying 
capacity and therefore endurance performance [45]. While an increase in RBCs is regarded as the 
critical response to altitude training through the up-regulation of erythropoietin [30, 130, 164], 
many other unexplored changes have been demonstrated to occur during this time [46]. For 
instance, non-haematological changes occur with improvements in exercise economy, skeletal 
muscle buffering and cellular adaptations such as HIF -1a, as well as changes to aerobic and 
anaerobic enzyme concentration [31, 46]. Therefore, it is recognised that changes in Hbmass are 
not solely responsible for changes in performance [46, 47]. Given the possible benefits, the non-
haematological mechanisms warrant further examination.  
Metabolomics has a history of use in human biological samples [34, 307, 308] and more recently 
in the area of exercise sciences [35, 246, 260, 263, 309]. This technique provides the ability to 
comprehensively characterise system level changes in metabolism at a given time point [207], 
thus providing a unique metabolite profile. The use of techniques consistent with metabolomics 
(GC-MS, LC-MS and NMR) can help to better understand the physiological response to hypoxia 
by providing the ability to monitor systemic changes through the construction of metabolite 
profiles. Limited metabolite profiling research has been conducted to explore altitude exposure in 
athletes, and to the authors knowledge, metabolite profiling is yet to be used to explore the use of 
blood donation as a hypoxic model. Therefore, the purpose of the thesis is to explore low oxygen 
carrying capacity and its influence on fitness and performance as well as describe the acute and 
chronic physiological and biochemical adaptions to low oxygen carrying capacity.  This chapter 
provides a summary of the important results from the experimental chapters of this thesis and 
integration of the findings. Finally, this chapter concludes with an assessment of the thesis 
findings resulting in the identification and rationalisation of future research.  
Chapter Three was conducted as a component of a larger observational study 
investigating the influence of pre and post-exercise hepcidin levels in well-trained runners during 
a 14 d altitude camp [16]. Specifically, Chapter Three utilised metabolomics to examine the acute 
metabolite profiles in response to 14-d moderate altitude exposure (~3000 m). This analysis 
demonstrated separation in metabolite profiles (173 metabolites) at the three sampled time points 
(baseline, 3 d and 14 d), indicating a temporal association with outcome measures. From the 
original 176 metabolites, 36 were identified from metabolite classes including amino acids, 
glycolysis and purine metabolism. These findings are consistent with previous literature [31, 49] 
and indicate a shift in substrate utilisation (i.e. greater carbohydrate use) during acute hypoxic 
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exposure. Through further analyses using CVA, the correlated structure of the 36 metabolites and 
their associated trajectories were identified, with two different trajectories observed during the 
acute moderate altitude exposure. The first trajectory revealed metabolites decreasing in the early 
phase of altitude exposure (3 d) that returned to baseline levels by 14 d. The second set of 
metabolites demonstrated either an increase or decrease in concentration upon altitude exposure 
and did not return to baseline levels by 14 d. The metabolites identified in the two trajectory sets 
warrant further investigation, as it is possible that they could help to further explain the acute 
metabolic changes associated with altitude exposure [49, 269].  In addition to differences in the 
metabolic profiles, analyses of the PCA plots demonstrated greater between-person compared 
with within-person variance. These findings provide further support to previous literature 
suggesting a high level of individual variability during the adaptive response to altitude exposure 
[47, 269].  
Chapter Three indicates that acute metabolic adaptations occur in response to a decrease 
in oxygen carrying capacity during short-term hypoxic exposure. Nevertheless, several potential 
limitations have been identified that may have influenced data collection and the interpretation of 
the results. This study was a collaboration with the Australian Institute of Sport during a 
predetermined altitude training camp. The use of athletes (sample of convenience), while 
providing an elite calibre population, did result in a relatively small sample size and therefore 
affected the study’s statistical power. While every effort was taken to ensure a similar level of 
control during the altitude camp to reduce variability on the blood metabolome, inevitable some 
variables were outside of the researcher’s control (i.e. recording of diet and physical activity). It 
is possible that some metabolic changes identified during this study were the consequence of 
training and diet, and not directly due to altitude exposure [316-318]. Finally, due to scheduling 
restrictions, the use of the Australian Institute of Sport altitude facilities was limited to 14 d. The 
findings in Chapter Three therefore only represent acute metabolic changes associated with 
altitude exposure, as a greater measurement period (up to ~42 d) would be needed to assess full 
acclimatisation (i.e. metabolic and haematological change; [15]).  
In Chapters Four and Five, Australian Red Cross blood donation (~470 mL) was used to 
induce a reduced oxygen carrying capacity in 13 male participants. This allowed the ability to 
examine the adaptive processes occurring over the course of normal red blood cell maturity (~42 
d).  During this study, measures of [Hb] and Hct % were obtained before blood removal (baseline) 
and at seven time points (24 h, 7, 14, 21, 28, 35 and 42 d) following blood removal to indicate 
oxygen carrying capacity (Chapters Four and Five). Additionally, exercise tests were performed 
to assess fitness (V̇O2max) and performance through a 4-min self-paced cycling test (4MMP) 
Chapters Four and Five, as well as the collection of a 4 mL blood sample for subsequent 
metabolomic analysis (Chapter Five). Importantly, as purine metabolism was identified as an area 




 Performance during middle-distance endurance events is reliant on aerobic metabolism 
[43], while pacing during these events has been associated with the conservation of anaerobic 
energy stores [68, 319]. Furthermore, consistent with previous research [288, 320] and data from 
Chapter Three, acute hypoxic exposure results in a greater reliance on anaerobic metabolism. 
Thus, in Chapter Four the aim was to determine the influence of blood donation on pacing and 
energy resources during self-paced middle distance cycling in trained cyclists. Seven of the 13 
participants regarded as ‘trained’ were used for data analysis. Consistent with previous research 
[117, 198, 201], [Hb], Hct %, and V̇O2max were reduced up to 7 d following blood donation. 
However, a novel finding was that 4MMP average power output was reduced up to 21 d, despite 
the return of [Hb], Hct % and V̇O2max. In addition to average power output, pacing during the 
4MMP was influenced by the removal of blood. Initial power outputs were reduced over the first 
2 min of the 4MMP trials when compared to baseline. Contributing to the differences in individual 
pacing profiles were corresponding reductions in aerobic power; yet, no significant changes in 
anaerobic power contributions were observed.  
The absence of a change in anaerobic power contribution to the 4MMP after blood 
removal contradicts findings of a systemic shift to greater reliance on anaerobic metabolism 
(Chapter Three). For instance, a greater contribution of anaerobic power output would have been 
expected throughout the 4MMP, post blood donation, especially within the first 14 d. However, 
the high intensity nature of the 4MMP would require near maximal aerobic and anaerobic energy 
contribution [69], thus it is possible that although aerobic contribution was reduced, anaerobic 
contribution was already maximal. Alternatively, athletes may regulate anaerobic energy 
contribution during middle distance time trials to optimise performance [43]. It is possible that 
participants in this study could have subconsciously regulated use of anaerobic energy stores, 
attenuating any increase in anaerobic contribution to the 4MMPs.  
The focus of Chapter Five was to investigate metabolic changes immediately following 
and up to 42 d post blood removal using an untargeted metabolomic approach. In this chapter, an 
additional six participants (i.e. recreationally untrained) were added to the seven ‘trained’ 
participants in Chapter Four to increase robustness of the statistical analysis. To the authors 
knowledge, no evidence currently exists to indicate differential adaptive process to hypoxia 
between trained and untrained individuals. Following blood donation, a decrease in [Hb], Hct % 
and (4MMP) V̇O2 was observed, however changes in V̇O2 only persisted for 24 h when analysed 
as a combined group (n = 13). This finding was unexpected, as the same measures reported in the 
subset of trained males lasted 21 d (Chapter Four). The accelerated return in V̇O2 was likely 
associated with participant fitness level (i.e. V̇O2max: 53.0 ± 10.9 mL·kg-1·min-1; (Chapter Five) 
vs. V̇O2max: 60.7 ± 5.5 mL·kg-1·min-1 (Chapter Four)), as in this case the addition of lesser trained 
individuals seemingly diminished the influence of oxygen delivery in the later time points [10, 
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273, 321, 322]. Importantly, changes in V̇O2 and performance were not consistent with one 
another, providing additional evidence to support that fitness and performance are not intrinsically 
linked [323]. 
 Metabolomic analysis using mass spectrometry were conducted on 4 mL whole blood 
samples obtained before blood removal (baseline) and seven time points following blood removal 
(24 h, 7, 14, 21, 28, 35 and 42 d). From this data, multi-factorial changes were identified following 
blood donation, with n = 40 metabolites deemed significant. Hierarchical cluster analysis revealed 
eight metabolite cluster trajectories. Importantly, and consistent with findings in Chapter Three, 
one of the eight metabolite cluster trajectories were associated with purine metabolism. 
Furthermore, the trajectory of this cluster remained elevated, although trending back to baseline, 
through the 42 d monitoring period. These results indicate that purine metabolism influences both 
the acute (Chapter Three) and chronic adaptive phases (Chapter Five) of hypoxia. Therefore, it is 
possible that purine metabolites could be used as a marker of reduced oxygen carrying capacity 
and the adaptive responses of the body to chronic hypoxia such as altitude training.  
The findings from this thesis provide important insights into performance and metabolite 
changes to hypoxia, however, it is important to acknowledge some study limitations could 
potentially influenced our findings. Chapter 3 was an observational study and unfortunately 
provided several limitations. Firstly, it was not possible to implement a control group into the 
altitude camp study. As such, some of our metabolite findings may not be unique to altitude 
exposure and possible influenced by other external factors. However, the measured responses of 
EPO and Hbmass [16] were consistent with previous published LHTL studies and demonstrate an 
altitude adaption occurred [13, 15]. Another limitation of this study was the inability to analyse 
athletes’ training volume or dietary intake as covariates in our statistical model. As such, 
differences in athletes’ training volume during the LHTL could have confounded physiological 
adaptions to altitude. However, during the study athletes were instructed to maintain their normal 
diet and training program, therefore differences may account for some between-athlete variation 
in metabolic profiles. 
In Chapters 4 and 5 participants reported to each experimental session following similar 
dietary consumption to the previous experimental session and fasted for 8 h at the same of day 
which can acutely control for dietary influence on performance and blood metabolites [324, 325]. 
However, the influence of chronic dietary intake (i.e. 42 d) was not analysed and subsequently 
was not included as a covariate in the statistical models.  Previously, Walsh et al. (2006) suggested 
that consumption of a standardised diet before blood sampling may reduce inter-participant 
variations, as differences in diet may cause metabolic changes that may be difficult to differentiate 
from normal physiological variations [314]. Therefore, it is possible participant dietary choices 




influenced metabolite response. Another key limitation in Chapter 4 and 5 lies in the ability to 
understand training load on performance and the blood metabolome. While activity monitors were 
provided to participants to measure daily activity levels (EPOCHs), a significant limitation of this 
measure is the inability account for non-ambulatory physical activities (i.e. resistance training) 
and intensity of activities which could influence a participants overall training load and thus may 
have influenced the outcome of the performance trials.  
In summary, the metabolomics approach in Chapter Three revealed separation in plasma 
metabolite profiles during a moderate altitude camp. Importantly, the findings indicated anaerobic 
contribution was likely compensating for the hypoxic condition. Using blood donation to decrease 
oxygen carrying capacity in Chapter Four, anaerobic energy contribution did not compensate for 
the removal of 470 mL blood as measured by power output during a 4MMP trial; however, this 
finding was likely a consequence of the exercise intensity and intrinsic strategy to maintain 
anaerobic energy stores.  When examined over 42 d, hypoxia did result in metabolic disturbances, 
most notably an increase in purine metabolism. Importantly, purine metabolites could provide a 
robust marker for the adaptive process following hypoxic exposure.   
6.1 Directions for future research 
The results from this thesis provide support for the use of metabolomics to explore the 
influence of low oxygen carrying capacity in individuals. However, more research is required to 
further our understanding of the resultant biochemical changes. By understanding the impact of 
low oxygen carrying capacity on an individual, recommendations on the use of altitude training 
may be possible.  For example, in Chapter Three, PCA revealed a greater degree of separation 
between participants when compared to all time points. This finding is interesting and indicates 
hypoxic responses are individualised, providing further insights into the intra- and inter-individual 
differences. To this end, further investigation of these metabolites during moderate altitude 
exposure may help to more accurately describe the complex physiological and metabolic 
adaptions that occur in athletes during moderate altitude exposure.  
While this thesis was not designed for anti-doping research, the procedures and findings 
of these chapters can provide support to the athlete biological passport (ABP). Currently, the 
integrity of the ABP is formed through the understanding of normal fluctuations of biomarkers to 
assess an athlete for a doping offence [326]. However, environmental changes such as altitude 
may produce spurious results through variation in the biomarkers used in the haematological 
model. As such, low oxygen carrying environments, such as those used in Chapter Three, are 
regarded as one of the major confounders to the ABP [327]. For these reasons, new robust 
biomarkers which can indicate low oxygen carrying environments could help explain when 
athletes have been exposed to hypoxia and may be beneficial in advancing the ABP model.  
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Although not possible in this thesis, including a placebo to investigate the effects of blood 
donation on pacing would be of interest. Although pacing was altered following blood donation 
(Chapter Four), the mechanisms behind the change could not be accurately determined. To further 
investigate the influence of low oxygen carrying capacity on pacing, the use of a placebo, such as 
an opaque line during blood removal can further understanding of physiological mechanisms vs. 
psychological change, which may be attributed to the change in pacing strategy (Chapter Four).  
While Chapter Five provided an in-depth analysis of the metabolic changes associated 
with blood donation, future work is necessary to confirm metabolite identifications. Further 
studies are needed to establish the role of purines in athletes during hypoxia. This could be 
achieved through purine supplementation and through the development of a targeted analytical 
method to quantify the change in metabolite concentration. Both Chapters Three and Five only 
measured metabolites which were amenable to C18 chemistry. Future studies should include 
hydrophilic interaction chromatography (HILIC) to provide comprehensive metabolome 
coverage (i.e. separation of small polar metabolites). It would be interesting to determine 
metabolic pathways associated with identified purine metabolites. This would require 
implementing different analytical methods to capture metabolites which surround the purine 
pathway, such as using HILIC to measure ATP. Using HILIC is complimentary to C18, and it 
can provide two strengths: i) confirming already identified metabolites, and ii) providing greater 
coverage of the metabolome through retention of polar metabolites which are more amenable to 
HILIC chemistry. 
Finally, metabolite identification yield was increased in Chapter Five, through the use of 
the Thermo Scientific Q-Exactiveä Orbitrap and mzCloud repository, it is strongly suggested at 
minimum a library of metabolites of interest and associated fragmentation patterns is generated 






1. Coyle, E.F., Integration of the physiological factors determining endurance performance 
ability. Exercise and sport sciences reviews, 1995. 23: p. 25-63. 
2. Laursen, P.B., Training for intense exercise performance: high-intensity or high-volume 
training? Scandinavian journal of medicine & science in sports, 2010. 20 Suppl 2: p. 1-
10. 
3. Laursen, P.B. and D.G. Jenkins, The scientific basis for high-intensity interval training: 
optimising training programmes and maximising performance in highly trained 
endurance athletes. Sports medicine (Auckland, N.Z.), 2002. 32(1): p. 53-73. 
4. Buchheit, M. and P.B. Laursen, High-intensity interval training, solutions to the 
programming puzzle: Part I: cardiopulmonary emphasis. Sports medicine (Auckland, 
N.Z.), 2013. 43(5): p. 313-38. 
5. Conley, D.L. and G.S. Krahenbuhl, Running economy and distance running performance 
of highly trained athletes. Medicine and science in sports and exercise, 1980. 12(5): p. 
357-60. 
6. McLaughlin, J.E., et al., Test of the classic model for predicting endurance running 
performance. Medicine and science in sports and exercise, 2010. 42(5): p. 991-7. 
7. Joyner, M.J., Modeling: optimal marathon performance on the basis of physiological 
factors. Journal of applied physiology, 1991. 70(2): p. 683-687. 
8. Costill, D.L. and E. Winrow, A comparison of two middle-aged ultramarathon runners. 
Research Quarterly. American Association for Health, Physical Education and 
Recreation, 1970. 41(2): p. 135-139. 
9. Farrell, P.A., et al., Plasma lactate accumulation and distance running performance. 
1979. Medicine and science in sports and exercise, 1993. 25(10): p. 1091-7; discussion 
1089-90. 
10. Wagner, P.D., New ideas on limitations to VO2max. Exercise and sport sciences reviews, 
2000. 28(1): p. 10-4. 
11. Schmidt, W. and N. Prommer, Effects of various training modalities on blood volume. 
Scandinavian journal of medicine & science in sports, 2008. 18 Suppl 1: p. 57-69. 
12. Durussel, J., et al., Haemoglobin mass and running time trial performance after 
recombinant human erythropoietin administration in trained men. PloS one, 2013. 8(2): 
p. e56151. 
13. Gore, C.J., et al., Altitude training and haemoglobin mass from the optimised carbon 
monoxide rebreathing method determined by a meta-analysis. British journal of sports 
medicine, 2013. 47 Suppl 1: p. i31-9. 
14. Sawka, M.N., et al., Erythrocyte, plasma, and blood volume of healthy  young men. 
Medicine and science in sports and exercise, 1992. 24(4): p. 447-453. 
110 
15. Garvican-Lewis, L.A., et al., Influence of combined iron supplementation and simulated 
hypoxia on the haematological module of the Athlete Biological Passport. Drug testing 
and analysis, 2017. 
16. Govus, A.D., et al., Live high, train low - influence on resting and post-exercise hepcidin 
levels. Scandinavian journal of medicine & science in sports, 2016. 
17. Bonetti, D.L. and W.G. Hopkins, Sea-level exercise performance following adaptation to 
hypoxia: a meta-analysis. Sports medicine (Auckland, N.Z.), 2009. 39(2): p. 107-27. 
18. Pottgiesser, T., et al., Short-Term Hematological Effects Upon Completion of a Four-
Week Simulated Altitude Camp. International journal of sports physiology and 
performance, 2012. 7(1): p. 79-83. 
19. Robach, P., et al., Living high-training low: effect on erythropoiesis and aerobic 
performance in highly-trained swimmers. European journal of applied physiology, 2006. 
96(4): p. 423-33. 
20. Robach, P., et al., The role of haemoglobin mass on VO(2)max following normobaric 'live 
high-train low' in endurance-trained athletes. British journal of sports medicine, 2012. 
46(11): p. 822-7. 
21. Garvican-Lewis, L.A., et al., Altitude exposure at 1800 m increases haemoglobin mass 
in distance runners. Journal of Sports Science and Medicine, 2015. 14(2): p. 413-417. 
22. Robertson, E.Y., et al., Effects of simulated and real altitude exposure in elite swimmers. 
Journal of strength and conditioning research / National Strength & Conditioning 
Association, 2010. 24(2): p. 487-93. 
23. Roberts, A.D., et al., Changes in performance, maximal oxygen uptake and maximal 
accumulated oxygen deficit after 5, 10 and 15 days of live high:train low altitude 
exposure. European journal of applied physiology, 2003. 88(4-5): p. 390-5. 
24. Saugy, J.J., et al., Same Performance Changes after Live High-Train Low in Normobaric 
vs. Hypobaric Hypoxia. Front Physiol, 2016. 7: p. 138. 
25. Levine, B.D. and J. Stray-Gundersen, "Living high-training low": effect of moderate-
altitude acclimatization with low-altitude training on performance. Journal of applied 
physiology, 1997. 83(1): p. 102-12. 
26. Gore, C.J., et al., VO2max and haemoglobin mass of trained athletes during high intensity 
training. International journal of sports medicine, 1997. 18(6): p. 477-82. 
27. Robertson, E.Y., et al., Effectiveness of intermittent training in hypoxia combined with 
live high/train low. European journal of applied physiology, 2010. 110(2): p. 379-87. 
28. Saunders, P.U., et al., Improved running economy and increased hemoglobin mass in elite 
runners after extended moderate altitude exposure. Journal of science and medicine in 
sport / Sports Medicine Australia, 2009. 12(1): p. 67-72. 
29. Faiss, R., et al., Significant molecular and systemic adaptations after repeated sprint 




30. Saunders, P.U., D. Pyne, and C.J. Gore, Endurance Training at Altitude. High altitude 
medicine & biology, 2009. 10(2): p. 135-148. 
31. Messier, F.M., et al., The impact of moderate altitude on exercise metabolism in 
recreational sportsmen: a nuclear magnetic resonance metabolomic approach. Applied 
physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 
2017. 
32. Nikolic, S.B., et al., Serum metabolic profile predicts adverse central haemodynamics in 
patients with type 2 diabetes mellitus. Acta Diabetol, 2015. 
33. Catalan, U., et al., Biomarkers of food intake and metabolite differences between plasma 
and red blood cell matrices; a human metabolomic profile approach. Molecular 
bioSystems, 2013. 9(6): p. 1411-22. 
34. Edwards, L.M., et al., Metabolomics reveals increased isoleukotoxin diol (12,13-
DHOME) in human plasma after acute intralipid infusion. Journal of Lipid Research, 
2012. 53(9): p. 1979-1986. 
35. Lewis, G.D., et al., Metabolic signatures of exercise in human plasma. Sci Transl Med, 
2010. 2(33): p. 33ra37. 
36. Dunn, W.B., N.J. Bailey, and H.E. Johnson, Measuring the metabolome: current 
analytical technologies. The Analyst, 2005. 130(5): p. 606-25. 
37. Yan, B., et al., Metabolomic investigation into variation of endogenous metabolites in 
professional athletes subject to strength-endurance training. Journal of applied 
physiology (Bethesda, Md. : 1985), 2009. 106(2): p. 531-8. 
38. Al-Khelaifi, F., et al., A pilot study comparing the metabolic profiles of elite-level athletes 
from different sporting disciplines. Sports Med Open, 2018. 4(1): p. 2. 
39. Morris, C., et al., The relationship between aerobic fitness level andmetabolic profiles in 
healthy adults. Molecular Nutrition Food Research, 2013. 57: p. 1246-1254. 
40. Pohjanen, E., et al., A multivariate screening strategy for investigating metabolic effects 
of strenuous physical exercise in human serum. J Proteome Res, 2007. 6(6): p. 2113-20. 
41. Saltin, B. and P.O. Astrand, Maximal oxygen uptake in athletes. Journal of applied 
physiology, 1967. 23(3): p. 353-8. 
42. Billat, L.V., Use of blood lactate measurements for prediction of exercise performance 
and for control of training. Recommendations for long-distance running. Sports medicine 
(Auckland, N.Z.), 1996. 22(3): p. 157-75. 
43. Foster, C., et al., Effect of competitive distance on energy expenditure during simulated 
competition. International journal of sports medicine, 2004. 25(3): p. 198-204. 
44. Coyle, E.F., et al., Determinants of endurance in well-trained cyclists. Journal of applied 
physiology (Bethesda, Md. : 1985), 1988. 64(6): p. 2622-30. 
45. Lundby, C., et al., Does 'altitude training' increase exercise performance in elite athletes? 
British journal of sports medicine, 2012. 46(11): p. 792-5. 
112 
46. Gore, C.J., S.A. Clark, and P.U. Saunders, Non-hematological mechanisms of improved 
sea-level performance after hypoxic exposure. Medicine and science in sports and 
exercise, 2007. 39(9): p. 1600-9. 
47. Chapman, R.F., J. Stray-Gundersen, and B.D. Levine, Individual variation in response to 
altitude training. Journal of applied physiology (Bethesda, Md. : 1985), 1998. 85(4): p. 
1448-56. 
48. Armitage, E.G., et al., Metabolic profiling reveals potential metabolic markers associated 
with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells. Sci Rep, 
2015. 5: p. 15649. 
49. Liao, W.T., et al., Metabolite Modulation in Human Plasma in the Early Phase of 
Acclimatization to Hypobaric Hypoxia. Sci Rep, 2016. 6: p. 22589. 
50. Bassini, A. and L.C. Cameron, Sportomics: building a new concept in metabolic studies 
and exercise science. Biochem Biophys Res Commun, 2014. 445(4): p. 708-16. 
51. Costill, D.L. and E. Winrow, Maximal oxygen intake among marathon runners. Archives 
of physical medicine and rehabilitation, 1970. 51(6): p. 317-20. 
52. Farrell, P.A., et al., Time course of lung volume changes during prolonged treadmill 
exercise. Medicine and science in sports and exercise, 1983. 15(4): p. 319-24. 
53. Paliczka, V.J., A.K. Nichols, and C.A. Boreham, A multi-stage shuttle run as a predictor 
of running performance and maximal oxygen uptake in adults. British journal of sports 
medicine, 1987. 21(4): p. 163-5. 
54. Tomlin, D.L. and H.A. Wenger, The relationship between aerobic fitness and recovery 
from high intensity intermittent exercise. Sports medicine (Auckland, N.Z.), 2001. 31(1): 
p. 1-11. 
55. Daniels, J.T., A physiologist's view of running economy. Medicine and science in sports 
and exercise, 1985. 17(3): p. 332-8. 
56. Pollock, M.L., Submaximal and maximal working capacity of elite distance runners. Part 
I: Cardiorespiratory aspects. Annals of the New York Academy of Sciences, 1977. 301: 
p. 310-22. 
57. Astrand, P., Rodahl K, Textbook of Work Physiology. 1970, New York: McGraw-Hill. 
58. Warpeha, J. and E.D. Student, Limitation of maximal oxygen consumption: The holy grail 
of exercise physiology or fool's gold? Professionalization of Exercise Physiologyonline.-
2003.-V ol, 2003. 6. 
59. Jeukendrup, A.E., N.P. Craig, and J.A. Hawley, The bioenergetics of World Class 
Cycling. Journal of science and medicine in sport / Sports Medicine Australia, 2000. 3(4): 
p. 414-33. 
60. Hettinga, F.J., et al., Pacing strategy and the occurrence of fatigue in 4000-m cycling 




61. Tucker, R. and T.D. Noakes, The physiological regulation of pacing strategy during 
exercise: a critical review. British journal of sports medicine, 2009. 43(6): p. e1. 
62. Skorski, S., et al., Effects of Training-Induced Fatigue on Pacing Patterns in 40-km 
Cycling Time Trials. Medicine and science in sports and exercise, 2015. 47(3): p. 593-
600. 
63. Abbiss, C.R. and P.B. Laursen, Describing and understanding pacing strategies during 
athletic competition. Sports medicine (Auckland, N.Z.), 2008. 38(3): p. 239-52. 
64. Wu, S.S., et al., Pacing strategies during the swim, cycle and run disciplines of sprint, 
Olympic and half-Ironman triathlons. European journal of applied physiology, 2015. 
115(5): p. 1147-54. 
65. Losnegard, T., K. Kjeldsen, and O. Skattebo, An Analysis of the Pacing Strategies 
Adopted by Elite Cross-Country Skiers. Journal of strength and conditioning research / 
National Strength & Conditioning Association, 2016. 30(11): p. 3256-3260. 
66. St Clair Gibson, A., et al., The role of information processing between the brain and 
peripheral physiological systems in pacing and perception of effort. Sports medicine 
(Auckland, N.Z.), 2006. 36(8): p. 705-22. 
67. Wiles, J.D., et al., The effects of caffeine ingestion on performance time, speed and power 
during a laboratory-based 1 km cycling time-trial. Journal of sports sciences, 2006. 
24(11): p. 1165-71. 
68. de Alcantara Santos, R., et al., Caffeine alters anaerobic distribution and pacing during 
a 4000-m cycling time trial. PloS one, 2013. 8(9): p. e75399. 
69. Mulder, R.C., et al., Anaerobic work calculated in cycling time trials of different length. 
International journal of sports physiology and performance, 2015. 10(2): p. 153-9. 
70. Hettinga, F.J., et al., Biodynamics. Effect of pacing strategy on energy expenditure during 
a 1500-m cycling time trial. Medicine and science in sports and exercise, 2007. 39(12): 
p. 2212-8. 
71. Lima-Silva, A.E., et al., Prior exercise reduces fast-start duration and end-spurt 
magnitude during cycling time-trial. International journal of sports medicine, 2013. 
34(8): p. 736-41. 
72. Correia-Oliveira, C.R., et al., Prior low- or high-intensity exercise alters pacing strategy, 
energy system contribution and performance during a 4-km cycling time trial. PloS one, 
2014. 9(10): p. e110320. 
73. Gore, C.J., et al., Increased arterial desaturation in trained cyclists during maximal 
exercise at 580 m altitude. Journal of applied physiology, 1996. 80: p. 2204-2210. 
74. Gore, C.J., et al., Reduced performance of male and female athletes at 580 m altitude. 
European journal of applied physiology, 1997. 75(2): p. 136-143. 
114 
75. Lawler, J., S.K. Powers, and D. Thompson, Linear relationship between VO2max and 
VO2max decrement during exposure to acute hypoxia. Journal of applied physiology, 
1988. 64(4): p. 1486-1492. 
76. Wehrlin, J.P. and J. Hallen, Linear decrease in .VO2max and performance with 
increasing altitude in endurance athletes. European journal of applied physiology, 2006. 
96(4): p. 404-12. 
77. Clark, S.A., et al., The effect of acute simulated moderate altitude on power, performance 
and pacing strategies in well-trained cyclists. European journal of applied physiology, 
2007. 102(1): p. 45-55. 
78. Peltonen, J.E., H.O. Tikkanen, and H.K. Rusko, Cardiorespiratory responses to exercise 
in acute hypoxia, hyperoxia and normoxia. European journal of applied physiology, 
2001. 85(1-2): p. 82-8. 
79. Noakes, T.D., J.E. Peltonen, and H.K. Rusko, Evidence that a central governor regulates 
exercise performance during acute hypoxia and hyperoxia. The Journal of experimental 
biology, 2001. 204(Pt 18): p. 3225-34. 
80. Ferretti, G., et al., The decrease of maximal oxygen consumption during hypoxia in man: 
a mirror image of the oxygen equilibrium curve. The Journal of physiology, 1997. 498 
( Pt 1): p. 231-7. 
81. Gore, C.J., et al., Increased arterial desaturation in trained cyclists during maximal 
exercise at 580 m altitude Journal of applied physiology, 1996. 80(6): p. 2204-2210. 
82. Dempsey, J.A., P.G. Hanson, and K.S. Henderson, Exercise-Induced Arterial Hypoxemia 
in Healthy-Human Subjects at Sea-Level. J Physiol-London, 1984. 355(Oct): p. 161-175. 
83. Powers, S.K., et al., Effects of incomplete pulmonary gas exchange on VO2 max. Journal 
of applied physiology (Bethesda, Md. : 1985), 1989. 66(6): p. 2491-5. 
84. Dempsey, J.A. and P.D. Wagner, Exercise-induced arterial hypoxemia. Journal of 
applied physiology (Bethesda, Md. : 1985), 1999. 87(6): p. 1997-2006. 
85. Spriet, L.L., et al., Effect of graded erythrocythemia on cardiovascular and metabolic 
responses to exercise. Journal of applied physiology (Bethesda, Md. : 1985), 1986. 61(5): 
p. 1942-8. 
86. Hopkins, S.R., Exercise induced arterial hypoxemia: the role of ventilation-perfusion 
inequality and pulmonary diffusion limitation, in Hypoxia and Exercise. 2006, Springer. 
p. 17-30. 
87. Hammond, M., et al., Pulmonary gas exchange in humans during exercise at sea level. 
Journal of applied physiology, 1986. 60(5): p. 1590-1598. 
88. Petersson, J. and R.W. Glenny, Gas exchange and ventilation-perfusion relationships in 




89. Spina, R.J., et al., Exercise training prevents decline in stroke volume during exercise in 
young healthy subjects. Journal of applied physiology (Bethesda, Md. : 1985), 1992. 
72(6): p. 2458-62. 
90. Peltonen, J.E., et al., Arterial haemoglobin oxygen saturation is affected by F(i)O2 at 
submaximal running velocities in elite athletes. Scandinavian journal of medicine & 
science in sports, 1999. 9: p. 265-271. 
91. Bassett, D.R., Jr. and E.T. Howley, Limiting factors for maximum oxygen uptake and 
determinants of endurance performance. Medicine and science in sports and exercise, 
2000. 32(1): p. 70-84. 
92. Jones, J.H. and S.L. Lindstedt, Limits to maximal performance. Annual review of 
physiology, 1993. 55: p. 547-69. 
93. Burtscher, M., Exercise limitations by the oxygen delivery and utilization systems in 
aging and disease: coordinated adaptation and deadaptation of the lung-heart muscle 
axis - a mini-review. Gerontology, 2013. 59(4): p. 289-96. 
94. Cerretelli, P., & DiPrampero, P.E., Gas exchange in exercise. In: Handbook of 
Physiology., ed. L.E.F. A. P. Fishman, S.M. Tenney, & S.R. Geiger. 1987, Bethesda, 
Maryland: American Physiological Society. 
95. La Gerche, A. and M. Gewillig, What Limits Cardiac Performance during Exercise in 
Normal Subjects and in Healthy Fontan Patients? International journal of pediatrics, 
2010. 2010. 
96. Warburton, D.E., et al., Blood volume expansion and cardiorespiratory function: effects 
of training modality. Medicine and science in sports and exercise, 2004. 36(6): p. 991-
1000. 
97. Gerstenblith, G., D. Renlund, and E. Lakatta. Cardiovascular response to exercise in 
younger and older men. in Federation proceedings. 1987. 
98. Ekblom, B., et al., Effect of training on circulatory response to exercise. Journal of 
applied physiology, 1968. 24(4). 
99. McArdle WD, K.F., Katch VL, Training for anaerobic and aerobic power. In: Exercise 
physiology. Energy, nutrition, & human performance. 2007, Philadelphia: Lippincott 
Williams & Wilkins. 
100. Bada, A., et al., Peripheral vasodilatation determines cardiac output in exercising 
humans: insight from atrial pacing. The Journal of physiology, 2012. 590(8): p. 2051-
2060. 
101. Ogawa, T., et al., Effects of aging, sex, and physical training on cardiovascular responses 
to exercise. Circulation, 1992. 86(2): p. 494-503. 
102. Rogers, M.A., et al., Decline in VO2max with aging in master athletes and sedentary 
men. Journal of applied physiology, 1990. 68(5): p. 2195-2199. 
116 
103. Buskirk, E. and J. Hodgson. Age and aerobic power: the rate of change in men and 
women. in Federation proceedings. 1987. 
104. Hagberg, J. Effect of training on the decline of VO2max with aging. in Federation 
proceedings. 1987. 
105. Peiffer, J.J., et al., Physiological characteristics of masters-level cyclists. Journal of 
strength and conditioning research / National Strength & Conditioning Association, 2008. 
22(5): p. 1434-40. 
106. Saltin, B. and J.A. Calbet, Point: in health and in a normoxic environment, VO2 max is 
limited primarily by cardiac output and locomotor muscle blood flow. Journal of applied 
physiology (Bethesda, Md. : 1985), 2006. 100(2): p. 744-5. 
107. Wagner, P.D., Determinants of maximal oxygen transport and utilization. Annual review 
of physiology, 1996. 58: p. 21-50. 
108. Woodson, R.D., R.E. Wills, and C. Lenfant, Effect of acute and established anemia on 
O2 transport at rest, submaximal and maximal work. Journal of applied physiology: 
respiratory, environmental and exercise physiology, 1978. 44(1): p. 36-43. 
109. Schmidt, W., et al., Training induced effects on blood volume, erythrocyte turnover and 
haemoglobin oxygen binding properties. European journal of applied physiology and 
occupational physiology, 1988. 57(4): p. 490-8. 
110. Convertino, V.A., Blood volume response to physical activity and inactivity. American 
Journal of the Medical Sciences, 2007. 334(1): p. 72-79. 
111. Sawka, M.N., et al., Blood volume: importance and adaptations to exercise training, 
environmental stresses, and trauma/sickness. Medicine and science in sports and 
exercise, 2000. 32(2): p. 332-48. 
112. Ekblom, B., A.N. Goldbarg, and B. Gullbring, Response to exercise after blood loss and 
reinfusion. Journal of applied physiology, 1972. 33(2): p. 175-80. 
113. Ekblom, B., G. Wilson, and P.O. Astrand, Central circulation during exercise after 
venesection and reinfusion of red blood cells. Journal of applied physiology, 1976. 40(3): 
p. 379-83. 
114. Gledhill, N., The influence of altered blood volume and oxygen transport capacity on 
aerobic performance. Exercise and sport sciences reviews, 1985. 13: p. 75-93. 
115. Ahlgrim, C., et al., Are 10 min of seating enough to guarantee stable haemoglobin and 
haematocrit readings for the athlete's biological passport? International journal of 
laboratory hematology, 2010. 32(5): p. 506-11. 
116. Ziegler, A.K., et al., Time course for the recovery of physical performance, blood 
hemoglobin, and ferritin content after blood donation. Transfusion, 2015. 55(4): p. 898-
905. 
117. Van Remoortel, H., et al., The effect of a standard whole blood donation on oxygen uptake 




118. Birnbaum, L., T. Dahl, and T. Boone, Effect of blood donation on maximal oxygen 
consumption. The Journal of sports medicine and physical fitness, 2006. 46(4): p. 535-9. 
119. Hsia, C.C., Respiratory function of hemoglobin. The New England journal of medicine, 
1998. 338(4): p. 239-47. 
120. Convertino, V.A., Blood volume response to physical activity and inactivity. Am J Med 
Sci, 2007. 334(1): p. 72-9. 
121. Mairbaurl, H., Red blood cells in sports: effects of exercise and training on oxygen supply 
by red blood cells. Front Physiol, 2013. 4: p. 332. 
122. Bejder, J., et al., Plasma volume reduction and hematological fluctuations in high-level 
athletes after an increased training load. Scandinavian journal of medicine & science in 
sports, 2017. 
123. Costill, D.L., et al., Alterations in red cell volume following exercise and dehydration. 
Journal of applied physiology, 1974. 37(6): p. 912-6. 
124. Nielsen, B., et al., Human circulatory and thermoregulatory adaptations with heat 
acclimation and exercise in a hot, dry environment. The Journal of physiology, 1993. 
460(1): p. 467-485. 
125. Jimenez, C., et al., Plasma volume changes during and after acute variations of body 
hydration level in humans. European journal of applied physiology and occupational 
physiology, 1999. 80(1): p. 1-8. 
126. Sawna, M.N. and E.F. Coyle, Influence of Body Water and Blood Volume on 
Thermoregulation and Exercise Performance in the Heat. Exercise and sport sciences 
reviews, 1999. 27(1): p. 167-218. 
127. Sanchis-Gomar, F., et al., Current limitations of the Athlete's Biological Passport use in 
sports. Clinical chemistry and laboratory medicine : CCLM / FESCC, 2011. 49(9): p. 
1413-5. 
128. Sawka, M.N. and A.J. Young, Acute Polycythemia and Human Performance During 
Exercise and Exposure to Extreme Environments. Exercise ad Sport Sciences Reviews, 
1989. 17(1): p. 265-294. 
129. Gledhill, N., D. Warburton, and V. Jamnik, Haemoglobin, blood volume, cardiac 
function, and aerobic power. Canadian journal of applied physiology, 1999. 24(1): p. 54-
65. 
130. Schmidt, W. and N. Prommer, Impact of alterations in total hemoglobin mass on VO 
2max. Exercise and sport sciences reviews, 2010. 38(2): p. 68-75. 
131. Schmidt, W. and N. Prommer, The optimised CO-rebreathing method: a new tool to 
determine total haemoglobin mass routinely. European journal of applied physiology, 
2005. 95(5-6): p. 486-95. 
118 
132. Gore, C.J., W.G. Hopkins, and C.M. Burge, Errors of measurement for blood volume 
parameters: a meta-analysis. Journal of applied physiology (Bethesda, Md. : 1985), 
2005. 99(5): p. 1745-58. 
133. Eastwood, A., et al., Stability of hemoglobin mass over 100 days in active men. Journal 
of applied physiology, 2008. 104(4): p. 982-5. 
134. Pottgiesser, T., et al., Hb mass measurement suitable to screen for illicit autologous blood 
transfusions. Medicine and science in sports and exercise, 2007. 39(10): p. 1748-56. 
135. Garvican, L.A., et al., Seasonal variation of haemoglobin mass in internationally 
competitive female road cyclists. European journal of applied physiology, 2010. 109(2): 
p. 221-31. 
136. Schumacher, Y.O., et al., Hemoglobin mass in an elite endurance athlete before, during, 
and after injury-related immobility. Clinical journal of sport medicine : official journal 
of the Canadian Academy of Sport Medicine, 2008. 18(2): p. 172-3. 
137. Eastwood, A., et al., No change in hemoglobin mass after 40 days of physical activity in 
previously untrained adults. Scandinavian journal of medicine & science in sports, 2012. 
22(6): p. 722-8. 
138. Garvican, L., et al., Time course of the hemoglobin mass response to natural altitude 
training in elite endurance cyclists. Scandinavian journal of medicine & science in sports, 
2012. 22(1): p. 95-103. 
139. Morkeberg, J., et al., Detecting autologous blood transfusions: a comparison of three 
passport approaches and four blood markers. Scandinavian journal of medicine & 
science in sports, 2011. 21(2): p. 235-43. 
140. Prommer, N., et al., Total hemoglobin mass--a new parameter to detect blood doping? 
Medicine and science in sports and exercise, 2008. 40(12): p. 2112-8. 
141. Honig, C.R., R.J. Connett, and T.E. Gayeski, O2 transport and its interaction with 
metabolism; a systems view of aerobic capacity. Medicine and science in sports and 
exercise, 1992. 24(1): p. 47-53. 
142. Jubrias, S.A., et al., Large energetic adaptations of elderly muscle to resistance and 
endurance training. Journal of applied physiology (Bethesda, Md. : 1985), 2001. 90(5): 
p. 1663-70. 
143. Hoppeler, H., et al., Endurance training in humans: aerobic capacity and structure of 
skeletal muscle. Journal of applied physiology (Bethesda, Md. : 1985), 1985. 59(2): p. 
320-7. 
144. Ingjer, F., Effects of endurance training on muscle fibre ATP-ase activity, capillary 
supply and mitochondrial content in man. The Journal of physiology, 1979. 294: p. 419-
32. 
145. Gollnick, P.D., et al., Effect of training on enzyme activity and fiber composition of human 




146. Saltin, B., Hemodynamic adaptations to exercise. The American journal of cardiology, 
1985. 55(10): p. 42D-47D. 
147. Brodal, P., F. Ingjer, and L. Hermansen, Capillary supply of skeletal muscle fibers in 
untrained and endurance-trained men. American Journal of Physiology-Heart and 
Circulatory Physiology, 1977. 232(6): p. H705-H712. 
148. Kanstrup, I.L. and B. Ekblom, Acute hypervolemia, cardiac performance, and aerobic 
power during exercise. Journal of applied physiology, 1982. 52(5): p. 1186-1191. 
149. Schmidt, W., et al., Blood volume and hemoglobin mass in endurance athletes from 
moderate altitude. Medicine and science in sports and exercise, 2002. 34(12): p. 1934-
40. 
150. Segura, J., N. Monfort, and R. Ventura, Detection methods for autologous blood doping. 
Drug testing and analysis, 2012. 4(11): p. 876-81. 
151. McCarthy, J.P., et al., Resistance exercise training and the orthostatic response. 
European journal of applied physiology and occupational physiology, 1997. 76(1): p. 32-
40. 
152. Brotherhood, J., B. Brozovic, and L.G. Pugh, Haematological status of middle- and long-
distance runners. Clin Sci Mol Med, 1975. 48(2): p. 139-45. 
153. Hu, M. and W. Lin, Effects of exercise training on red blood cell production: implications 
for anemia. Acta haematologica, 2012. 127(3): p. 156-64. 
154. Berger, N.J., et al., Influence of acute plasma volume expansion on VO2 kinetics, VO2 
peak, and performance during high-intensity cycle exercise. Journal of applied 
physiology (Bethesda, Md. : 1985), 2006. 101(3): p. 707-14. 
155. Warburton, D.E.R., et al., Blood Volume Expansion and Cardiorespiratory Function: 
Effects of Training Modality. Medicine & Science in Sports & Exercise, 2004. 36(6): p. 
991-1000. 
156. Richardson, R., et al., Evidence of a secondary hypervolemia in trained man following 
acute high intensity exercise. International journal of sports medicine, 1996. 17(04): p. 
243-247. 
157. Kanstrup, I.L. and B. Ekblom, Blood volume and Hb concentration as determinants of 
maximal aerobic power. Medicine and science in sports and exercise, 1984. 16: p. 256-
262. 
158. Coyle, E.F., M.K. Hopper, and A.R. Coggan, Maximal oxygen uptake relative to plasma 
volume expansion. International journal of sports medicine, 1990. 11(2): p. 116-9. 
159. Coyle, E.F., M.K. Hemmert, and A.R. Coggan, Effects of detraining on cardiovascular 
responses to exercise: role of blood volume Journal of applied physiology, 1986. 60(1): 
p. 95-99. 
160. Lundby, C., M. Gassmann, and H. Pilegaard, Regular endurance training reduces the 
exercise induced HIF-1alpha and HIF-2alpha mRNA expression in human skeletal 
120 
muscle in normoxic conditions. European journal of applied physiology, 2006. 96(4): p. 
363-9. 
161. Ashenden, M.J., et al., A comparison of the physiological response to simulated altitude 
exposure and r-HuEpo administration. Journal of sports sciences, 2001. 19(11): p. 831-
7. 
162. Milett, G.P. and R. Faiss, Hypoxic conditions and exercise-to-rest ratio are likely 
paramount. Sports medicine (Auckland, N.Z.), 2012. 42(12): p. 1081-1083. 
163. Semenza, G.L., O2-regulated gene expression: transcriptional control of 
cardiorespiratory physiology by HIF-1. Journal of applied physiology, 2004. 96: p. 1173-
1177. 
164. Rusko, H., H. Tikkanen, and J. Peltonen, Altitude and endurance training. Journal of 
sports sciences, 2004. 22(10): p. 928-945. 
165. Levine, B.D. and J. Stray-Gundersen, Dose-response of altitude training: how much 
altitude is enough?, in Hypoxia and Exercise. 2006, Springer. p. 233-247. 
166. Bonetti, D.L. and W.G. Hopkins, Sea-Level Exercise Performance Following Adaptation 
to Hypoxia Sports Medicine 2009. 39: p. 107-127. 
167. McLean, B.D., et al., Physiological and performance responses to a preseason altitude-
training camp in elite team-sport athletes. International journal of sports physiology and 
performance, 2013. 8(4): p. 391-399. 
168. Chapman, R.F., et al., Defining the "dose" of altitude training: how high to live for 
optimal sea level performance enhancement. Journal of applied physiology (Bethesda, 
Md. : 1985), 2014. 116(6): p. 595-603. 
169. Gore, C., et al., Altitude training at 2690m does not increase total Haemoglobin mass or 
sea level V̇O2max in world champion track cyclists. Journal of Science and Medicine in 
Sport, 1998. 1(3): p. 156-170. 
170. Alvarez-Herms, J., et al., Popularity of hypoxic training methods for endurance-based 
professional and amateur athletes. Physiol Behav, 2015. 143: p. 35-8. 
171. Stray-Gundersen, J., R.F. Chapman, and B.D. Levine, “Living high-training low” 
altitude training improves sea level performance in male and female elite runners. 
Journal of applied physiology, 2001. 91: p. 1113-1120. 
172. Humberstone, C.E., Comparison of Live High: Train Low Altitude and Intermittent 
Hypoxic Exposure. Journal of sports science & medicine, 2013. 
173. Garvican-Lewis, L.A., et al., Ten days of simulated live high:train low altitude training 
increases Hbmass in elite water polo players. British journal of sports medicine, 2013. 
47 Suppl 1: p. i70-3. 
174. Garvican, L.A., et al., The contribution of haemoglobin mass to increases in cycling 
performance induced by simulated LHTL. European journal of applied physiology, 2011. 




175. Eaton, J.W., G.J. Brewer, and R.F. Grover, Role of red cell 2, 3-diphosphoglycerate in 
the adaptation of man to altitude. The Journal of laboratory and clinical medicine, 1969. 
73(4): p. 603-609. 
176. Ostojic, S.M., K. Idrizovic, and M.D. Stojanovic, Sublingual nucleotides prolong run 
time to exhaustion in young physically active men. Nutrients, 2013. 5(11): p. 4776-85. 
177. Scopesi, F., et al., Dietary Nucleotide Supplementation Raises Erythrocyte 2,3-
Diphosphoglycerate Concentration in Neonatal Rats. Journal of Nutrition, 1999. 129: p. 
662-665. 
178. Semenza, G.L., Regulation of oxygen homeostasis by hypoxia-inducible factor 1. 
Physiology (Bethesda), 2009. 24: p. 97-106. 
179. Plenge, U., et al., Erythropoietin treatment enhances muscle mitochondrial capacity in 
humans. Front Physiol, 2012. 3: p. 50. 
180. Ninot, G., P. Connes, and C. Caillaud, Effects of recombinant human erythropoietin 
injections on physical self in endurance athletes. Journal of sports sciences, 2006. 24(4): 
p. 383-91. 
181. Reeves, J.T., et al., Oxygen Transport During Exercise at Altitude and the Lactate 
Paradox: Lessons from Operation Everest II and Pikes Peak. Exercise and sport sciences 
reviews, 1992. 20(1): p. 275-296. 
182. Lundby, C., B. Saltin, and G. Van Hall, The ‘lactate paradox’, evidence for a transient 
change in the course of acclimatization to severe hypoxia in lowlanders. Acta 
Physiologica, 2000. 170(4): p. 265-269. 
183. Lundby, C., B. Saltin, and G. van Hall, The 'lactate paradox', evidence for a transient 
change in the course of acclimatization to severe hypoxia in lowlanders. Acta 
physiologica Scandinavica, 2000. 170(4): p. 265-269. 
184. Brooks, G.A., et al., Decreased reliance on lactate during exercise after acclimitisation 
to 4,300 m. Journal of applied physiology, 1991. 71(1): p. 333-341. 
185. Kayser, B., Lactate during exercise at high altitude. European journal of applied 
physiology and occupational physiology, 1996. 74(3): p. 195-205. 
186. Faude, O., W. Kindermann, and T. Meyer, Lactate threshold concepts: how valid are 
they? Sports medicine (Auckland, N.Z.), 2009. 39(6): p. 469-90. 
187. Stallknecht, B., J. Vissing, and H. Galbo, Lactate production and clearance in exercise. 
Effects of training. A minireview. Scandinavian journal of medicine & science in sports, 
1998. 8: p. 127 - 131. 
188. Hochachka, P., et al., Metabolic and work efficiencies during exercise in Andean natives. 
Journal of applied physiology, 1991. 70(4): p. 1720-1730. 
189. Wadley, G., et al., Effect of exercise intensity and hypoxia on skeletal muscle AMPK 
signaling and substrate metabolism in humans. American Journal of Physiology-
Endocrinology and Metabolism, 2006. 290(4): p. E694-E702. 
122 
190. McClelland, G.B., P.W. Hochachka, and J.-M. Weber, Carbohydrate utilization during 
exercise after high-altitude acclimation: a new perspective. Proceedings of the National 
Academy of Sciences, 1998. 95(17): p. 10288-10293. 
191. Butterfield, G.E., et al., Increased energy intake minimizes weight loss in men at high 
altitude. Journal of applied physiology, 1992. 72(5): p. 1741-1748. 
192. Rennie, M.J. and K.D. Tipton, Protein and amino acid metabolism during and after 
exercise and the effects of nutrition. Annual review of nutrition, 2000. 20(1): p. 457-483. 
193. Edwards, L.M., et al., The effect of high-altitude on human skeletal muscle energetics: P-
MRS results from the Caudwell Xtreme Everest expedition. PloS one, 2010. 5(5): p. 
e10681. 
194. Tissot van Patot, M.C., et al., Enhanced leukocyte HIF-1alpha and HIF-1 DNA binding 
in humans after rapid ascent to 4300 m. Free Radic Biol Med, 2009. 46(11): p. 1551-7. 
195. Jefferson, J.A., et al., Increased oxidative stress following acute and chronic high altitude 
exposure. High altitude medicine & biology, 2004. 5(1): p. 61-69. 
196. Mounier, R. and J.V. Brugniaux, Counterpoint: Hypobaric hypoxia does not induce 
different responses from normobaric hypoxia. Journal of applied physiology, 2012. 
112(10): p. 1784-1786. 
197. Pottgiesser, T., et al., Recovery of hemoglobin mass after blood donation. Transfusion, 
2008. 48(7): p. 1390-7. 
198. Judd, T.B., et al., Time course for recovery of peak aerobic power after blood donation. 
Journal of strength and conditioning research / National Strength & Conditioning 
Association, 2011. 25(11): p. 3035-8. 
199. Burnley, M., et al., Influence of blood donation on O2 uptake on-kinetics, peak O2 uptake 
and time to exhaustion during severe-intensity cycle exercise in humans. Experimental 
physiology, 2006. 91(3): p. 499-509. 
200. Gordon, D., et al., Influence of blood donation on oxygen uptake kinetics during moderate 
and heavy intensity cycle exercise. International journal of sports medicine, 2010. 31(5): 
p. 298-303. 
201. Hill, D.W., J.L. Vingren, and S.D. Burdette, Effect of plasma donation and blood 
donation on aerobic and anaerobic responses in exhaustive, severe-intensity exercise. 
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et 
metabolisme, 2013. 38(5): p. 551-7. 
202. Balke, B., et al., Work capacity after blood donation. Journal of applied physiology, 1954. 
7(3): p. 231-8. 
203. Meurrens, J., et al., Effect of Repeated Whole Blood Donations on Aerobic Capacity and 
Hemoglobin Mass in Moderately Trained Male Subjects: A Randomized Controlled Trial. 




204. Rodriguez, F.A., et al., Erythropoietin acute reaction and haematological adaptations to 
short, intermittent hypobaric hypoxia. European journal of applied physiology, 2000. 
82(3): p. 170-7. 
205. Ashenden M, J., et al., Simulated moderate altitude elevates serum erthyropoietin but 
does not increase reticulocyte production in well-trained runners. European journal of 
applied physiology, 2000. 81(5): p. 428-435. 
206. Mazzeo, R.S., Physiological responses to exercise at altitude - An update. Sports 
Medicine, 2008. 38(1): p. 1-8. 
207. Dunn, W.B., et al., Systems level studies of mammalian metabolomes: the roles of mass 
spectrometry and nuclear magnetic resonance spectroscopy. Chemical Society reviews, 
2011. 40(1): p. 387-426. 
208. Palsson, B., The challenges of in silico biology. Nature Biotechnology, 2000. 18: p. 1147-
1150. 
209. D'Alessandro, A., F. Gevi, and L. Zolla, A robust high resolution reversed-phase HPLC 
strategy to investigate various metabolic species in different biological models. 
Molecular bioSystems, 2011. 7(4): p. 1024-32. 
210. Kell, D.B., Systems biology, metabolic modelling and metabolomics in drug discovery 
and development. Drug discovery today, 2006. 11(23-24): p. 1085-92. 
211. Kell, D.B. and S.G. Oliver, Here is the evidence, now what is the hypothesis? The 
complementary roles of inductive and hypothesis-driven science in the post-genomic era. 
BioEssays : news and reviews in molecular, cellular and developmental biology, 2004. 
26(1): p. 99-105. 
212. Creek, D.J., et al., Metabolite identification: are you sure? And how do your peers gauge 
your confidence? Metabolomics, 2014. 10(3): p. 350-353. 
213. Dunn, W.B., et al., Mass appeal: metabolite identification in mass spectrometry-focused 
untargeted metabolomics. Metabolomics, 2012. 9(S1): p. 44-66. 
214. Dunn, W.B., et al., Procedures for large-scale metabolic profiling of serum and plasma 
using gas chromatography and liquid chromatography coupled to mass spectrometry. 
Nat Protoc, 2011. 6(7): p. 1060-83. 
215. Bouatra, S., et al., The human urine metabolome. PloS one, 2013. 8(9): p. e73076. 
216. Trushina, E., et al., Identification of altered metabolic pathways in plasma and CSF in 
mild cognitive impairment and Alzheimer's disease using metabolomics. PloS one, 2013. 
8(5): p. e63644. 
217. Dame, Z.T., et al., The human saliva metabolome. Metabolomics, 2015. 11(6): p. 1864-
1883. 
218. Le Gall, G., et al., Metabolomics of fecal extracts detects altered metabolic activity of gut 
microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res, 2011. 
10(9): p. 4208-18. 
124 
219. Alves, R.D.A.M., et al., Global profiling of the muscle metabolome: method optimization, 
validation and application to determine exercise-induced metabolic effects. 
Metabolomics, 2014. 11(2): p. 271-285. 
220. Vuckovic, D., Current trends and challenges in sample preparation for global 
metabolomics using liquid chromatography-mass spectrometry. Analytical and 
bioanalytical chemistry, 2012. 403(6): p. 1523-48. 
221. Yin, P., R. Lehmann, and G. Xu, Effects of pre-analytical processes on blood samples 
used in metabolomics studies. Analytical and bioanalytical chemistry, 2015. 
222. Stump, C.S., et al., The metabolic syndrome: role of skeletal muscle metabolism. Ann 
Med, 2006. 38(6): p. 389-402. 
223. Wu, H., et al., High-throughput tissue extraction protocol for NMR- and MS-based 
metabolomics. Anal Biochem, 2008. 372(2): p. 204-12. 
224. Lesche, D., et al., Does centrifugation matter? Centrifugal force and spinning time alter 
the plasma metabolome. Metabolomics, 2016. 12(10). 
225. Teahan, O., et al., Impact of analytical bias in metabonomic studies of human blood serum 
and plasma. Anal Chem, 2006. 78(13): p. 4307-18. 
226. Denery, J.R., A.A. Nunes, and T.J. Dickerson, Characterization of differences between 
blood sample matrices in untargeted metabolomics. Anal Chem, 2011. 83(3): p. 1040-7. 
227. Yang, W., et al., Liquid chromatography-tandem mass spectrometry-based plasma 
metabonomics delineate the effect of metabolites' stability on reliability of potential 
biomarkers. Anal Chem, 2013. 85(5): p. 2606-10. 
228. Anton, G., et al., Pre-analytical sample quality: metabolite ratios as an intrinsic marker 
for prolonged room temperature exposure of serum samples. PloS one, 2015. 10(3): p. 
e0121495. 
229. Yin, P. and G. Xu, Current state-of-the-art of nontargeted metabolomics based on liquid 
chromatography-mass spectrometry with special emphasis in clinical applications. 
Journal of chromatography. A, 2014. 1374: p. 1-13. 
230. Rico, E., et al., Evaluation of human plasma sample preparation protocols for untargeted 
metabolic profiles analyzed by UHPLC-ESI-TOF-MS. Analytical and bioanalytical 
chemistry, 2014. 406(29): p. 7641-52. 
231. Bang, D.Y., S.K. Byeon, and M.H. Moon, Rapid and simple extraction of lipids from 
blood plasma and urine for liquid chromatography-tandem mass spectrometry. Journal 
of chromatography. A, 2014. 1331: p. 19-26. 
232. Edmands, W.M., P. Ferrari, and A. Scalbert, Normalization to specific gravity prior to 
analysis improves information recovery from high resolution mass spectrometry 




233. Dieterle, F., et al., Probabilistic Quotient Normalization as Robust Method to Account 
for Dilution of Complex Biological Mixtures. Application in 1H NMR Metaboonomics. 
Analytical chemistry, 2006. 78: p. 4281-4290. 
234. Kemperman, R.F., et al., Comparative urine analysis by liquid chromatography-mass 
spectrometry and multivariate statistics: method development, evaluation, and 
application to proteinuria. J Proteome Res, 2007. 6(1): p. 194-206. 
235. Bollard, M.E., et al., NMR-based metabonomic approaches for evaluating physiological 
influences on biofluid composition. NMR Biomed, 2005. 18(3): p. 143-62. 
236. Wishart, D.S., et al., HMDB 3.0--The Human Metabolome Database in 2013. Nucleic 
acids research, 2013. 41(Database issue): p. D801-7. 
237. Lenz, E.M. and I.D. Wilson, Analytical strategies in metabonomics. J Proteome Res, 
2007. 6(2): p. 443-58. 
238. Psychogios, N., et al., The human serum metabolome. PloS one, 2011. 6(2): p. e16957. 
239. Moco, S., et al., Metabolomics technologies and metabolite identification. TrAC Trends 
in Analytical Chemistry, 2007. 26(9): p. 855-866. 
240. Mamas, M., et al., The role of metabolites and metabolomics in clinically applicable 
biomarkers of disease. Arch Toxicol, 2011. 85(1): p. 5-17. 
241. Emwas, A.H., The strengths and weaknesses of NMR spectroscopy and mass 
spectrometry with particular focus on metabolomics research. Methods in molecular 
biology (Clifton, N.J.), 2015. 1277: p. 161-93. 
242. Bathen, T.F., et al., MR-determined metabolic phenotype of breast cancer in prediction 
of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat, 2007. 104(2): 
p. 181-9. 
243. Dona, A.C., et al., A guide to the identification of metabolites in NMR-based 
metabonomics/metabolomics experiments. Computational and Structural Biotechnology 
Journal, 2016. 
244. Gummer, J., et al., Use of mass spectrometry for metabolite profiling and metabolmics. 
Australian Biochemist, 2009. 40(3): p. 5-16. 
245. Novotny, M.V., H.A. Soini, and Y. Mechref, Biochemical individuality reflected in 
chromatographic, electrophoretic and mass-spectrometric profiles. Journal of 
Chromatography B, 2008. 866(1-2): p. 26-47. 
246. Heaney, L.M., K. Deighton, and T. Suzuki, Non-targeted metabolomics in sport and 
exercise science. Journal of sports sciences, 2017: p. 1-9. 
247. Dunn, W.B., et al., The importance of experimental design and QC samples in large-
scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis, 2012. 
4(18): p. 2249-64. 
126 
248. Theodoridis, G., H.G. Gika, and I.D. Wilson, Mass spectrometry-based holistic 
analytical approaches for metabolite profiling in systems biology studies. Mass Spectrom 
Rev, 2011. 30(5): p. 884-906. 
249. Creek, D.J., et al., Toward global metabolomics analysis with hydrophilic interaction 
liquid chromatography-mass spectrometry: improved metabolite identification by 
retention time prediction. Anal Chem, 2011. 83(22): p. 8703-10. 
250. Zelena, E., W.B. Dunn, and D.I. Broadhurst, Develepment of a Robust and Repeatable 
UPLC-MS Method for Long-Term Metabolomic Study of Human Serum. Anal Chem, 
2009. 81: p. 1357 - 1364. 
251. van den Berg, R.A., et al., Centering, scaling, and transformations: improving the 
biological information content of metabolomics data. BMC Genomics, 2006. 7: p. 142. 
252. Begley, P., et al., Development and performance of a gas chromatography-time-of-flight 
mass spectrometry analysis for large-scale nontargeted metabolomic studies of human 
serum. Anal Chem, 2009. 81(16): p. 7038-46. 
253. Xia, J., et al., Translational biomarker discovery in clinical metabolomics: an 
introductory tutorial. Metabolomics, 2013. 9(2): p. 280-299. 
254. Broadhurst, D.I. and D.B. Kell, Statistical strategies for avoiding false discoveries in 
metabolomics and related experiments. Metabolomics, 2006. 2(4): p. 171-196. 
255. Goodacre, R., et al., Proposed minimum reporting standards for data analysis in 
metabolomics. Metabolomics, 2007. 3(3): p. 231-241. 
256. Eriksson, L., et al., Multi- and Megavariate Data Analysis, Basic Principles and 
Applications, M.U. AB, Editor. 2013: Malmo, Sweden. 
257. Westerhuis, J.A., et al., Multivariate paired data analysis: multilevel PLSDA versus 
OPLSDA. Metabolomics, 2010. 6(1): p. 119-128. 
258. Gromski, P.S., et al., A tutorial review: Metabolomics and partial least squares-
discriminant analysis--a marriage of convenience or a shotgun wedding. Anal Chim 
Acta, 2015. 879: p. 10-23. 
259. Gerber, T., et al., High-intensity intermittent cycling increases purine loss compared with 
workload-matched continuous moderate intensity cycling. European journal of applied 
physiology, 2014. 114(7): p. 1513-20. 
260. Danaher, J., et al., The use of metabolomics to monitor simultaneous changes in metabolic 
variables following supramaximal low volume high intensity exercise. Metabolomics, 
2015. 12(1). 
261. Pechlivanis, A., et al., 1H NMR-Based Matabonomic Investigation of the Effect of Two 
Different Exercise Sessions on the Metabolic Fingerprint of the Human Urine. Journal of 




262. Pechlivanis, A., et al., 1H NMR study on the short- and long-term impact of two training 
programs of sprint running on the metabolic fingerprint of human serum. J Proteome Res, 
2013. 12(1): p. 470-80. 
263. Nieman, D.C., et al., Serum metabolic signatures induced by a three-day intensified 
exercise period persist after 14 h of recovery in runners. J Proteome Res, 2013. 12(10): 
p. 4577-84. 
264. Nieman, D.C., et al., Metabolomics approach to assessing plasma 13- and 9-hydroxy-
octadecadienoic acid and linoleic acid metabolite responses to 75-km cycling. American 
journal of physiology. Regulatory, integrative and comparative physiology, 2014. 307(1): 
p. R68-74. 
265. Lustgarten, M.S., et al., Identification of serum analytes and metabolites associated with 
aerobic capacity. European journal of applied physiology, 2013. 113(5): p. 1311-20. 
266. Tesch, P.A., E.B. Colliander, and P. Kaiser, Muscle metabolism during intense, heavy-
resistance exercise. European journal of applied physiology and occupational 
physiology, 1986. 55(4): p. 362-6. 
267. Blair, S.N., et al., Physical fitness and all-cause mortality. A prospective study of healthy 
men and women. JAMA : the journal of the American Medical Association, 1989. 
262(17): p. 2395-401. 
268. Muhsen Ali, A., et al., Metabolomic Profiling of Submaximal Exercise at a Standardised 
Relative Intensity in Healthy Adults. Metabolites, 2016. 6(1). 
269. Lou, B.S., et al., Effects of acute systematic hypoxia on human urinary metabolites using 
LC-MS-based metabolomics. High altitude medicine & biology, 2014. 15(2): p. 192-202. 
270. D'Alessandro, A., et al., AltitudeOmics: Red Blood Cell metabolic adaptation to high 
altitude hypoxia. J Proteome Res, 2016. 
271. Dudzik, D., et al., Quality assurance procedures for mass spectrometry untargeted 
metabolomics. a review. J Pharm Biomed Anal, 2018. 147: p. 149-173. 
272. Dunn, W.B., et al., Quality assurance and quality control processes: summary of a 
metabolomics community questionnaire. Metabolomics, 2017. 13(5). 
273. Bartsch, P. and B. Saltin, General introduction to altitude adaptation and mountain 
sickness. Scandinavian journal of medicine & science in sports, 2008. 18 Suppl 1: p. 1-
10. 
274. Gore, C.J., et al., Altitude training at 2690m does not increase total haemoglobin mass 
or sea level VO2max in world champion track cyclists. Journal of science and medicine 
in sport / Sports Medicine Australia, 1998. 1(3): p. 156-70. 
275. Gore, C.J., et al., Live high:train low increases muscle buffer capacity and submaximal 
cycling efficiency. Acta physiologica Scandinavica, 2001. 173(3): p. 275-86. 
128 
276. McLean, B.D., C.J. Gore, and J. Kemp, Application of 'live low-train high' for enhancing 
normoxic exercise performance in team sport athletes. Sports medicine (Auckland, N.Z.), 
2014. 44(9): p. 1275-87. 
277. Peeling, P., et al., Effect of iron injections on aerobic-exercise performance of iron-
depleted female athletes. International journal of sport nutrition and exercise metabolism, 
2007. 17(3): p. 221-31. 
278. Bligh, E.G. and W.J. Dyer, A rapid method of total lipid extraction and purification. 
Canadian journal of biochemistry and physiology, 1959. 37(8): p. 911-917. 
279. Chambers, M.C., et al., A cross-platform toolkit for mass spectrometry and proteomics. 
Nature biotechnology, 2012. 30(10): p. 918-920. 
280. Smith, C.A., et al., XCMS: Processing mass spectrometry data for metabolite profiling 
using Nonlinear peak alignment, matching, and identification. Analytical Chemistry, 
2006. 78(3): p. 779-787. 
281. Kirwan, J.A., et al., Characterising and correcting batch variation in an automated direct 
infusion mass spectrometry (DIMS) metabolomics workflow. Analytical and bioanalytical 
chemistry, 2013. 405(15): p. 5147-57. 
282. Sumner, L.W., et al., Proposed minimum reporting standards for chemical analysis 
Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). 
Metabolomics, 2007. 3(3): p. 211-221. 
283. Speed, T., Statistical analysis of gene expression microarray data. 2003: CRC Press. 
284. Storey, J.D. and R. Tibshirani, Statistical significance for genomewide studies. 
Proceedings of the National Academy of Sciences of the United States of America, 2003. 
100(16): p. 9440-5. 
285. Principles of multivariate analysis: a user's perspective, ed. W.J. Krzanowski. 1988: 
Oxford University Press, Inc. 
286. Reynafarje, C., et al., Humoral Control of Erythropoietic Activity in Man During and 
After Altitude Exposure.∗. Proceedings of the Society for experimental Biology and 
Medicine, 1964. 116(3): p. 649-650. 
287. Holden, J.E., et al., Enhanced cardiac metabolism of plasma glucose in high-altitude 
natives: adaption against chronic hypoxia. Journal of applied physiology, 1995. 79(1): 
p. 222-228. 
288. Horsecroft, J. and A.J. Murray, Skeletal muscle energy metabolism in environmental 
hypoxia: climbing towards consensus. Extreme Physiology Medicine, 2014. 3(19). 
289. Eckardt, K.U., A. Kurtz, and C. Bauer, Triggering of erythropoietin production by 
hypoxia is inhibited by respiratory and metabolic acidosis. American Journal of 
physiology., 1990. 258: p. 678-683. 
290. Ely, B.R., et al., Heat acclimation and cross tolerance to hypoxia: Bridging the gap 




291. Pottgiesser, T., et al., Short-term hematological effects upon completion of a four-week 
simulated altitude camp. International journal of sports physiology and performance, 
2012. 7(1): p. 79-83. 
292. Brien, A.J. and T.L. Simon, The effects of red blood cell infusion on 10-km race time. 
JAMA : the journal of the American Medical Association, 1987. 257(20): p. 2761-5. 
293. Pottgiesser, T., et al., Post-transfusion stability of haemoglobin mass. Vox sanguinis, 
2009. 96(2): p. 119-27. 
294. Panebianco, R.A., et al., Effects of blood donation on exercise performance in competitive 
cyclists. American heart journal, 1995. 130(4): p. 838-40. 
295. Ekblom, B. and R. Huot, Response to submaximal and maximal exercise at different 
levels of carboxyhemoglobin. Acta physiologica Scandinavica, 1972. 86(4): p. 474-82. 
296. de Alcantara Santos, R., et al., Caffeine Alters Anaerobic Distribution and Pacing during 
a 4000-m Cycling Time Trial. PloS one, 2013. 8(9). 
297. Corbett, J., et al., Influence of competition on performance and pacing during cycling 
exercise. Medicine and science in sports and exercise, 2012. 44(3): p. 509-15. 
298. Borg, G.A., Psychophysical bases of perceived exertion. Medicine and science in sports 
and exercise, 1982. 14(5): p. 377-81. 
299. Abbiss, C.R., et al., Effect of carbohydrate ingestion and ambient temperature on muscle 
fatigue development in endurance-trained male cyclists. Journal of applied physiology 
(Bethesda, Md. : 1985), 2008. 104(4): p. 1021-8. 
300. Garby, L. and A. Astrup, The relationship between the respiratory quotient and the 
energy equivalent of oxygen during simultaneous glucose and lipid oxidation and 
lipogenesis. Acta physiologica Scandinavica, 1987. 129(3): p. 443-4. 
301. Hopker, J.G., D.A. Coleman, and J.D. Wiles, Differences in efficiency between trained 
and recreational cyclists. Applied physiology, nutrition, and metabolism = Physiologie 
appliquee, nutrition et metabolisme, 2007. 32(6): p. 1036-42. 
302. Hopkins, W.G., Linear models and effect magnitudes for research, clinical and practical 
applications. Sportscience, 2010. 14(1): p. 49-57. 
303. Hopkins, W.G., Measures of reliability in sports medicine and science. Sports medicine 
(Auckland, N.Z.), 2000. 30(1): p. 1-15. 
304. Krip, B., et al., Effect of alterations in blood volume on cardiac function during maximal 
exercise. Medicine and science in sports and exercise, 1997. 29(11): p. 1469-76. 
305. Aisbett, B., et al., Influence of all-out and fast start on 5-min cycling time trial 
performance. Medicine and science in sports and exercise, 2009. 41(10): p. 1965-71. 
306. de Koning, J.J., M.F. Bobbert, and C. Foster, Determination of optimal pacing strategy 
in track cycling with an energy flow model. Journal of science and medicine in sport / 
Sports Medicine Australia, 1999. 2(3): p. 266-77. 
130 
307. Nikolic, S.B., et al., Metabolomics in hypertension. Journal of hypertension, 2014. 32(6): 
p. 1159-69. 
308. Xiao, Q., et al., Habitual sleep and human plasma metabolomics. Metabolomics, 2017. 
13(5). 
309. Brugnara, L., et al., Metabolomics approach for analyzing the effects of exercise in 
subjects with type 1 diabetes mellitus. PloS one, 2012. 7(7): p. e40600. 
310. Global Report: World Blood Donor Day 2016, World Health Organisation: The 
Netherlands. 
311. Lawler, N.G., et al., Blood Removal Influences Pacing During a 4-Minute Cycling Time 
Trial. International journal of sports physiology and performance, 2017: p. 1-25. 
312. Squires, R.W. and E.R. Buskirk, Aerobic capacity during acute exposure to simulated 
altitude, 914 to 2286 meters. Medicine and science in sports and exercise, 1982. 14(1): 
p. 36-40. 
313. Benesch, R. and R.E. Benesch, Intracellular Organic Phosphates as Regulators of 
Oxygen Release by Haemoglobin. Nature, 1969. 221: p. 618-622. 
314. Walsh, M.C., et al., Effect of acute dietary standardization on the urinary, plasma, and 
salivary metabolomic profiles of healthy humans. Am J Clin Nutr, 2006. 84(3): p. 531-9. 
315. Chorell, E., et al., Physical fitness level is reflected by alterations in the human plasma 
metabolome. Molecular bioSystems, 2012. 8(4): p. 1187-96. 
316. Kirwan, G.M., et al., Spectroscopic correlation analysis of NMR-based metabonomics in 
exercise science. Anal Chim Acta, 2009. 652(1-2): p. 173-9. 
317. Miccheli, A., et al., The Influence of a Sports Drink on the Postexercise Metabolism of 
Elite Athletes as Investigated by NMR-Based Metabolomics. Journal of the American 
College of Nutrition, 2009. 28(5): p. 553-564. 
318. Chorell, E., et al., Predictive metabolomics evaluation of nutrition-modulated metabolic 
stress responses in human blood serum during the early recovery phase of strenuous 
physical exercise. J Proteome Res, 2009. 8(6): p. 2966-77. 
319. Silva-Cavalcante, M.D., et al., Caffeine increases anaerobic work and restores cycling 
performance following a protocol designed to lower endogenous carbohydrate 
availability. PloS one, 2013. 8(8): p. e72025. 
320. Scott, B.R., P.S. Goods, and K.M. Slattery, High-Intensity Exercise in Hypoxia: Is 
Increased Reliance on Anaerobic Metabolism Important? Front Physiol, 2016. 7: p. 637. 
321. Mollard, P., et al., Role of Maximal Heart Rate and Arterial O2 Saturation on the 
Decrement of V· O2max in Moderate Acute Hypoxia in Trained and Untrained Men. 
International journal of sports medicine, 2007. 28(03): p. 186-192. 
322. Woorons, X., et al., Moderate exercise in hypoxia induces a greater arterial desaturation 
in trained than untrained men. Scandinavian journal of medicine & science in sports, 




323. Lorenz, D.S., et al., What performance characteristics determine elite versus nonelite 
athletes in the same sport? Sports Health, 2013. 5(6): p. 542-7. 
324. Hopkins, W.G., J.A. Hawley, and L.M. Burke, Design and analysis of research on sport 
performance enhancement. Medicine and science in sports and exercise, 1999. 31(3): p. 
472-85. 
325. El-Chab, A., C. Simpson, and H. Lightowler, The reproducibility of a diet using three 
different dietary standardisation techniques in athletes. Eur J Clin Nutr, 2016. 70(8): p. 
954-8. 
326. Sottas, P.E., et al., The athlete biological passport. Clin Chem, 2011. 57(7): p. 969-76. 
327. Sanchis-Gomar, F., et al., Altitude exposure in sports: the Athlete Biological Passport 












Appendix B Additional publications 
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K.G., Peiffer J.J., Gore C.J., Garvican-Lewis L.A. (2016). 
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Appendix B represents a separate study conducted in the same study population as in Chapter 
Three to investigate high-intensity interval exercise influences iron metabolism (i.e. hepcidin) in 
endurance athletes undertaking 14 d moderate altitude exposure. The primary analysis was 
conducted by Dr Govus, but significant contribution in regard to the experimental procedures and 
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